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Abstract
Radiotherapy is currently one of the most important treatment methods used in cancer treat-
ment. Its aim is to deliver prescribed dose to the target volume while sparing healthy tissues.
In order to reach this aim radiotherapy treatment should be applied in as precise manner as
possible. Therefore patients setup uncertainties and their influence on the dose received during
radiotherapy course was a subject of many research done through last decades. Studies at that
time based on limited amount of information. Nowadays, technological progress in radiotherapy
treatment allows to collect setup data during entire course of treatment. Analysis of such a big
data are still lacking.
In presented work two sets of clinical data were analyzed. First group consisted of 100
patients treated in Maria Sklodowska-Curie Institute — Oncology Center in Warsaw (Poland),
second group consisted of 835 patients treated in Erasmus MC University Medical Center Rot-
terdam (Netherlands). Both groups included data of setup errors for prostate cancer patients.
The difference was in number of fractions received during entire treatment and methods used
to detect setup errors (bony anatomy or gold markers).
The statistical analysis of the data collected for both populations showed that they were
not normally distributed. Presence of inter-fraction time trends was investigated as one of
possible reasons of non-normal distribution of setup errors. As in limited fraction treatment
some trends can always be detected, the method to distinguish physiological trends (i.e. related
to patient physiology and anatomy) from these which can be attributed to limited number of
measurements was proposed.
The presented studies were done on two previously mentioned clinical datasets as well as
on many different datasets with artificial setup errors mimicking the natural patients behav-
ior — so called synthetic populations. Those synthetic populations were created in order to
cover wide range of clinically relevant population parameters. Current methods of dealing
with setup errors and incorporating this knowledge into the treatment planning and delivery
process are mostly based on population parametrizations and concept of cumulative dose. In
this work a parametrization taking into account time trends was investigated and compared
with the conventional one, most often used in the clinical practice. It was shown that a wrong
parametrization used to describe population of patients setup errors may lead to the under-
estimation of CTV-PTV margins. The investigated parametrization may be further used in
margin-less planning.
In the presented work, apart from investigating alternative parametrization method, a pos-
sibility of estimating patient specific cumulative dose was examined. That methodology can be
further used for individualization of margin-less planning algorithms.
One of the methods to deal with setup errors and uncertainties is to apply off-line and on-
line verification protocols. Offline verification protocols require less workload. Still it is known
from clinical practice that some patients will require an on-line verification. The mostly applied
No Action Level protocol efficiency is related to mean setup error estimation. A modification
of this protocol was proposed in order to provide an easy method to distinguish patients who
require more attention (i.e. more fractions with imaging). The modified protocol does not
require additional workload in terms of average number of fractions with imaging. Instead of
doing imaging in the same number of fractions for each patient, the fractions with imaging are
not-equally spread within the population of patients.
Although off-line verification protocols may reduce the systematic errors, some residual
errors will always be present. To ensure a proper irradiation of the target some margin is added
to it during the treatment planning process. Currently the most applied margin recipes are
based on conventional parametrization. That is why it does not take into account inter-fraction
time trends. As existence of this trends was shown during population data analysis, the new
recipe for margin calculation was provided. In limit of no time trends this new recipe simplifies
to currently used one.
Keywords:
radiotherapy, setup errors, cumulative dose, verification protocols, CTV-PTV margins, time
trends, Monte Carlo simulations
Streszczenie
Radioterapia jest obecnie jedną z najważniejszych metod leczenia nowotworów. Jej celem jest
dostarczenie przepisanej dawki do obszaru tarczowego przy jednoczesnym zminimalizowaniu
dawki w tkankach zdrowych. Aby osiągnąć ten cel radioterapia powinna być przeprowadzana jak
najbardziej precyzyjnie. Z tego powodu niepewności ułożenia pacjentów i ich wpływ na dawki
dostarczone w trakcie kursu radioterapii były przedmiotem wielu badań w czasie minionych
dekad. Ówczesne badania bazowały na ograniczonej liczbie danych. Postęp technologiczny
w radioterapii umożliwia obecnie zbieranie danych dotyczących niepewności ułożenia pacjenta
podczas całego procesu leczenia. Ciągle jednak nieliczne są badania analizujące takie dane.
W prezentowanej pracy przeprowadzono analizę dwóch zbiorów danych klinicznych. Pierw-
szą grupę stanowiło 100 pacjentów leczonych w Centrum Onkologii — Instytucie im. Marii
Skłodowskiej-Curie w Warszawie (Polska), drugą grupę stanowiło 835 pacjentów leczonych
w szpitalu uniwersyteckim Erasmus MC w Rotterdamie (Holandia). Obie grupy zawierały dane
dotyczące niepewności ułożenia pacjentów leczonych z powodu nowotworu prostaty. Grupy róż-
niły się liczbą frakcji radioterapii jaka składała się na kurs leczenia a także metodami użytymi
do oceny niepewności ułożenia (struktury kostne i znaczniki złota).
Statystyczna analiza danych zebranych dla obu populacji pokazała, iż nie zawsze podle-
gają one rozkładowi normalnemu. Obecność trendów czasowych pomiędzy frakcjami leczenia
była badana jako jedna z potencjalnych przyczyn znalezionych rozbieżności w stosunku do roz-
kładów normalnych. w przypadku skończonej liczby frakcji pewien trend czasowy może być
zawsze znaleziony, dlatego opracowano metodę rozróżniania trendów fizjologicznych (tj. zwią-
zanych z fizjologią i anatomią pacjenta) od tych, które mogą być wyjaśnione skończoną liczbą
pomiarów. Prezentowane w pracy badania przeprowadzono na dwóch, wspomnianych wcześniej,
klinicznych bazach danych niepewności ułożeń pacjentów, a także na licznych innych bazach
danych ze sztucznie generowanymi niepewnościami ułożenia pacjentów odzwierciedlającymi ich
naturalne zachowanie — tzw. populacjach syntetycznych. Te syntetyczne populacje zostały
wygenerowane w taki sposób by pokryć jak największy zakres klinicznie istotnych parametrów.
Obecne metody uwzględniania niepewności ułożenia pacjentów w procesie planowania i re-
alizacji radioterapii bazują przede wszystkim na parametryzacji populacji pacjentów i koncepcji
dawki skumulowanej. W prezentowanej pracy parametryzacja populacji uwzględniająca trendy
czasowe została przebadana i porównana z konwencjonalną parametryzacją, najczęściej wy-
korzystywaną w praktyce klinicznej. Zostało pokazane, że niewłaściwy dobór parametryzacji
użytej do opisu populacji niepewności ułożenia pacjentów może prowadzić do zbyt małych
marginesów CTV-PTV. W prezentowanej pracy, poza zaproponowaniem alternatywnej para-
metryzacji, zbadano możliwości estymowania skumulowanej dawki dla pojedynczego pacjenta.
Zaproponowana metodologia, a w szczególności badana parametryzacja, może zostać w przy-
szłości użyta w zindywidualizowanej wersji algorytmów planowania bez marginesów.
Jedną z metod minimalizowania niepewności ułożenia pacjentów jest stosowanie protokołów
weryfikacji off-line i on-line. Protokoły weryfikacji off-line wymagają mniejszego nakładu pracy.
Wiadomo jednak z praktyki klinicznej, że niektórzy pacjenci będą wymagali zastosowania wery-
fikacji on-line. Szeroko stosowany protokół weryfikacji „No Action Level” opiera się na estymacie
średniej niepewności ułożenia pacjenta. W niniejszej pracy została zaproponowana modyfikacja
tego protokołu umożliwiająca rozróżnienie pacjentów wymagających większej uwagi (tj. więk-
szej liczby frakcji z obrazowaniem). Zmodyfikowany protokół nie wymaga zwiększonego nakładu
pracy rozumianego jako średnia ilość frakcji z obrazowaniem w populacji pacjentów. Wykonywa-
nie obrazowania w tej samej liczbie frakcji u wszystkich pacjentów zastąpiono w proponowanej
metodzie nierównomierną dystrybucją frakcji z obrazowaniem w populacji pacjentów.
Protokoły weryfikacji off-line mają za zadanie zmniejszenie niepewności systematycznych
jednak pewne niepewności rezydualne zawsze będą obecne. Aby zapewnić prawidłowe napro-
mienienie obszaru tarczowego pewien margines jest dodawany do niego w trakcie procesu plano-
wania radioterapii. Obecnie najczęściej używana metoda wyznaczania wielkości tego marginesu
opiera się na klasycznej parametryzacji. W konsekwencji nie są w niej uwzględnione między-
frakcyjne trendy czasowe, których obecność została wykazana w trakcie statystycznej analizy
danych klinicznych. W prezentowanej pracy została zaproponowana nowa formuła oblicza-
nia marginesu, uwzględniająca trendy czasowe. W granicy braku tych trendów prezentowana
formuła uprasza się do obecnie stosowanej.
Słowa kluczowe:
radioterapia, niepewność ułożenia, dawka skumulowana, protokoły weryfikacji, marginesy CTV-
PTV, trendy czasowe, symulacje Monte Carlo
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Chapter 1
Introduction
Question about life, its borders, and sense of suffering is present in human life since thousands
of years, though nowadays that discussion seems to be a bit different. It is hard to argue
that a particular person would like to live as long as possible while being in good and healthy
condition [22]. Most of us know someone in their family or at least in close relations who got
cancer. As cancer is one of most frequent reasons of death [45], being diagnosed with a cancer is
often taken as a sentence. That is why so much effort is taken to find out the best cure. Many
different types of treatment, such as surgery, chemotherapy, radiotherapy, hormonotherapy and
immunotherapy are possible.
Surgery may seem to be the best option as one gets rid of the cancer at all, but it cannot be
always performed (e.g. due to the cancer site and/or patient general health state). Moreover,
sometimes surgery ends up with a positive margin (carcinogenic cells are found in the material
removed from body). That is why in many cases after surgery further additional treatment is
required.
Chemotherapy bases on a strong drugs treatment which can stop cell divisions, slow down
their growth and lead to death of cancer cells diffused other the body. Therefore it seems to be
a good method, especially for patients with higher cancer stage and metastases in lymph nodes.
Chemotherapy influences also normal cells. That is why it often leads to stop hair growth.
Radiotherapy uses radiation in order to treat cancer. The source of radiation can be inside
the patient (brachytherapy) or outside the patient (External Beam RadioTherapy (EBRT) also
called teletherapy). Radiation can cause DNA damage and therefore may lead to cell death. It
is impossible to irradiate only the target volume, so there is always a probability of side effects.
Usually the radiotherapy is performed for well localized cancers. However, there are procedures
like Total Body Irradiation (TBI) in which the whole body is irradiated.
Hormonotherapy is based on the fact that growth and extent on many cancers is related to
hormones existence. That is why cancer can sometimes be cured or, more often, stopped or
slowed down by hormones. Hormonotherapy is often a part of combined treatment.
The aim of immunotherapy is to modulate the immune system to force it to fight cancer.
One of the ideas is to identify antigens present on cancer cells and create antibody for that
particular antigen.
The choice of treatment, in general, depends on the stage and type of cancer, its place in
body and patient general health. There are many protocols on how to treat each cancer site.
One can easily find recommendations given for example by Polish Society of Clinical Oncology
(PTOK – Polskie Towarzystwo Onkologii Klinicznej ) [44], American Society for Clinical Oncol-
ogy (ASCO) [69] or European Organisation for Research and Treatment of Cancer (EORTC)
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[26]. A combined treatment is often performed. Decision on treatment type should be made
by a multidisciplinary group. The patient preference should also be taken into consideration.
Each type of treatment mentioned above should be applied in a manner as precise as pos-
sible. Still, there may appear some errors which may influence the outcome of the treatment.
Therefore they should be taken into account and minimized.
In the thesis presented here I studied patient setup error during EBRT and its influence on
the doses received during irradiation. As I will concentrate only on EBRT, in the remainder of
the Thesis the "radiotherapy" term would be used to describe it.
1.1 Radiotherapy Process
The aim of radiotherapy is to deliver high, usually uniform dose to the target volume while
sparing surrounding healthy tissues. In order to do that one has to choose patient position
on treatment couch — for example whether the patient should lie in prone or supine position.
During the patient preparation it should be decided if any support, like knee wedge, vacuum
bag or mask, should be used [10, 50, 64, 66, 68, 77, 81, 86]. After patient position is established
the Computed Tomography (CT) scan is performed. In the case of cancer localized in pelvis
region protocols of bladder fulfillment or rectum purification are often applied prior to CT
scan. After CT scans are performed, physicians and/or radiographers have to delineate target
volumes and organs at risk (OARs). The CT scans prepared in such a way are then used in
Treatment Planning System (TPS) in order to choose treatment parameters and calculate dose
distribution. After the treatment plan is completed and accepted by a physician the irradiation
may start.
1.2 Imaging during radiotherapy
During radiotherapy we have to deal with many sources of uncertainties and errors. Much
effort is taken to minimize the uncertainty of not delivering the right amount of dose into the
right volume. One of the most widely applied methods is to check the patient position (setup)
which should be as similar as possible to the position during the CT scan used for planning
radiotherapy. That is why modern medical accelerators (often called linacs) are equipped with
imaging systems which can be used to check and monitor patient position. The easiest way is to
use megavolt (MV) beam for patient positioning (see Fig. 1.1). In that case linac should have
the flat panel detector for MV imaging. Another solution is to use an additional classical X-ray
tube lamp, this is called the kilovolt (kV) imaging and also requires dedicated flat panel (see
Fig. 1.2). As the energy used in kV imaging is much lower than in MV imaging the contrast of
obtained setup images is better (see Fig. 1.3).
Despite the fact which modality (kV or MV) is used, the image have to be compared with a
reference image in order to define the patient setup error. Usually these reference image would
be generated from the CT and therefore would be called Digitally Reconstructed Radiograph
(DRR).
Additionally some linacs have a possibility of acquiring the so called Cone-Beam CT (CBCT)
which is claimed to be a better choice at least for some treatment sites [56]. In that case a 3D
volume comparison is done between CBCT and planning CT (see Fig. 1.4b).
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Figure 1.1: Photography of the MV imaging system in use. The radiation beam goes from the
linear accelerator itself (accelerator head is seen on the left), crosses the patient (here anthropo-
morphic phantom) and is detected by a flat panel (on the right). Attenuation coefficients over
the whole beam path are measured. Photography was taken in the Maria Sklodowska-Curie
Institute — Oncology Center in Warsaw.
Figure 1.2: Photography of the kV imaging system in use. The radiation beam goes from the
X-ray tube (on the left), crosses the patient (here anthropomorphic phantom) and is detected
by a flat panel (on the right). Attenuation coefficients over the whole beam path are measured.
Photography was taken in the Maria Sklodowska-Curie Institute — Oncology Center in Warsaw.
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(a) Anterior kV image (b) Anterior MV image
(c) Lateral kV image (d) Lateral MV image
Figure 1.3: Comparison of kV (on left) and MV (on right) imaging done for anthropomorphic
phantom (see Fig. 1.1-1.2). Upper images show anterior-posterior imaging, lower images show
left-right imaging. Scans were taken in the Maria Sklodowska-Curie Institute — Oncology
Center in Warsaw.
1.3 Individualization 5
(a) Planning CT (b) CBCT aquired prior to treatment
Figure 1.4: Comparison between planning CT and CBCT. Structures seen on planning CT are:
yellow – CTV, red – PTV, green – rectum. Scans were taken in the Maria Sklodowska-Curie
Institute — Oncology Center in Warsaw.
1.3 Individualization
European SocieTy of Radiotherapy and Oncology (ESTRO) wrote in its vision 2020: "Every
cancer patient in Europe will have access to state-of-the-art radiation therapy as part of a mul-
tidisciplinary approach where treatment is individualized for the specific patients cancer, taking
account of the patient’s personal circumstances." These circumstances are related among other
things to prescribed dose, dose fractionation and dose distribution [46]. Due to the fact that
each patient has different setup errors we can think of individualization of treatment execution.
One of the approaches is Adaptive RadioTherapy (ART) [24, 96]. Another approach is plan
of the day [31, 41]. Also new treatment planning concepts are investigated like probability
planning or margin-less planning [5, 27, 28]. The aim of individualization during radiotherapy
process is to decrease volume of normal tissues receiving high dose with the dose in target
remaining the same.
1.4 Research hypothesis and aim
The influence of patients setup errors on the doses received by them during radiotherapy was
widely analyzed by different groups [4, 7, 11, 12, 15, 90, 89]. These studies concerned cumulative
dose distribution, verification protocols and CTV-PTV margin concepts. In most of these
studies it was assumed that setup errors have Gaussian distribution. In the presented thesis
that assumption was checked in two different sets of clinical data. Influence of these findings
on previously mentioned concepts was investigated. Propositions were made how to overcome
the issues found.
As mentioned in Section 1.3 there is much effort done nowadays in order to individualize
radiotherapy treatment. These methods often require much workload — like imaging done
everyday with on-line registration. This requires additional time on a machine and people
resources to perform such procedures. It is also important to mention that with longer session
time the higher is the chance of the patient movement during the session.
Not all hospitals can afford additional workload to provide an individualized treatment.
Also new treatment planning algorithms are often still not clinically implemented or require
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additional budget for their license.
Last but not least, some patients have two or more targets irradiated at the same time.
These targets do not always behave (in terms of motion during radiotherapy) in the same
manner [29, 72, 93]. In such a case on-line verification procedures can fit only one of the
targets.
The hypothesis standing prior to the performed studies was that it is possible to propose
simple forms of radiotherapy individualization not requiring much increase in workload. In
order to check this hypothesis an analysis of large clinical data was performed. Afterwards
the currently applied methods and concepts (like setup errors parametrization, verification
protocols, margins) were investigated and alternative solutions were proposed. Aim of this
alternative solutions was to overcome obstacles which were seen during analysis and provide as
simple and individualized approaches as possible not requiring much additional workload.
1.5 The structure of the thesis
At the beginning of this thesis I will start with providing some necessary theoretical basis –
see Chapter 2. In Chapter 3 I will statistically analyze two populations of prostate cancer
patients in terms of their setup errors. First group would consist of 100 patients treated
in the Maria Sklodowska-Curie Institute — Oncology Center. Positioning of that group of
patients was done on the basis of bony anatomy. Second group of patients would consist of
835 patients treated in Erasmus MC University Medical Center Rotterdam (Erasmus MC) in
the Netherlands. Positioning of that group of patients was done on the basis of gold markers.
On the basis of statistical analysis of clinical data I will discuss methods of Monte Carlo (MC)
Simulation of population of patients – see Chapter 4. In Chapter 5 I will discuss methods
of calculating and estimating the cumulative dose distribution for a particular patient. Next
I will propose a new off-line verification protocol (OVP) and compare it with existing ones,
previously described in Chapter 2. Theoretical basis of the new OVP would be discussed and
MC simulations results would be provided – see Chapter 6. In Chapter 7 I will discuss problems
while using CTV-PTV margin calculated with van Herk recipe [90] in presence of time trends.
I will propose some new solutions; a validation and comparison with van Herk recipe would be
also provided. The Thesis would be finally concluded in Chapter 8.
Chapter 2
Theoretical Basis
2.1 Systematic and random errors
Radiotherapy, like every other complex process may be divided into certain steps. During
each step errors and uncertainties may occur. Sources of that errors were widely discussed in
literature as well as their systematic and random nature [1, 4, 58, 89].
In order to understand sources of errors during radiotherapy one has to keep in mind all
steps it consists of. After the decision for radiotherapy is made, patient’s position during
treatment has to be chosen (e.g. anterior/posterior). If needed, additional support equipment,
like thermoplastic masks (see Fig. 2.1) or vacuum bag (see Fig. 2.2), should be prepared.
Following decision on patient’s position a Computed Tomography (CT) scan has to be
performed. A laser system is used to made patient’s position reproducible. Each CT and
therapeutic room is equipped with two lateral lasers (vertical and horizontal one placed on walls
parallel to couch) and one sagittal laser (placed on wall opposite to CT/treatment machine).
The points on the patient’s body, where two lasers cross, have to be marked. In the pelvis and
chest region the point tattoos on the skin are usually done. In the head and neck and brain
region laser positions are drawn on adhesive tapes put on the patient’s mask. (see Fig. 2.1 and
2.3).
As one has to know where the laser crossings points are on the patient’s CT, radio-opaque
markers have to be put on the patient’s body before the scan is performed (see Fig. 2.4). The
CT scan is the first place where errors can occur. Some big errors may appear when equipment
is broken or misused. These errors are rather rare. Despite such large errors we have to keep
in mind all smaller errors which may appear and influence whole radiotherapy process and
therefore would be considered as systematic errors. First of all, during CT, the tattoos are
done on skin, which can move relative to internal anatomy (this is not the case for head and
neck patients because they do not have tattoos1). Another source of error is related to the fact
that moving organs and target are frozen during CT scan in some position, which does not
have to be the most representative one. Third source of error lies in patient setup. All these
errors mentioned above, which can appear during CT scan, have impact on whole radiotherapy
process and therefore should be considered as systematic errors.
CT scans are used to calculate dose in target volume and normal tissues. Before it is done
those structures have to be outlined on the CT scans. Delineation process also may lead to
1There are known situations that patient removed the adhesive tapes with the marker and afterwards put it
in a different position causing a large positional error.
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Figure 2.1: Photography presents a patient lying on a treatment couch in the individualised
thermoplastic mask (yellow) for head and neck region immobilization. Laser system (red)
crossing on adhesive tapes attached to the mask can be also seen. Photography was taken with
patient permission in Maria Sklodowska-Curie Institute — Oncology Center in Warsaw.
Figure 2.2: Photography presents a patient lying on a treatment couch in the individualised
vacuum bag (blue) with additional knee support (green). Photography was taken with patient
permission in Maria Sklodowska-Curie Institute — Oncology Center in Warsaw.
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Figure 2.3: Laser system (red) in pelvic region. Marker can be seen as a small black dot on
the laser crossing. Photography was taken with patient permission in Maria Sklodowska-Curie
Institute — Oncology Center in Warsaw.
certain systematic errors. There are three sources of errors at that step of patient preparation
to treatment. First effect is known as partial volume effect [52] and is related to restricted
resolution in the axis perpendicular to the scans. In other words — last scan with the structure
delineation does not have to be the end of structure in patient body. Next two sources of
errors are related to intra- and inter-observer variations. The same observer asked to delineate
the target volume twice would do it slightly differently [25]. Even though there are protocols
defining how the target and structures should be delineated the delineation uncertainty would
be even bigger if different observers are asked to delineate the same structure [25]. Due to the
fact that the whole radiotherapy process depends on treatment plan which is based on CT and
delineations made on it, delineation errors are systematic ones.
The last step of radiotherapy process is irradiation. In a typical treatment it is done during a
course of treatment when patient receives many (usually 25-35) fractions of the whole treatment,
typically one each day. Setup errors as well as organ and target motion can occur not only
during treatment preparation but also during irradiation. It has to be clarified that some
errors which lead to systematic errors during CT scan, during irradiation would have a random
nature, because in each fraction they may be different. For example the organ motion frozen
on a CT can lead to systematic error, while during radiotherapy it would lead to random inter-
or intrafraction error.
As was described before we divide the errors into the systematic (preparation) and random
(treatment execution) ones. That division is important due to the fact that both kind of errors
have a different impact on cumulative dose distribution [89]. Assume that we have planned the
ideal i.e. homogeneous dose distribution around the target volume (see Fig. 2.5a). Systematic
error would shift the dose distribution (see Fig. 2.5b) while the random errors would blur it
(see Fig. 2.5c). In other words systematic error can cause underdosage in the part of target
volume and random errors usually make dose distribution less homogeneous. Fig. 2.5d shows
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(a) Markers placed on body. (b) Markers seen on CT slice.
Figure 2.4: Methodology of transformation of laser crossing point into CT. Radio-opaque mark-
ers are placed on patient body prior to CT scan (left figure) in order to represent tattoos. These
markers can be seen on CT exam slice (right figure). Photography was taken with patient per-
mission in Maria Sklodowska-Curie Institute — Oncology Center in Warsaw.
(a) Planned dose distribution. (b) Systematic setup error.
(c) Random setup errors. (d) Systematic and random setup errors.
Figure 2.5: Influence of setup errors on dose distribution. The black circle indicates the target
volume. The dot indicates the planned isocenter position. Vector shown on 2.5b and 2.5d
indicates the systematic displacement of the treatment isocenter relative to the planned one.
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(a) Comparison of anterior setup image (0°). (b) Comparison of lateral setup image (270°).
Figure 2.6: Setup images performed prior to treatment aligned to DRRs on which bony struc-
tures are delineated. Images were acquired in Maria Sklodowska-Curie Institute — Oncology
Center in Warsaw.
the typical case during the radiotherapy treatment i.e. the existence of both systematic and
random errors.
There are different methods used to reduce the systematic and random errors. Former ones
can be minimized by verification protocols which would be described further in section 2.3.
Random errors can be minimized by improvement of patient immobilization.
The common way to detect, at least some errors, is to compare the Digitally Reconstructed
Radiographs (DRRs), based on CT scans, with setup images taken prior to treatment when
patient is already lying on the treatment couch (see Section 2.6). The methodology of such a
comparison is based on delineation of important and meaningful structures on DRRs. Knowing
the distance between the setup field isocenter and the structures one can define the exact
position of isocenter on the setup image relative to the patient anatomy.
According to definitions proposed by Bijhold [4] the displacement vectormp,f measured for
patient p in fraction f can be given as:
mp,f = ∆p + δp,f +Ep + εp,f (2.1)
where:
∆p → systematic displacement between planned and treatment isocenter in relative to patient anatomy for
patient p during whole treatment
δp,f → random deviation of displacement between planned and treatment isocenter position in relative to
patient anatomy for patient p in fraction f
Ep → systematic measurement error for patient p (the source of this error can be for example the error during
the structure delineation on the DRRs or the error in definition of setup field edges which is normally
used in order to define the treatment isocenter position on the image)
εp,f → random measurement error which can vary from fraction to fraction (that error would account for
inaccuracy of the alignment between the DRRs and setup images)
Equation (2.1) can be rewritten in order to emphasize its systematic and random component:
mpf = Sp + µpf (2.2)
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where:
Sp = ∆p +Ep
µpf = δpf + εpf
Assuming that Sp and µpf have normal distribution and are not correlated Bijhold [4] states
that their distributions can be interpreted as covariance matrices.
Somehow alternative notation is used by van Herk [90]. Variation of systematic errors
calculated for each patient p in population P is denoted as Σ. In order to make description
more transparent I would focus only on one principal axis. Equations for all other axes are the
same. Assume that we have measured mp,f for each patient p from the group of patients P
who were undergoing the same kind of treatment (same cancer site, same positioning, similar
fractionation and so on). If we have done setup measurements in all fractions f for each patient
p, one can calculate the mean setup error mp of patient p and its standard deviation SDp:
mp =
F∑
f=1
mp,f
F
(2.3)
SDp =
√√√√ F∑
f=1
(mpf −mp)2
F − 1 (2.4)
where:
F → total number of fractions in a treatment course
The mean setup error mp describes the systematic error for patient p, while the standard
deviation SDp describes the magnitude of random errors for that patient.
The systematic error for the whole population P is described with the mean of all means
M (i.e. the mean systematic error for whole population) and its standard deviation Σ:
M =
N∑
p=1
mp
N
(2.5)
Σ =
√√√√ N∑
p=1
(mp −M)2
N − 1 (2.6)
where:
N → number of patients p in their population P
According to van Herk [89] Σ describes how well, i.e. how reproducible, the treatment prepa-
ration is performed.
In notation used by van Herk a term σ describes random errors by providing the best
possible estimate of mean SDp in population of patients. As van Herk [89] mentioned, for
limited number of fractions with measurement it is hard to prove that differences between
patients exist. Therefore in order to describe the group mean of SDp the Root Mean Square
(RMS) should be used:
σ =
√√√√ N∑
p=1
SDp
2
N
(2.7)
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The width of SDp distribution can be calculated as follows [91]:
SDSD =
√√√√ N∑
p=1
(SDp − SDp)2
N − 1 (2.8)
In practice it is rather impossible to minimize setup errors to zero value. Therefore in order
to take them into account during radiotherapy planning the margin is added to the target
volume - for details on how it is done please look into section 2.2.
2.2 CTV-PTV margins
In order to standardize the nomenclature and procedures used in radiotherapy the Interna-
tional Commission on Radiation Units and Measurements (ICRU) provided the Report No. 50
"Prescribing, recording and reporting photon beam therapy" [47] and then its supplement —
Report No. 62 [92]. The latter one gives a three-volume concept which describes irradiated
target volume in a detailed manner [9, 78] — see Fig. 2.7.
Gross Tumor Volume
Clinical Target Volume
Planning Target Volume
Treated Volume
Irradiated Volume
Figure 2.7: Schematic illustration of volumes used in prescribing and reporting radiotherapy
(graph derived from my Master Thesis [32]).
Gross Tumor Volume (GTV) also known as Gross Target Volume consist of tumor volume
i.e. the volume with macroscopic extent of the tumor. It can be detected e.g. on diagnostic
scans like CT, Positron Emission Tomography (PET) or Nuclear Magnetic Resonance (NMR)
(known also as Magnetic Resonance Imaging (MRI)).
The definition of Clinical Target Volume (CTV) given by ICRU [47] is: "The CTV is a tissue
volume that contains a gross tumor volume (GTV) which is the gross palpable or visible/demon-
strable extent and location of the malignant growth, and/or subclinical microscopic malignant
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disease, which has to be eliminated. This volume has to be treated adequately in order to reach
the aim of therapy: cure or palliation." GTV can be defined based on imaging (like CT or MRI)
or palpation examination. GTV border is clear and well defined. It has to be emphasized that
GTV cannot be defined after R0 (i.e. no cancerous cells in margin) surgery. In the presence
of GTV, CTV is created usually by adding isotropic margin. If GTV, as a result of surgery or
difficulty in tumor recognition on CT/MRI (like in prostate case), does not exist the CTV is
delineated itself.
The definition of Planning Target Volume (PTV) given by ICRU [47] is: "The PTV is
a geometrical concept, and it is defined to select appropriate beam sizes and beam arrangements,
taking into consideration the net effect of all the possible geometrical variations and inaccuracies
in order to ensure that the prescribed dose is actually absorbed in the CTV." The PTV is created
by adding margin to CTV. That margin does not have to be isotropic because errors in different
directions can be of different magnitude.
ICRU Reports define also the Treated Volume (TV) i.e. the volume receiving the prescribed
dose (usually 95% of prescribed dose) and Irradiated Volume (IV) i.e. the volume included in
an isodose with a possible impact on normal tissues.
There are many ways of calculating the margin between CTV and PTV [89]. The two most
popular formulas were given by van Herk [90] and Stroom [82]. The first one, as the most often
used in clinical practice, would be described in a more detailed way below.
2.2.1 van Herk formula for CTV-PTV margin calculation
Marcel van Herk et al. proposed their formula for CTV-PTV margin calculation in the year 2000
[90]. This concept is based on probability histograms of the cumulative dose over a population
of patients (dose-population histograms). These histograms are derived with analysis of the
blurred dose distribution (see Fig. 2.5c), i.e. the dose distribution including random errors.
Probability of specified target coverage in population of patients is checked and presented as
dose-population histograms. Assume, for point CTV, that dose blurring is the same for whole
patient population. That blurring of cumulative dose distributionDcum is done by incorporation
of all random errors i.e. organ motion and setup error. Let further assume that we know the
probability density function of systematic errors. Then we can calculate (by integration) how
many systematic errors and how many patients (each patient have one systematic error) would
have the cumulated dose (the blurred one) above the specified threshold (Dthreshold). Afterwards
we can prepare the histogram of probability in patient population in case of the CTV receiving
at least a given dose. In other words we can look into the blurred dose distribution to check
the volume surrounded by the isodose of Dthreshold. Finally we check on the probability density
distribution (P (Dcum > Dthreshold)) of how many patients would fall into that volume. It is the
same as checking percentage of possible systematic errors which are within that volume.
This can be written in equations as follows (bold letters describe vectors):
C : {x|Dcum > Dthreshold} (2.9)
P (Dcum > Dthreshold) =
∫
C
Q(z)dz (2.10)
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where:
Dcum → cumulative dose in CTV, i.e. dose which was blurred in order to consider random errors
Dthreshold → given value of dose which describes requirement for example for minimum dose in CTV
C→ collection of all possible positions x of CTV in which the condition of Dcum >= Dthreshold is fulfilled
z→ systematic error
Q(z)→ probability density of z
Assumption of no correlation between different errors (organ motion, delineation error and
setup error) leads to conclusion that Q(z) can be expressed as a normal (Gaussian) distribution
with zero mean and variance Σ which would be sum of variances of each kind of error mentioned
above.
Q(z) = G(z,Σ2) = G(z,Σm
2 + Σs
2 + Σd
2) (2.11)
where:
Σm
2 → variance of the organ motion during treatment preparation
Σs
2 → variance of the setup error during treatment preparation
Σd
2 → variance of the delineation error
The creation of margin formula is a reversion of the procedure of preparing the dose-
population histograms. At first one has to decide on the desired probability that patient from
the population would receive at least the specified dose in CTV. Let us take as an example a
probability of patient population equal 90% and minimum required dose in CTV equal 95%
of prescribed dose. At first we have to choose all possible systematic errors which would fall
into 90% of their probability density distribution. The extent of these systematic errors can
be easily written as αΣ, where Σ is a vector, as it can be different in all directions, of all
systematic errors components (organ motion, setup error and delineation error). For 3D case
and probability/prescribed dose levels mentioned above value of α would be 2.5. As it is high-
lighted by van Herk this is purely geometrical concept and therefore it does not depend on dose
distribution and the shape of CTV.
Second step is to find an extra margin in order to incorporate the random errors. It means
that necessary extra extend of the CTV has to be found in order to reassure that 95% isodose of
blurred dose distribution would surround all the points of CTV even though they would change
location due to random errors. If we would describe the distance between the 95% and 50%
isodose of blurred dose distribution, Dblurred, as βσ and distance between the 95% and 50%
isodose of planned dose distribution, Dplanned, as βσp then the extent in CTV can be written
as βσ − βσp.
In the end we come to the total PTV margin recipe:
MPTV = αΣ + βσ − βσp (2.12)
where:
σ2 = σm
2 + σs
2 + σp
2 and:
σm
2 → variance of the organ motion during treatment execution
σs
2 → variance of the setup error during treatment execution
σp → beam penumbra width
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(a) Derivation of dose-population histogram.
(b) Dose-population histogram.
Figure 2.8: Figure presents the methodology of creating probability histogram of the cumulative
dose over a population of patients (dose-population histogram). For simplicity CTV consisting
of one point is assumed. Fig. 2.8a shows how dose-population histogram is obtained. Red curve
on upper graph presents dose in point CTV in relation to error in CTV position. We have to
decide on Dthreshold which should be delivered (e.g. the minimum dose in CTV, here 95%).
Then we look into the range/collection of all possible CTV positions in which the dose would
be at least Dthreshold. Knowing this collection we check what fraction of whole population it
is (in other words we check the probability that CTV would have this location) — see lower
graph of Fig. 2.8a for probability of CTV displacement (CTV position error). That procedure
leads us to a single point in dose-population histogram (Fig. 2.8b) and therefore has to be
repeated for each Dthreshold[0%; 100%]. Dose-population histogram prepared for data shown
here is presented in Fig. 2.8b. Selected point (95%, 90%) shows that 95% of dose would be
achieved in 90% of patients. These figure was created on the basis of van Herk paper [90].
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In Eq. (2.12) margin mPTV and all variances are vector variables. Therefore also non-isotropic
margins can be calculated with the usage of this formula. Equation (2.12) can be rewritten if
the penumbra width has to be excluded. In that case we end up with:
MPTV = αΣ + κσ′ (2.13)
where:
σ′ =
√
σm2 + σs2 and:
κ→ parameter achieved for linear fit used to approximate βσ − βσp with κσ′ for SD of random errors in
range [0 mm, 5 mm].
Parameter κ is valid only for limited range of uncertainties and for a specified penumbra width.
Setting the σp to 3.2 mm (which is adequate for 5 mm distance between 50% and 95% isodose
in normal, i.e. not blurred dose distribution) and setting the requirement of 95% minimum
dose in CTV in 90% of patients we come to the most applied margin formula [89] (please not
that often σ′ is denoted as σ):
MPTV = 2.5Σ + 0.7σ′ (2.14)
2.3 Verification Protocols
The aim of radiotherapy is to deliver high, generally uniform, dose to target volume and spare
healthy tissue at the same time. The magnitude of irradiated healthy tissue volume depends
on the size of CTV-PTV margin. Therefore it is important to minimize that margin. As was
previously described (see Section 2.1) during radiotherapy one has to deal with two types of
errors: random and systematic ones. Reduction of random errors can be achieved with better
immobilization and on-line verification procedure [94]. In such a procedure setup images are
taken prior to each fraction. There are compared with reference images immediately (on-line)
and corrections are applied. Patient is irradiated afterwards. That makes this procedure rather
time-consuming. The on-line verification protocol seems to be very efficient as it would correct
for daily setup error. However it was shown that intrafraction motion might have greater impact
in that case [57].
Reduction of systematic errors can be done by off-line verification protocols (OVP). The
main idea of OVP is to estimate patient systematic error and correct for it. This estimation
would not be perfect and therefore some residual systematic error would remain. Still, if OVP
works accurately variation of residual systematic error for whole patient population — Σres
would be smaller than Σ. Due to van Herk formula (Eq. (2.14)) decrease in systematic errors
is more important for margin reduction than decrease in random errors.
2.3.1 No Action Level Protocol
No Action Level (NAL) protocol was proposed by de Boer and Heijmen in 2001 [14]. It is
widely used in the clinical practice [17, 54, 76] and some extensions were proposed [16, 15, 55]
NAL protocol needs a minimum workload. In that protocol each patient has setup images
done in first n fractions. During this first n fractions no corrections are applied and a comparison
of setup images with reference images is done after the treatment (i.e. offline). After n fractions
the average setup vector Vn is calculated. It consist of average setup error in each direction. All
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Figure 2.9: Example of NAL protocol performance. Figure shows NAL in case when mean
setup error (i.e. the correction value) is well estimated on the basis of 3 first fractions. Arrow
shows an example shift between corrected an uncorrected Setup Error.
upcoming fractions are corrected with −Vn — see Fig. 2.9. Value of n should be large enough
to sufficiently estimate systematic error and small enough to assure minimal workload. De Boer
and Heijmen [14] suggested n = 3, Bortfled [7] concluded that it would be more efficient to use
n = 4.
2.3.2 Extended No Action Level Protocol
The much applied NAL protocol (see Section 2.3.1) was extended by de Boer and Heijmen in
2007 in order to deal with inter-fraction time trends [16]. In first three fractions this protocol
works in the same manner as NAL protocol, so images are taken and no correction is applied.
Afterwards, the mean setup error is calculated and taken as a correction value for upcoming
week of treatment (five fractions). At the last fraction of each following week images are also
taken. A linear fit is done for uncorrected setup errors and new correction value is calculated
according to this linear fit. In such a way correction value is updated weekly. An example of
the extended NAL (eNAL) protocol performance is shown in Fig. 2.10.
2.3 Verification Protocols 19
Figure 2.10: Example of eNAL protocol performance in presence of inter-fraction time trend.
First three fractions (black dots) are irradiated without any correction. Afterwards a correction
is calculated and applied for five upcoming fractions (first arrow indicates this correction value).
In 8th fraction an imaging is performed and a linear fit is done for uncorrected setup errors. On
the basis of this fit correction the value for upcoming five fractions is recalculated. The imaging
is done in each fifth fraction, followed by a linear fit and update of correction factor. Arrows
show first fractions after the new correction value was calculated and dotted black lines show
the correction value and fractions in which it was applied. It can be seen how the correction
value is changing in time.
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2.4 Dose Volume Histograms (DVHs)
After the radiotherapy plan is created in TPS, it has to be accepted by a physician. Only
after that acceptance the further preparation (double check of dose calculations, pretreatment
QA, transfer to patient management and/or record and verify system) and finally irradiation
may happen. In order to check the plan the physician examines dose distributions in single
CT scans. The conformity, hot and cold spots are investigated visually. As there are some
dose-volume constraints in the planning protocols they also have to be checked. It is done with
dose volume histograms (DVH).
There are two types of DVHs: differential and cumulative. Both are representations of
dose distribution but without the spatial information. Creation of both types of histograms
is explained below. For simplicity the 2D dose distribution presented in Fig. 2.11 was used.
Knowing dose matrix (i.e. dose distribution) one has to check which voxels lie in the structure.
Coping with voxels partly in the structure is done differently in different TPS. In the example I
consider all voxels with PTV. In classical histogram one has to calculate number of occurrences
(see Fig. 2.12a). As it would be hard to present in TPS (there are many fluctuations and bins are
usually very thin) the decision was made to take only middle position of each bar and connect
them with the line (see Fig. 2.12b). Ideal uniform distribution in PTV should have Dirac delta
shape in differential DVH. Let us denote a point on a differential histogram as DVHdiff . In
order to present data in a more clear and understandable way cumulative histogram DVHcum
is created:
DVHcum(Di+1) =
(
1−
∫ Di
0
DVHdiff (Di)
)
· Vtotal (2.15)
where Vtotal is total structure volume. The cumulative histogram created for presented example
is shown in Fig. 2.13.
2.4.1 Dose Constraints
Statistical dose evaluation is done on basis of some dose or dose-volume parameters (ofted
called dosimetric parameters). Usually dose-volume parameters are presented as DV or VD.
First parameter DV (e.g. D2% or D1cc) is such a dose D that doses greater or equal D would
be in volume equal V (see Fig. 2.14a). Second parameter VD (e.g. V20 = V20 Gy) is a volume V
in which doses would be equal D or greater (see Fig. 2.14b).
For target volumes maximum dose Dmax, minimum dose Dmin and mean dose Dmean are
usually evaluated [47]. Due to the fact that Dmax and Dmin are point doses and they depend
on structure delineation and dose grid the concept of dose close to minimum D98% and dose
close to maximum D2% were proposed [18].
Dose parameters evaluated for Organs at Risk (OARs) depend on the structure of the organ.
For so-called serial OAR for which destruction of one element can cause destruction of whole
organ maximum dose Dmax is evaluated. For so-called parallel OAR for which even if some part
is destructed other part will remain working Dmean and VD or DV parameters are evaluated.
For OARs with mixed structure all of these parameters are taken into consideration.
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(a) Differential (b) Cumulative
Figure 2.11: Simple 2D dose matrix with a PTV contour (red circle) is presented. While
considering Di = 40 Gy, for a differential histogram only two voxels (marked in light red)
would be taken into account. For a cumulative histogram, while considering Di = 40 Gy, all
voxels with D ≥ 40Gy (marked in light red) would be counted.
(a) Classical histogram (b) Differential DVH
Figure 2.12: Explanation on how differential DVH is created. The classical histogram is created
from the dose matrix at first (2.12a). Afterwards the middle positions of bars are taken and
joined with line (2.12b).
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Figure 2.13: Cumulative Dose Volume Histogram. For some dose-volume constraints cubic
centimeters are used, more often volume is given in percentage of total structure volume.
(a) DV parameter (b) VD parameter
Figure 2.14: Illustration of dosimetric parameters. In order to check DV = D95% we look
on volume V = 95% on the y-axis, search for point on a curve and check adequate dose D
(Fig. 2.14a). In order to check VD = V30 Gy we look on dose D = 30 Gy on the x-axis, search
for point on a curve and check adequate volume V (Fig. 2.14b).
Chapter 3
Clinical Data
3.1 Background
Work presented in the thesis was done on the basis of two databases of setup errors for prostate
cancer patients. First group of patients were irradiated in Maria Skłodowska-Curie Cancer
Center and Institute of Oncology in Warsaw (COI). Second group of patients were irradiated
in Erasmus MC University Medical Center Rotterdam (Erasmus MC).
Prostate cancer is one of the most frequent cancer case in males population for many indus-
trialized nations [80, 84]. In Poland, in terms of frequency, prostate cancer has a second place
(1st place goes to lung cancer) [20]. Prostate cancer can be treated with surgery, radiotherapy,
hormonotherapy or with combination of these therapies [39, 40].
In current chapter I will describe both clinical databases in terms of underwent treatment
and recorded setup errors. I will also provide some statistical analysis of the data.
3.2 Materials
3.2.1 Database from Maria Sklodowska-Curie Institute — Oncology
Center in Warsaw (COI)
In COI patients suffering from prostate cancer can receive radiotherapy as a part of their
treatment. There are two main schemes of the irradiation. First is a standard therapy: 25
fractions with 2.6 Gy per fraction. Second one is Simultaneous Integrated Boost (SIB) therapy
[2, 21, 48, 49] consisting of 27 fractions with 2.6 Gy per fraction in CTV and 2.45 Gy per
fraction in PTV. Standard therapy is usually done with 3D Conformal Radiotherapy (3D-CRT)
or Intensity Modulated Radiation Therapy (IMRT) [65, 98] technique, while SIB treatment is
mainly performed with IMRT or Volumetric Arc Therapy (VMAT) [8, 70, 97].
Prostate cancer patients treated in COI undergo special verification protocol which was
published in 2012 [74]. Patient has to empty his bladder and drink 0.5 l of water. CT scan
or irradiation is done half an hour later with full bladder. That leads to the same stability
of prostate position as for empty bladder irradiation with the reduction of bladder volume
receiving high dose [73]. Patient is treated in supine position with a knee support used for
more relaxed position — see Fig. 3.1. During CT tattoos are done on skin to mark lasers
intersection and radio-opaque materials are put at that places. The width of CT scans is 2.5
mm.
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Figure 3.1: CT scan for prostate cancer patient. Knee support is shown. Photography was
taken with patient permission in the Maria Sklodowska-Curie Institute — Oncology Center in
Warsaw.
In the treatment room patient is set up in the treatment couch using tatoos and laser system.
During first 3 fractions orthogonal setup images (0°and 90°— see Fig. 2.6) and Cone-Beam CT
(CBCT) images are taken (see Fig. 1.4b). Afterwards the displacement vector between bony
structures (defined on orthogonal images) and prostate gland (defined on CBCT) is calculated.
That vector is assumed to be a constant displacement in all fractions and used as a correction
factor. Therefore in all upcoming fractions orthogonal images are taken, patient is shifted on
the basis on bony anatomy match and afterwards correction based on displacement between
bony anatomy and protate gland is applied.
The retrospective look on the setup images performed and recorded before each fraction
allowed to calculate setup error in the regard to isocenter (i.e. in the regard to the laser
coordinate system). That was a raw setup error without implemented corrections. In this
work the analysis of such setup error was done for 100 patients who received standard 3D-CRT
treatment between the May 2013 and the August 2015.
Before each of 25 fractions, and also prior to corrections, orthogonal setup images were
taken. They were compared to DRRs on the basis of bony anatomy [43].
Comparison between DRRs and setup images resulted in setup errors values in three dimen-
sions. In the vertical setup image the Head-Feet (z axis) and Left-Right (x axis) setup error
were defined. In the lateral setup image the Head-Feet and Anterior-Posterior (y axis) setup
error were defined. The accuracy of determination of setup error was 1 mm. Head-Feet setup
error was defined from both images and therefore its accuracy was 0.5 mm. Rotations were not
included in the analysis.
3.3 Methods 25
3.2.2 Database from Erasmus MC University Medical Center Rotter-
dam (Erasmus MC)
The database of 835 prostate cancer patients who underwent 39 fractions radiotherapy in Eras-
mus MC was also evaluated. Setup images were taken in each fraction and compared with
reference images (DRRs or CT) on the basis of implanted gold fiducials [61].
3.3 Methods
3.3.1 Testing normality
The Shapiro-Wilk test [79], which is considered to be the most powerful test for normality
[30, 38], was used in order to check the hypothesis that setup errors of each particular patient
for each axis have normal distribution. The null hypothesis of these tests were that the setup
errors have normal distribution. The hypothesis that the distribution of mean patient setup
error mp and patient’s standard deviation of setup errors SDp have normal distribution in the
entire population of patients was also checked.
3.3.1.1 Reliability of Shapiro-Wilk test
At first I checked whether 25 samples, which correspond to 25 fractions of treatment, are enough
to acquire a reliable result of Shapiro-Wilk test. The check was done on the basis of simulation.
25 samples were randomized from a normal distribution with standard deviation calculated as
RMS of clinical patient data for each axis. The exact values were: 2.0 mm for left-right, 3.0 mm
for anterior-posterior and 1.6 mm for head-feet. Then I checked the p-value of Shapiro-Wilk
test. Procedure was done 105 times for each axis. Histogram plots were prepared.
The results obtained in simulation are presented in Fig. 3.2-3.4. It can be seen that distri-
bution of p-values is rather uniform and that number of counts with p < 0.05 corresponds to
the significance level which was set to 5%.
3.3.1.2 Data analysis for single patients
The Shapiro-Wilk test was performed for each patient and each axis of setup error. I collected
all p-values and looked into their distribution in order to check the ratio of patients with not
normal setup error distribution. Histogram plots of setup errors for each patient and each
error direction (left-right, anterior-posterior, head-feet) were prepared. Additionally I prepared
histograms of p-values for each direction for all patients.
Due to the fact that not normal distribution in at least one axis can influence correction
procedure or margin calculation procedure I was also interested in number of patients with
normal distribution in all directions. Adequate analysis was performed.
3.3.1.3 Data analysis for population of patients
Ditribution of patient’s mean setup error — mp (see Eq. 2.3) was analyzed. Shapiro-Wilk test
was used in order to check probability that data came from the normal distribution. Similar
analysis was done for distribution of patient’s standard deviation — SDp (see Eq. 2.4). All
principal directions were treated separately.
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Figure 3.2: Histogram of p-values for setup error in left-right direction. Simulation for 105
cases. Each case consist of 25 samples randomized from normal distribution of given standard
deviation.
Figure 3.3: Histogram of p-values for setup error in anterior-posterior direction. Simulation
for 105 cases. Each case consist of 25 samples randomized from normal distribution of given
standard deviation.
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Figure 3.4: Histogram of p-values for setup error in head-feet direction. Simulation for 105
cases. Each case consist of 25 samples randomized from normal distribution of given standard
deviation.
3.3.2 Time trends analysis
In order to check whether there is a time trend in setup errors for each patient and each
direction, ordinary least square (OLS) fit was done. The two tailed p-values of the t-test for
the parameters of fitted linear regression parameters were calculated as well. As the time trend
was a potential source of not normal distributions of setup errors I have checked if the residuals
(i.e. setup errors without time regression) would fulfill the normality assumption. This was
tested again with Shapiro-Wilk test (see 3.3.1)
In order to see if there is a significant change in normality of pure setup errors and time
trend Shapiro-Wilk statistic W achieved for both was compared and Wilcoxon signed-rank test
was performed. The null hypothesis stated that there is no difference between Shapiro-Wilk
statistic W values achieved for pure setup errors and for time regression residuals. Comparison
of number of patients with normal error distribution in all directions for pure setup error and
time regression residuals was also done.
The important question was whether existence of time trends could explain the setup errors
distribution with low probability (p < 0.05) of having normal distribution. In order to answer
that question a possible correlation between time regression slope and difference in p-value for
pure and residual setup error was examined as well as the possible correlation between p-values
of OLS fit and Shapiro-Wilk test.
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3.3.3 Fitting probability distributions
Distributions of patient’s specific characterisations of setup errors (like mp, SDp) for Erasmus
MC database were evaluated in order to find the probability distribution which would fit best
to the data. Several functions were fitted to the distributions of mean (mp) and std (SDp)
of setup errors. The goodness of fit was calculated for each probability function as a residual
sum of squares (RSS). The function with the smallest RSS for all directions was fitted and
afterwards presented in comparison with the data histogram.
3.4 Results - COI
3.4.1 Testing normality
3.4.1.1 Data analysis for single patients
In Fig. 3.5 the worst and the best results of Shapiro-Wilk test for normality are shown. In
left-right direction p-value varied between 0.0 and 0.894. In anterior-posterior direction p-value
varied between 0.0 and 0.597. In head-feet direction p-value varied between 0.0 and 0.836.
In Fig. 3.6-3.8 histograms of p-values achieved with Shapiro-Wilk test of setup errors for
each patient are shown. In Fig. 3.9 p-values for all setup error directions are shown in order
to make it easy to compare them. It can be seen that p-values distributions are similar. Best
results in terms of normal distribution of setup errors were achieved for head-feet direction. If
significance level is set to 0.05 the null hypothesis of normal distribution of setup errors can
be rejected for 42% of patients in left-right and head-feet direction and for 43% of patients in
anterior-posterior direction.
Setup errors have a spatial nature although all procedures (verification, margin calculations)
are done per direction but in a combined manner. Due to that non-normal distribution in one
direction can influence the whole patient procedure. Therefore the min p-value for each patient
was also examined (see Fig. 3.10). With the confidence interval set to 95% the hypothesis of
normal distribution of setup errors in all three directions was fulfilled in 22% of patients. All
other patients had significant probability that distribution of their setup errors is not normal
in at least one principal direction (see Fig. 3.11).
3.4.1.2 Data analysis for population of patients
Fig. 3.12 shows distribution of mp which are interpreted as systematic errors. With the confi-
dence interval set to 99%, the null hypothesis that systematic errors have normal distribution
cannot be rejected for left-right and head-feet direction. The p-value for anterior-posterior di-
rection is lower than 0.001. Despite the fact that not all of the patients have normal distribution
of setup errors the population mean, M (see Eq. 2.5), of mean patient setup errors, mp (see
Eq. 2.3), was calculated. Spread ofmp distribution was also calculated as Σ (see Eq. 2.6). It was
assumed that M was the best estimator of systematic error for whole population of patients.
The values of Σ were: 1.99 mm for left-right, 2.98 mm for anterior-posterior and 1.65 mm for
head-feet direction.
Variability of the SDp (see Eq. 2.4) which was assumed to be the best estimator of the
standard deviation of patient’s random errors was also calculated. As it is shown in Fig. 3.12
there is significant difference between the SDp distribution and normal distribution for all
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(a) Patient with the lowest observed p-value (b) Patient with the highest observed p-value
(c) Patient with the lowest observed p-value (d) Patient with the highest observed p-value
(e) Patient with the lowest observed p-value (f) Patient with the highest observed p-value
Figure 3.5: Histogram of setup errors distributions in left-right direction (3.5a and 3.5b),
anterior-posterior direction (3.5c and 3.5d) and head-feet direction (3.5e and 3.5f). In the
left column distribution of setup errors with the lowest p-value is presented. In the right col-
umn distribution of setup errors with the highest p-value is presented. Data achieved for COI
database.
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Figure 3.6: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in left-right
direction. Data achieved for COI database.
principal directions. Values of σ (see Eq. 2.7) were: 2.23 mm for left-right, 2.05 mm for
anterior-posterior and 1.53 mm for head-feet direction. The width of SDp distribution, denoted
as SDSD, was also calculated and was equal: 0.64 mm, 0.65 mm and 0.43 mm for left-right,
anterior-posterior and head-feet direction respectively — see Fig. 3.12.
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Figure 3.7: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in anterior-
posterior direction. Data achieved for COI database.
Figure 3.8: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in head-feet
direction. Data achieved for COI database.
32 3 Clinical Data
Figure 3.9: Comparison of histograms of p-values achieved with Shapiro-Wilk test for setup
errors in all directions. Data achieved for COI database.
Figure 3.10: Histogram of minimum p-value, out of three directions, for all patients. Data
achieved for COI database.
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Figure 3.11: Number of patients with probable not normal setup error distribution in 0-1-2-3
directions. Confidence interval was set to 95%. Data achieved for COI database.
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(a) Distribution of mp (b) Distribution of SDp
(c) Distribution of mp (d) Distribution of SDp
(e) Distribution of mp (f) Distribution of SDp
Figure 3.12: Histograms ofmp and SDp for setup errors in left-right direction (3.12a and 3.12b),
anterior-posterior direction (3.12c and 3.12d) and head-feet direction (3.12e and 3.12f). The
p-value of Shapiro-Wilk test is written on each histogram. Data achieved for COI database.
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3.4.2 Time trends analysis
Absolute value of slope for time regression fit varied from 0.0 to 0.21 mm/fraction for left-right
direction, from 0.0 to 0.47 mm/fraction for anterior-posterior direction, and from 0.0 to 0.14
mm/fraction for head-feet direction (see Fig. 3.13). The biggest observed negative change in
time was about −0.5 mm/fraction. That leads to change in patient position of 5 mm per 10
fractions. In that situation setup error is a decreasing function of time. The greatest observed
positive change in time was about 0.3 mm/fraction. In that situation setup error is an increasing
function of time. It has to be noticed that not only slope value has an impact on behaviour
of setup errors during treatment but also offset (initial setup error). In order to check if the
absolute setup error value decreases or increases during the course of treatment the difference
between the absolute setup error in last and first fraction has to be examined. That has to
be done not for random errors but for errors lying on the fitted time trend line (denoted as
trendline errors in this thesis). The concept of dividing setup errors for random errors and
trendline errors was depicted and widened in Section 4.2.2.2 and Section 7.2.1 Fig. 3.15-3.17
show that for all principal directions slightly more patients experienced increase in setup error
during course of treatment. Histograms of slope values are shown in Fig. 3.14.
Wilcoxon signed-rank test showed that there is a significant difference between Shapiro-Wilk
W statistic values obtained for pure setup errors and for that obtained for time regression resid-
uals – p-values were of order 10−14-10−15 (see Fig. 3.18-3.20). Despite that normal distribution
still cannot be assumed for about 20% of patients if the significance level is set to 5% (22% for
left-right, 18% for anterior-posterior and 20% for head-feet direction). Due to this it can be
concluded that non-normality problem can be explained by the existence of time trend only in
half of the cases. Detailed results are shown in Fig. 3.21-3.23.
Fig. 3.24 shows that there is a significant difference between number of patients with normal
distribution in setup errors in all directions if we consider time regression residuals. Despite that
for 48% of patients distribution of setup error is rather not normal for at least one direction.
It has to be emphasized that for some patients the Shapiro-Wilk test p-value was lower for
residual setup errors than for pure ones. Some setup errors distributions which appeared to be
normal for pure errors seemed to be not normal for time trend residuals.
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(a) Patient with the lowest observed slope (b) Patient with the highest observed slope
(c) Patient with the lowest observed slope (d) Patient with the highest observed slope
(e) Patient with the lowest observed slope (f) Patient with the highest observed slope
Figure 3.13: Plots of setup error distribution along left-right axis (3.13a and 3.13b), anterior-
posterior axis (3.13c and 3.13d) and head-feet axis (3.13e and 3.13f). On the left patients
with the lowest observed absolute slope values are shown (i.e. patients with no observed time
trend), on the right patients with highest observed slope values are shown (significant time
trend observed). LRse, APse, HFse stands for mpf in particular direction while nf describes
fraction number and is a measure of time. Data achieved for COI database.
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(a) Histogram of slope values (b) Histogram of offset values
(c) Histogram of slope values (d) Histogram of offset values
(e) Histogram of slope values (f) Histogram of offset values
Figure 3.14: Histograms of slope (left) and offset (right) values for time trend OLS analysis of
setup errors in each direction. Data achieved for COI database.
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Figure 3.15: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for COI database.
Figure 3.16: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for COI database.
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Figure 3.17: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for COI database.
Figure 3.18: Histograms of Shapiro-Wilk W statistic values achieved during normality test of
setup errors in left-right direction for each patient. Histograms for pure setup errors and time
regression residuals are shown. Data achieved for COI database.
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Figure 3.19: Histograms of Shapiro-Wilk W statistic values achieved during normality test of
setup errors in anterior-posterior direction for each patient. Histograms for pure setup errors
and time regression residuals are shown. Data achieved for COI database.
Figure 3.20: Histograms of Shapiro-Wilk W statistic values achieved during normality test of
setup errors in head-feet direction for each patient. Histograms for pure setup errors and time
regression residuals are shown. Data achieved for COI database.
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Figure 3.21: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
Left-Right direction. Data achieved for COI database.
Figure 3.22: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
Anterior-Posterior direction. Data achieved for COI database.
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Figure 3.23: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
Head-Feet direction. Data achieved for COI database.
Figure 3.24: Histograms of number of patients with specified number of directions with probable
not normal distribution — comparison between pure setup errors and time trend residuals. Data
achieved for COI database.
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3.5 Results - Erasmus MC
3.5.1 Testing normality
3.5.1.1 Data analysis for single patients
In Fig. 3.25, for each principal direction, setup errors distributions with the worst and the best
p-value of Shapiro-Wilk test for normality are shown. In all directions these p-values varied
between 0.0 and, approximately, 1.0.
In Fig. 3.26-3.28 histograms of p-values achieved with Shapiro-Wilk test of setup errors for
each patient are shown. Distributions of p-values for all principal directions are similar (see
Fig. 3.29). Best results in terms of normal distribution of setup errors were achieved for head-feet
direction. If significance level is set to 0.05 the null hypothesis of normal distribution of setup
errors can be rejected for 12.1% of patients in left-right, for 15.7% patients in anterior-posterior
direction and for 10.5% of patients in head-feet direction. With the change of significance level
to 0.1 these values were 18.4%, 22.5% and 17.2% respectively.
Similarly to the COI database the min p-value for each patient other three principal direc-
tions was also examined (see Fig. 3.30). With the confidence interval set to 95% the hypothesis
of normal distribution of setup errors in all three directions was fulfilled in 67.3% of patients.
The hypothesis of normal distribution of setup errors in at least two directions was fulfilled in
94.7% of patients (see Fig. 3.31).
3.5.1.2 Data analysis for population of patients
The mean value of setup error for each patient, mp, was calculated and assumed to be the best
estimator of systematic error. The standard deviation of setup errors for each patient — SDp
was also calculated. As it is shown in Fig. 3.32 in none of the three directions mp nor SDp have
the normal distribution (see Fig. 3.32). The values of Σ, i.e. the width of mp distribution, were:
2.50 mm for left-right, 3.47 mm for anterior-posterior and 3.37 mm for head-feet direction.
Analogically the values of σ (which is the RMS of SDp) were: 1.93 mm for left-right, 2.77
mm for anterior-posterior and 2.64mm for head-feet direction. The width of SDp distributions,
SDSD, was equal 0.71 mm, 0.80 mm and 0.68 mm respectively — see Fig. 3.32.
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(a) Patient with the lowest observed p-value (b) Patient with the highest observed p-value
(c) Patient with the lowest observed p-value (d) Patient with the highest observed p-value
(e) Patient with the lowest observed p-value (f) Patient with the highest observed p-value
Figure 3.25: Histograms of setup error distribution in left-right direction (3.25a and 3.25b),
anterior-posterior direction (3.25c and 3.25d) and head-feet direction (3.25e and 3.25f). Data
achieved for Erasmus MC database.
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Figure 3.26: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in left-right
direction. Data achieved for Erasmus MC database.
Figure 3.27: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in anterior-
posterior direction. Data achieved for Erasmus MC database.
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Figure 3.28: Histogram of p-values achieved with Shapiro-Wilk test for setup errors in head-feet
direction. Data achieved for Erasmus MC database.
Figure 3.29: Comparison of histograms of p-values achieved with Shapiro-Wilk test for setup
errors in all directions. Data achieved for Erasmus MC database.
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Figure 3.30: Histogram of minimum p value, out of three directions, for all patients. Data
achieved for Erasmus MC database.
Figure 3.31: Number of patients with probable not normal setup error distribution in 0-1-2-3
directions. Confidence interval was set to 95%. Data achieved for Erasmus MC database.
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(a) Distribution of mp (b) Distribution of SDp
(c) Distribution of mp (d) Distribution of SDp
(e) Distribution of mp (f) Distribution of SDp
Figure 3.32: Histograms ofmp and SDp for setup errors in left-right direction (3.32a and 3.32b),
anterior-posterior direction (3.32c and 3.32d) and head-feet direction (3.32e and 3.32f). The
p-value of Shapiro-Wilk test comparing normal ditribution with presented histogram is written
on each figure. Data achieved for Erasmus MC database.
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3.5.2 Time trends analysis
Absolute value of slope for time regression fit varied from 0.0 to 0.28 mm/fraction for left-
right direction, from 0.0 to 0.65 mm/fraction for anterior-posterior direction, and from 0.0 to
0.46 mm/fraction for head-feet direction (see Fig. 3.33). Mean slope value was negative for all
directions. Values of mean slope were: −0.78 mm/fraction for left-right, −0.57 mm/fraction
for anterior-posterior, −0.71 mm/fraction for head-feet direction with standard deviation of
0.78, 0.59 and 0.69 respectively. The greatest observed negative change in time was about
−0.35 mm/fraction. In that situation setup error is a decreasing function of time. The biggest
observed positive change in time was about 0.65 mm/fraction. In that situation setup error
is an increasing function of time. Presented slope values lead to more than 2 cm change in
time during 39 fractions of treatment course. In order to check if the absolute setup error
value decreases or increases during the course of treatment the difference between the absolute
trendline setup error in last and first fraction was examined. Fig. 3.35-3.37 show that for all
directions in more than 50% (up to almost 63%) of patients setup errors increased during the
course of treatment. Histograms of slope values are presented in Fig. 3.34.
Wilcoxon signed-rank test was used to compare Shapiro-Wilk W statistic values obtained
for pure setup errors and obtained for time trend residuals. It showed that, with confidence
level set to 95%, we cannot neglect the null hypothesis in left-right and head-feet direction (see
Fig. 3.38-3.40). We can interpret this result that at least for this two directions time trends
do not explain non-normality of setup errors for some patients. Histograms of Shapiro-Wilk
p-values achieved for each patient and direction are shown in Fig. 3.41-3.43.
Fig. 3.44 shows that there is no significant difference between number of patients with normal
distribution in setup errors in all directions for pure setup errors and time trend residuals.
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(a) Patient with the lowest observed slope (b) Patient with the highest observed slope
(c) Patient with the lowest observed slope (d) Patient with the highest observed slope
(e) Patient with the lowest observed slope (f) Patient with the highest observed slope
Figure 3.33: Plots of setup error distribution along left-right axis (3.33a and 3.33b), anterior-
posterior axis (3.33c and 3.33d) and head-feet axis (3.33e and 3.33f). On the left patients with
the lowest observed absolute slope values are shown (with no observed time trend), on the right
patients with highest observed slope values are shown (significant time trend observed). LRse,
APse, HFse stands for mpf in particular direction while nf describes fraction number and is a
measure of time. Data achieved for Erasmus MC database.
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(a) Histogram of slope values (b) Histogram of offset values
(c) Histogram of slope values (d) Histogram of offset values
(e) Histogram of slope values (f) Histogram of offset values
Figure 3.34: Histogram of slope (left) and offset (right) values for time trend OLS analysis of
setup errors in each direction. Data achieved for Erasmus MC database.
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Figure 3.35: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for Erasmus MC database.
Figure 3.36: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for Erasmus MC database.
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Figure 3.37: Histogram of difference between absolute trendline setup error achieved in last
and first fraction. Negative value indicates that setup error got smaller during the course of
treatment. Data achieved for Erasmus MC database.
Figure 3.38: Histogram of Shapiro-Wilk statistic W values achieved during normality test of
setup errors in left-right direction for each patient. Histograms for pure setup errors and time
regression residuals are shown. Data achieved for Erasmus MC database.
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Figure 3.39: Histogram of Shapiro-Wilk statistic W values achieved during normality test of
setup errors in anterior-posterior direction for each patient. Histograms for pure setup errors
and time regression residuals are shown. Data achieved for Erasmus MC database.
Figure 3.40: Histogram of Shapiro-Wilk statistic W values achieved during normality test of
setup errors in head-feet direction for each patient. Histograms for pure setup errors and time
regression residuals are shown. Data achieved for Erasmus MC database.
3.5 Results - Erasmus MC 55
Figure 3.41: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
left-right direction. Data achieved for Erasmus MC database.
Figure 3.42: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
anterior-posterior direction. Data achieved for Erasmus MC database.
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Figure 3.43: Histogram of p-values achieved with Shapiro-Wilk test for time trend residuals in
head-feet direction. Data achieved for Erasmus MC database.
Figure 3.44: Comparison of number of patients with non-normal distribution of pure/time trend
residual setup errors in 0-1-2-3 directions. Confidence level was set to 95%. Data achieved for
Erasmus MC database.
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3.5.3 Fitting probability distributions
3.5.3.1 Mean Setup Error and SD of setup error
Fig. 3.45 presents the distributions of mean setup error and SD of setup errors calculated in
three principal directions for Erasmus MC database. The best fitted distribution (in terms
of RSS) for mean setup errors was Generalized Logistic distribution with probability density
function given by:
f(x;α) =
αe−x
(1 + e−x)α+1
, where α > 0, x > 0 (3.1)
The best fitted distribution for standard deviation of setup errors was Burr distribution with
probability density function given by:
f(x; c, d) = c · d · x
−c−1
(1 + x−c)d+1
(3.2)
Fig. 3.45 presents also normal distribution commonly used in simulation of patient population
setup errors. The probability density function for a normal distribution is given by:
f(x;µ, σ2) =
1
√
2piσ2e−
(x−µ)2
2σ2
(3.3)
3.5.3.2 Time Trend Parameters
The best fitted distribution for slope and offset of time trends was Burr (Eq. (3.2)) and General-
ized Logistic distribution (Eq. (3.1)) respectively – see Fig. 3.46. Standard deviation of residual
setup errors SDttp have Burr distribution (Eq. (3.2)). Histograms with fitted distributions are
presented in Fig. 3.47.
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(a) Distribution of m¯p (b) Distribution of SDp
(c) Distribution of m¯p (d) Distribution of SDp
(e) Distribution of m¯p (f) Distribution of SDp
Figure 3.45: Comparison between histograms of mean setup errors and SD of setup errors and
fitted distributions. Data achieved for Erasmus MC database.
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(a) Distribution of ap (b) Distribution of bp
(c) Distribution of ap (d) Distribution of bp
(e) Distribution of ap (f) Distribution of bp
Figure 3.46: Comparison between trendline slope/offset histograms and fitted distributions.
Data achieved for Erasmus MC database.
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(a)
(b)
(c)
Figure 3.47: Comparison between histograms of SD of Time Trend residual setup errors and
fitted distributions. Data achieved for Erasmus MC database.
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3.6 Discussion
Analysis of patient data showed that the null hypothesis of normal distribution of setup errors
can be rejected for about 40% of patients in case of COI database and for about 20% in case
of Erasmus MC database. The difference between both databases is rather big. The possible
reasons might be the difference in number of patients in each group (100 vs 835), number of
treatment fractions (25 vs 39) and different way of quantifying setup errors (bony anatomy
vs gold fiducials implanted in the prostate). Nevertheless for both databases the number of
patients with not normal distribution of setup errors is bigger than expected 5% while we use
Shapiro-Wilk test with confidence level set to 95%. That results are in contradiction to those
presented by Bijhold [4]. It has to be emphasized that although Bijhold concluded the normality
of analyzed data it is not clear how tests were done. The only thing presented in his paper,
on that matter, are confidence ellipses which seem to present data from normal distribution.
In more recent paper Lin et al. [51] investigated normality of prostate motion based on real-
time intrafraction tracking. They also performed statistical analysis, with Lilliefors test, for
accumulative fractions for 24 patients with at least 30 fractions with measurements. They
showed that only 33% of patients had Gaussian distribution in left-right direction, 12.5% in
anterior-posterior direction and 8.3% in head-feet direction. My results are based on Shapiro-
Wilk test and were performed only for one setup measurement per fraction.
According to Central Limit Theorem one would expect setup errors to have normal distri-
bution. That is because there are many factors influencing patient setup error. All of that
errors seem to be of the same order of magnitude and rather small. It is possible that such
unpredictable factors like stress (for example related to family and work life) and change in
RTTs operating the machine can influence the distribution of setup errors significantly. It has
to be emphasized that it is only a hypothesis and therefore should be checked in other works
and projects. The importance of the distribution of setup errors is related to the fact that most
of protocols and margin recipes used nowadays assume the normal distribution of setup errors
[89].
For both databases distribution of SDp was shown to be not normal. Also distribution of
mp in all principal directions for Erasmus MC database and for two directions in COI database
was shown to be not normal. This finding and its influence on the methods how we parametrize
population of patients was further investigated in Chapter 4.
During radiotherapy we deal with limited number of fractions. That is why it may happen
that observed trend has its origin in statistic not in physiology. In order to investigate this
issue MC simulation of 104 patients, with 40 setup errors each, was created. Four different
SD of random errors were used: 1, 2, 3 or 4 mm. Mean systematic error for each patient was
taken from the G(0,Σ = 3 mm). Time trend slope was calculated with OLS method using 3
to 40 fractions (see Fig. 3.48). It can be seen that absolute slope value bigger or equal to 0.04
mm/frac can be achieved for 39 fractions treatment with 35% probability. It means that 1.5
mm trend over whole 39 fraction treatment can have a statistic nature.
In order to propose a method of distinguishing between the statistical (apparent) time trend
and a physiological one (related to patient body and organ movements) I compared distribution
of trend slopes a achieved in synthetic population created without time trend with distribution
achieved clinically [34]. Mean slope Ma and width of its distribution Σa were compared. The
synthetic population consisted of 106 patients with F = 39 fraction treatment. Setup errors
were randomized from Gaussian distributions. Each patient systematic errormp was taken from
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Figure 3.48: SD of slope changing with number of fractions used in OLS trend fit. Histogram
of achieved slope values for 39 fractions and SD = 3 mm is also shown.
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Figure 3.49: Comparison of slope distribution achieved for Erasmus MC database in left-right
direction (clinical) and simulated population of 106 patients whose setup errors were not influ-
enced by physiological time trends.
G(M,Σ) and SDp was taken from G(σ, SDSD). Random errors were taken from G(mp, SDp).
All parameters used in this MC simulation were taken from clinical database analysis (per
principal direction). Statistical comparison of synthetic and clinical distribution was done with
Kolmogorov-Smirnov test. Fig. 3.49-3.51 show achieved distributions, p-values were << 0.001.
Therefore it can be concluded that time trends observed for Erasmus MC database have a
physiological component.
Time trend slope of order 0.1 mm/fraction leads to almost 4 mm change during 39 fractions
treatment. The observed slope, in both databases, varied up to 0.5-0.6 mm/fraction. The
distribution of total trend motion, i.e. difference between first and last fraction according to
trendline, for Erasmus MC database is shown in Fig. 3.52.
While analyzing trends, it was also shown, especially for Erasmus MC database, that for
more than half of population the setup errors increased during time (see Fig. 3.35-3.37). Usually
one would expect that during treatment patient would be more relaxed because he would be
more familiar with machine and whole radiotherapy process. This should lead to setup errors
decreasing with time. On the other hand there can be so many sources of stress (like medical
appointment, change in RTTs staff, machine breakdown, work or family situation, long waiting
time for specified fraction) that muscle tension can be hardly predicted. Slope values achieved
with OLS method showed greatest values for anterior-posterior direction see Fig. 3.34. That
can be explained by muscle tension (see Fig. 3.53). The influence of time trend existence on
population parametrization and margin calculation was investigated and would be presented in
Chapter 4 and Chapter 7 respectively.
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Figure 3.50: Comparison of slope distribution achieved for Erasmus MC database in anterior-
posterior direction (clinical) and simulated population of 106 patients whose setup errors were
not influenced by physiological time trends.
Figure 3.51: Comparison of slope distribution achieved for Erasmus MC database in head-
feet direction (clinical) and simulated population of 106 patients whose setup errors were not
influenced by physiological time trends.
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Figure 3.52: Histogram of observed total trend motion (i.e. change in setup errors related only
to trendline through the entire treatment). Data achieved for Erasmus MC database.
(a) Tighten buttock muscles (b) Relaxed buttock muscles
Figure 3.53: Comparison of two CT slices of the same patient. On the left the situation in
which muscles’ tension can be observed. On the right — relaxed muscles. The change in the
PTV position (red line) can be observed — PTV is higher in regard to table top while muscles
are tighten. GTV is shown as a yellow region while rectum is a green one.
σ [mm] Ma [mm/frac] Σa [mm/frac]
left-right 1.93 0.002 0.046
anterior-posterior 2.77 -0.019 0.083
head-feet 2.64 -0.042 0.075
Table 3.1: Parameters achieved for Erasmus MC database used to check whether observed
trends might have a physiological nature.

Chapter 4
Patient population characterization - the
choice of right parameters
4.1 Background
The aim of verification protocols is to minimize setup errors and deliver required therapeutic
dose to target volume. Probably the best solution is to use on-line verification protocols, i.e.
check the patient and target position each day prior to treatment and correct for detected mis-
alignment. The problem of this method is that it is rather time consuming. In clinical practice
one has to balance between efficiency and workload. That is why many off-line verification pro-
tocols [42] as well as CTV-PTV margins concepts were introduced [89]. Tests of such protocols
and margins are mostly done with Monte Carlo (MC) simulations of patient population setup
errors data [7, 14, 90]. That is why it is of high importance to have a good patient population
parametrization method which would be used during such MC simulations [34]. Otherwise
these simulations may lead to erroneous conclusions.
4.2 Materials and methods
In order to check the patient population parametrization methods setup errors of 835 prostate
cancer patients treated in Erasmus MC were analyzed. Description of these patient group is
given in Section 3.2.2. According to analysis results of the setup data presented in Section 3.5
two methods of population characterization were investigated. One was standard parametriza-
tion with Σ to describe systematic errors and σ to describe random errors distribution (see
Section 4.2.2.1). The other method incorporated the time trends (see Section 4.2.2.2).
In order to determine the proper way of implementing time trend parametrization pure
experiments were done at the beginning. For different simulation parameters setup errors
of 104 MC patients were simulated. Afterwards these, so called synthetic populations, were
analyzed and both parametrizations were applied and compared.
4.2.1 Synthetic population experiments
As it was discussed in Section 3.6 the trend fitted with OLS method to setup errors for treatment
with limited number of fractions (even as great as 40) might have only a statistical nature not a
physiological one. In consequence for population of patients one can expect to see the coupling
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effect of statistical and physiological trends. It has to be determined whether and how to
correct for that coupling effect. In order to resolve that problem pure, synthetic populations
were created with different parameters using MC simulations of setup errors. Mean population
setup error M was set to zero. Σ was taken from {1, 2, 3, 4} mm, and σ was taken from
{1, 2, 3} mm. Width of random error distribution SDSD was set to 0.75 mm. SD of trend slope
distribution, Σa, was taken from {0.0, 0.05, 0.1, 0.15} mm/fraction and mean slope, Ma, was
taken from {0.0,−0.05,−0.1} mm/fraction. For each set of parameters 39 setup errors (in one
direction) were created for 104 patients. In total 144 such synthetic populations were generated
and used to check and compare parametrization methods in terms of correcting for statistical
trends.
On the basis of simulated setup errors classical population parameters were calculated: M ,
Σ, σ and time trend parameters (Ma, Σa – see Section 4.2.2.2).
Assume that we want to reproduce a population with physiological time trend. Time trend
in clinical population has both components: statistical and physiological. That is why in order
to recreate similar trend in simulation one has to correct for the coupling effect. That can be
done by first simulating random errors and calculating slope arp as well as middle position mrp
for them. Afterwards trend defined by arp and mrp has to be subtracted from random errors and
required trend (ap, mp) has to be added. The same applies for standard parametrization in
which no trend is considered (ap = 0). As we can always fit a line to randomly chosen errors
also mean value, mrp, of them can be always calculated. That mean value, mrp, also has to
be subtracted from the random errors. Evaluation of simulated populations was done and is
described in Section 4.2.3. On the basis of these pure experiments, methodology of simulating
real database was proposed and tested afterwards.
4.2.2 Parametrization methods
Methods used to characterize population of patients in terms of setup errors are described below.
In each MC simulation, 104 patients with setup errors were generated. For each patient 39
fraction treatment was assumed. Synthetic populations had setup errors only in one direction.
4.2.2.1 Conventional Parametrization
In standard parametrization M , Σ (see Eq. 2.6) and σ with SDSD (see Eq. 2.8-2.7) were
obtained from the direct data. In this part of work synthetic populations served as direct data,
but clinical data can be used in the same manner. In order to create MC population following
steps were performed:
1. Systematic patient setup error, mp, was randomized from the normal distribution of mean
M and standard deviation equal Σ (G(M,Σ)).
2. Standard deviation of patient setup errors SDp was randomized from G(σ, SDSD) or Burr
distribution (see Fig. 3.45)
3. Random setup errors in each fraction were randomized from G(0, SDp).
4. In order to correct for statistical offset the mean value of random errors was calculated
as mrp and subtracted from random errors.
5. Total setup errors were calculated as sum of systematic error mp and random errors.
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4.2.2.2 Trendline Parametrization
In trendline parametrization [16] the time trend slope of patient p — ap and offset bp as well
as distribution of standard deviations of residual setup errors with SDp,res were obtained for
database of real patient data or for synthetic population. The mean setup error for patient p
can be calculated as:
mp =
1
F
F∑
f=1
(ap · f + bp) = F + 1
2
· (ap + bp) (4.1)
For total number of fractions F = 39 Eq. (4.1) simplifies to:
mp = 20 · ap + bp (4.2)
From Eq. (4.2) it can be concluded that there should be a straight correlation between time trend
parameters and mean setup error. Comparison between the distribution of mean setup error
calculated directly from setup errors and from time trend parameters is shown in Fig. 4.1-4.3.
The correlation between time trend parameters and mean setup error was also investigated (see
Fig. 4.4). TheR2 parameter and p-value were calculated. TheR2 parameter gives information of
how well data can be explained by the model (here linear fit). The p-value gives the information
of F statistic testing the null hypothesis that intercept-only model and linear fit are equal. From
results presented in Fig. 4.4 it can be concluded that the null hypothesis of correlation between
the mean setup error and time trend offset value cannot be neglected. The linear correlation
between the time trend slope and mean setup error is also significant (p-value below 0.05) but
not so visually clear like the one for offset.
In order to create MC populations with time trend parametrization following steps were
performed, assuming that required parameters were previously calculated for direct data:
1. Middle position of patient setup error, mp, was randomized from the normal distribution
of zero mean and standard deviation equal Σ (G(M,Σ)). Note that in order to emphasize
the difference between middle position and slope distribution m superscript was added:
M = Mm and Σ = Σm.
2. Patient slope ap was randomized from G(Ma,Σa)
3. Standard deviation of patient residual setup errors SDttp was randomized fromG(σtt, SDttSD)
or Burr distribution (see Fig. 3.47)
4. Random setup errors in each fraction were randomized from G(0, SDttp ).
5. In order to correct for statistical trend the OLS method was used to determine the trend
of random errors yielding to slope arp and mean error mrp. Afterwards this trend was
subtracted from residual random errors.
6. The patient trend was calculated as: (f − F+1
2
) · ap +mp, with f describing each fraction
of treatment.
7. Total setup errors were calculated as sum of patient trend and residual random errors.
70 4 Patient population characterization - the choice of right parameters
Figure 4.1: Histogram of left-right mean setup error calculated directly from database as well
as calculated from the time trend analysis parameters. Data achieved from the Erasmus MC
database.
Figure 4.2: Histogram of anterior-posterior mean setup error calculated directly from database
as well as calculated from the time trend analysis parameters. Data achieved from the Erasmus
MC database.
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Figure 4.3: Histogram of head-feat mean setup error calculated directly from database as well
as calculated from the time trend analysis parameters. Data achieved from the Erasmus MC
database.
4.2.3 Evaluating quality of parametrization
4.2.3.1 Ability of reproducing the initial data
In order to check the efficiency of the proposed parametrization methods distributions of param-
eters used to simulate the population were evaluated. It was assumed that a good parametriza-
tion should reproduce the inserted data. The distribution of mean setup error and standard
deviation of setup error were compared at the beginning. The distribution of time trend slope
and offset were also compared. Additionaly, for Erasmus MC database, the d100 defined as a
distance within each 100% of absolute setup errors lied in, was also evaluated. Two-sample
Kolmogorov-Smirnov test was used to compare distributions of input population with recre-
ated one (MC population). Null hypothesis stated that there is no difference between the two
and it was neglected if the probability of achieving statistic value as observed for two similar
distributions was lower than 0.001 (p-value ≤ 0.001). The choice of such low p-value was based
on many parameters influencing final distribution of setup errors and their parameters.
4.2.3.2 NAL and eNAL verification protocols performance
In order to check and compare population characterization methods NAL verification protocol
(Section 2.3.1) and eNAL verification protocol (Section 2.3.2) were applied for the clinical and
synthetic populations. NAL protocol was applied for different number of fractions taken into
the correction calculation (range 3 to 39). eNAL protocol was applied with starting 3 fractions
with imaging and a correction calculated afterwards and updated weekly in the remaining
treatment according to the fitted trend. The residual Σ (Σres, see Eq. 2.6) was calculated
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(a) (b)
(c) (d)
(e) (f)
Figure 4.4: Correlation between slope (left) and offset (right) for time trend OLS analysis and
mean value of setup errors in each direction. Data achieved for Erasmus MC database.
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each time and compared between the methods used to parametrize the patient population and
perform MC simulations. The hypothesis was that a good parametrization should allow to
predict NAL/eNAL protocol performance of inserted/based data. In case of NAL protocol it
means that relation between Σres and number of fractions used to calculate the correction factor
should be the same.
4.3 Results
4.3.1 Synthetic population experiments
4.3.1.1 Ability of reproducing the initial data
For both simulation methods, i.e. using the conventional parametrization (conventional MC)
and the trendline parametrization (trendline MC), distributions of mp fully reproduced dis-
tributions of synthetic populations (p-value > 0.001). SDp was significantly different for all
conventional MC populations and for most of trendline MC populations. Only 4 trendline
populations reproduced SDp distribution properly. Time trend slope (ap) distributions were
significantly different from the direct population for 122 out of 144 conventional MC popula-
tions. For trendline MC populations the slope was fully reproduced in all cases. Time trend
offset was significantly different for all conventional MC populations and for 36 trendline MC
populations.
4.3.1.2 NAL and eNAL verification protocols performance
Example results of NAL verification performance for synthetic and MC populations are shown
in Fig. 4.5. Despite the parameters used for the synthetic population generation, Σres for direct
simulation was well reproduced by trendline MC (in fact the direct simulation and trendline MC
curves lies on each other). It was not the case for the conventional MC. For most of the cases
with a trend present the conventional MC underestimated Σres. For populations with no trend
the conventional MC overestimated Σres. For some populations having trendline parameters
comparable with those related to limited number of fractions the conventional simulation could
properly reproduce Σres.
Fig. 4.6 presents results of Σres for n = 3 and different parameters of synthetic populations
(Ma, Σa, σ′). Presented results does not depend on value of Σ used for synthetic population cre-
ation. For Σa = 0, despite other parameters used, conventional parametrization overestimates
Σres. It might be explained by the fact that for Σa = 0 and Ma < 0 with increasing number
of fractions setup error was decreasing leading to smaller value of Σres. That behavior cannot
be properly modeled with conventional parametrization. For Σa = 0 and Ma = 0 there are
still trends related to limited number of fractions which were not corrected for in conventional
parametrization. With increasing Σa, Σres calculated for conventional parametrization gets
closer to direct simulation (synthetic population) depending on σ′ and Ma. For bigger values
of Σa conventional parametrization underestimates Σres. Using conventional parametrization
can lead to error in predicting Σres even of 1-1.5 mm. Trendline parametrization corrected for
limited number of fractions is the best to model synthetic population with differences in Σres
not exceeding 0.1 mm.
In Fig. 4.7 eNAL performance is compared between conventional and trendline parametriza-
tions. Similarly as for NAL protocol the trendline parametrization is in agreement with direct
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Figure 4.5: Comparison of Σres achieved with NAL protocol for five arbitrary chosen synthetic
and MC populations. Direct simulation shows the NAL performance for synthetic population,
it is ground truth for this evaluation.
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simulations (ground truth achieved here for synthetic populations). Unlike for NAL protocol
the conventional parametrization overestimates Σres which may lead to application of too big
margins.
4.3.2 Clinical Data
4.3.2.1 Ability of reproducing the initial data
Distributions of mean setup errormp, SD of patient setup errors SDp, d100, patient trend slope ap
and patient trend offset bp were investigated and compared between clinical data (Erasmus MC
database) and performed MC simulations. In total four simulation methods were compared at
this step. In general two methods of parametrization were used: conventional parametrization
(4.2.2.1) and trendline parametrization (4.2.2.2). Each of the parametrization methods was
corrected for limited number of fractions. For both methods two distributions of SDp were
tested for random errors generation: Gauss (see Eq. 3.3) and Burr (see Eq. 3.2).
Table 4.1 shows summary of achieved comparisons between performed MC simulations and
clinical data in terms of achieved p-values. If these p-values were bigger than 0.001 null hypoth-
esis that there is no difference between compared distributions couldn’t been neglected. These
values are presented in bold. It can be seen that in order to reproduce distribution of SDp and
d100 Burr distribution should be used to randomize SD of patient random errors. To reproduce
slope and offset distribution trendline parametrization should be used. Detailed results for both
parametrization methods are given in following two paragraphs.
mp SDp d100 ap bp
Conventional Paramentrization (Gauss)
Left-Right 0.249 0.0 0.0 0.0 0.031
Anterior-Posterior 0.021 0.0 0.286 0.0 0.0
Head-Feet 0.101 0.0 0.034 0.0 0.0
Conventional Paramentrization (Burr)
Left-Right 0.338 0.116 0.738 0.0 0.058
Anterior-Posterior 0.006 0.016 0.74 0.0 0.0
Head-Feet 0.176 0.079 0.275 0.0 0.0
Trendline Paramentrization (Gauss)
Left-Right 0.265 0.0 0.0 0.174 0.022
Anterior-Posterior 0.011 0.0 0.002 0.016 0.003
Head-Feet 0.174 0.0 0.015 0.042 0.009
Trendline Paramentrization (Burr)
Left-Right 0.441 0.899 0.469 0.105 0.032
Anterior-Posterior 0.03 0.493 0.586 0.041 0.003
Head-Feet 0.086 0.368 0.208 0.052 0.002
Table 4.1: Table presents p-values of Kolmogorov-Smirnov for comparison of clinical database
distributions with different methods of parametrizing and simulating setup errors. In brackets
distribution used in MC simulation for selection of SDp is given. p-values ≥ 0.001 are bold and
indicate for which parameter distribution achieved with tested parametrization was comparable
to clinical data (i.e. null hypothesis could not been rejected).
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Figure 4.6: Values of Σres achieved for 36 different synthetic populations (direct simulation) and
adequate MC populations: with standard parametrization (Conventional MC) and trendline
parametrization (Trendline MC). In each case NAL protocol was applied after first 3 fractions
with imaging. Total treatment time was set to 39 fractions.
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Figure 4.7: Values of Σres achieved for 36 different synthetic populations (direct simulation)
and adequate MC populations: with standard parametrization (Conventional MC) and trend-
line parametrization (Trendline MC). In each case eNAL protocol was applied in which first
correction was done after third fraction with update of correction factor done weekly. Total
treatment time was set to 39 fractions.
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Conventional Parametrization
Fig. 4.8-4.12 present comparison of distributions for parameters used to evaluate and parametrize
the database of setup errors between real data and MC simulations with conventional parametriza-
tion. It can be clearly seen that there is a significant difference between the real database and
simulation in distribution of SD of random errors while using Gaussian function to randomize
SDp. Also d100 is better reproduced with Burr distribution used for random errors generation.
With conventional parametrization it is impossible to reproduce slope and offset distribution
as it was calculated for real data. Still some distribution of slope would be observed according
to limited number of fractions. The slope calculated from data taken randomly from normal
distribution with 95% confidence level has an absolute value below 0.09 mm/fraction for Left-
Right, 0.17 mm/fraction for Anterior-Posterior and Head-Feet direction. Distribution of slope
for the conventional parametrization is more narrow and has a mean value close to zero (see
Fig. 4.11).
Trendline Parametrization
Fig. 4.13-4.17 present comparison of distributions for parameters used to evaluate and
parametrize database of setup errors between real data and MC simulations with trendline
parametrization. It can be seen that there is a significant difference between the real database
and simulation in distribution of SD of random errors while using Gaussian function to random-
ize SDp. Also d100 is not fully reproduced in that case. With the trendline parametrization the
slope and offset distributions are well reproduced. Especially for the trendline parametrization
with Burr distribution used for random error generation all parameters are reproduced properly
in terms of statistical analysis (see Table 4.1).
4.3.2.2 NAL and eNAL verification protocols performance
Fig. 4.18-4.20 show comparison between performance of MC parametrization and simulation
methods with clinical data for NAL protocol. It can be seen that the conventional parametriza-
tion (blue lines) underestimates the residual Σres (0.7 mm) when clinically relevant number of
fractions n is considered. The trendline parametrization (red lines) works better but still un-
derestimates Σres by about 0.3 mm. The difference between using Gauss or Burr distribution
to randomize SDp is small. Usage of Burr distribution generally gives slightly smaller Σres.
That can be explained by shift to smaller values of SDp with Burr distribution compared to
Gauss distribution. The smaller SDp the better estimation of mean value is. That mean value
is used as a correction factor in NAL protocol. Interestingly, NAL protocol performance for
Erasmus MC data depends on order of data. An inversion gives smaller Σres and that one
is well reproduced with the trendline parametrization. Σres dependence on order of fractions
would be discussed in 4.4.
Table 4.2 presents a comparison between parametrization methods in terms of simulating
NAL Nm = 3 and eNAL protocols performance for Erasmus MC database. The trendline
parametrization results for NAL protocol are closer to direct simulation than for conventionl
simulation. This is in agreement with Fig. 4.18-4.20. For eNAL both parametrizations worked
in comparable way.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.8: Comparison between histograms of mean setup error achieved for Erasmus MC
database and MC simulations with standard parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.9: Comparison between histograms of setup errors SD achieved for Erasmus MC
database and MC simulations with standard parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.10: Comparison between histograms of d100 achieved for Erasmus MC database and
MC simulations with standard parametrization. On the left the comparison is done for MC
simulations assuming Gaussian distribution of random error, on the right — Burr distribution
was assumed.
82 4 Patient population characterization - the choice of right parameters
(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.11: Comparison between histograms of time trend slope achieved for Erasmus MC
database and MC simulations with standard parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.12: Comparison between histograms of time trend offset achieved for Erasmus MC
database and MC simulations with standard parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.13: Comparison between histograms of mean setup error achieved for Erasmus MC
database and MC simulations with trendline parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.14: Comparison between histograms of setup errors SD achieved for Erasmus MC
database and MC simulations with trendline parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.15: Comparison between histograms of d100 achieved for Erasmus MC database and
MC simulations with trendline parametrization. On the left the comparison is done for MC
simulations assuming Gaussian distribution of random error, on the right — Burr distribution
was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.16: Comparison between histograms of time trend slope achieved for Erasmus MC
database and MC simulations with trendline parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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(a) Gauss distribution of random errors (b) Burr distribution of random errors
(c) Gauss distribution of random errors (d) Burr distribution of random errors
(e) Gauss distribution of random errors (f) Burr distribution of random errors
Figure 4.17: Comparison between histograms of time trend offset achieved for Erasmus MC
database and MC simulations with trendline parametrization. On the left the comparison is
done for MC simulations assuming Gaussian distribution of random error, on the right — Burr
distribution was assumed.
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NAL eNAL
Direct Trendline Conventional Direct Trendline Conventional
simulation MC MC simulation MC MC
LR 1.4 1.2 1.1 0.8 1.1 1.0
AP 2.0 1.7 1.3 0.8 1.1 1.0
HF 2.1 1.9 1.4 0.8 1.1 1.0
Table 4.2: Table presents Σres values achieved for Erasmus MC database in left-right (LR),
anterior-posterior (AP) and head-feet (HF) direction after the NAL (Nm = 3) and eNAL
protocols were simulated. All presented values are given in mm.
Figure 4.18: Comparison of Σres achieved with NAL protocol for Erasmus MC database and
MC populations in left-right direction.
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Figure 4.19: Comparison of Σres achieved with NAL protocol for Erasmus MC database and
MC populations in head-feet direction.
Figure 4.20: Comparison of Σres achieved with NAL protocol for Erasmus MC database and
MC populations in anterior-posterior direction.
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4.4 Discussion
Conventional parametrization of patient population setup errors was previously used to test
efficiency of OVP [7, 14]. Parametrization incorporating time trends was previously described
by de Boer and Heijmen [16]. In this chapter this parametrization was further explored and
widely compared with the conventional parametrization. According to findings presented in 4.3
if significant time trends are observed the conventional parametrization does not give the right
model. The trendline parametrization should be used instead, otherwise Σres can be 50%-70%
underestimated and in consequence too small CTV-PTV margin might be applied. That is
why it is of crucial importance to test setup errors in patients population for existence of time
trends. The method how to do that was proposed in Section 3.6.
In Section 4.3.2.2 it was shown that the trendline parametrization does not reproduce NAL
performance for Erasmus MC database (although it is closer to ground truth than conventional
parametrization). Σres strongly depends on goodness of estimation of the mean setup error mp.
The greater is SDp the worse is the estimation. Usually an assumption is made that SDp is
constant during the radiotherapy course. That was also assumed in provided MC simulations.
In a case the assumption is true if we reverse order of fractions the result should be the same.
It was the case in synthetic populations (see Fig. 4.21). In case of Erasmus MC database
inversion of fraction order gives different results (see Fig. 4.18-4.20). It can be seen that the
reverse order of fractions gives similar results for the simulation with trendline parametrization.
That indicates that SD′p taken in simulation was of the order of last part of the treatment. It
has to be kept in mind that in fact SD′p was calculated for whole treatment. From the difference
between normal and reversed order of fractions it can be presumed that SDp (and SD′p) are
changing during time of treatment. In order to check that hypothesis the change of σ in time
was evaluated. Eq. (2.7) was used to calculate σ for each following 3 fractions. In order to
do that setup errors for following 3 fractions (fractions 1-3, 2-4, . . . , 37-39) were extracted
from the database. Due to the fact that 3 is a small number of fractions the correction for
unbiased estimation was done (σ was divided by
√
pi/2). The results are presented in Fig. 4.22.
Especially for anterior-posterior direction it can be seen that σ is decreasing in time. That
trend seen for population does not have to be the case for a particular patient.
Patient setup errors and especially random setup errors can be influenced by many things,
like: stress, family life, waiting time, treatment staff, diet, being familiar with equipment and
so on. During the course of radiotherapy patient should be more and more familiar with the
treatment machine and radiotherapy process — that should generally decrease the SDp of
random error. Although it might happen that at the end of therapy patient would be bored
and nervous especially if it cost him a lot of effort to be on time and he has to wait for irradiation
afterwards. Everyday life with its stress, troubles, hope and joy is highly unpredictable. That
is why I think that stability of SDp should not be assumed. More other further methods of
investigating SDp change in time during course of treatment should be applied.
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Figure 4.21: Comparison of Σres achieved with NAL protocol for arbitrary chosen synthetic
populations (direct simulation). Performance in case of inverted fraction order is also shown
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Figure 4.22: Examination of σ/0.5
√
pi changes in time.

Chapter 5
Estimation of Cumulative Dose
5.1 Background
CTV-PTV margins designed on the basis of van Herk recipe (see Section 2.2) are population
based ones. The individual patient parameters (mp, SDp - see Eq. 2.3-2.4) are not taken
into account during creation of these margins. Moreover, their definition assume the normal
distribution of setup errors which is not always the case (see Chapter 3). That is why I decided
to check whether it would be possible to predict, in other words — to estimate, the cumulative
dose distribution for an individual patient after few first fractions of his treatment. If so,
methods of margin individualization might be considered. A treatment plan individualization
in terms of setup errors can influence dose both in PTV and OARs. Individualized margins may
give smaller field sizes and consequently decrease irradiated volume of healthy tissue. Much
effort is done nowadays to perform individualization in PTV definition [46]. Some authors
propose to include uncertainties into the optimization step in the margin-less planning concept
[5, 27, 62, 63], others propose the concept of probability PTV [85]. Both methodologies require
changes in TPS and therefore have to be implemented by vendors into new algorithms. For
clinical users it means the need of buying a new software and/or license. The simple method of
cumulative dose estimation proposed and verified in this work does not require any change in
TPS. Therefore it can be used with current software still allowing individualization of patient
treatment.
5.2 Material and methods
5.2.1 Clinical Data
Analysis of estimation of the cumulative dose distribution was done retrospectively for 25
patients who underwent 3D-CRT radiotherapy in COI. Those patients were a subgroup from
the patients described in Section 3.2.1. For all patients setup errors in all 25 fractions were
recorded during their treatment.
5.2.2 Radiotherapy Treatment Plans
All plans described below were prepared retrospectively. Eclipse 10.0 (Varian Medical Systems
Inc., Palo Alto, USA) TPS with Analytical Anisotropic Algorithm (AAA) version 10.0.28 was
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(a) 3D-CRT (b) IMRT
Figure 5.1: Treatment plan geometry for 3D-CRT (Fig. 5.1a) and IMRT (Fig. 5.1b) plans.
used. For each patient plans in three different techniques (3D-CRT, IMRT, VMAT) were
prepared by an experienced planner. Prescribed dose in each plan was 65 Gy in 25 fractions.
5.2.2.1 3D-CRT
3D-CRT plans consist of two lateral fields (90°and 270°) and one anterior beam: 0°(see Fig. 5.1a).
All beams were 15 MV. Both lateral beams had wedges. Multileaf Collimator (MLC) position
was set automatically with 0.9 cm distance to PTV in head-feet direction and 0.7 cm distance
in other directions.
5.2.2.2 IMRT
IMRT plans consist of five 15 MV fields with gantry angle of: 255°, 315°, 45°, 105°and 180°(see
Fig. 5.1a). MLC delivery was Sliding Window. Varian Leaf Motion Calculator was used to
calculate MLC pattern on the basis of optimal fluence, which is the results of optimization.
Inverse planning was done interactively in Helios (dedicated optimizer implemented in Eclipse).
Optimization parameters were changed during optimization process by experienced treatment
planner in order to achieve plan reaching such criteria as: DPTV99% >= 95%, V
rectum
61 Gy <= 25%,
V bladder52 Gy <= 50%.
5.2.2.3 VMAT
VMAT plans (also called RapidArc plans) consist of two full, coplanar, 6 MV arcs. The MLC
pattern, dose rate and gantry speed were optimized with the same criteria as for IMRT.
5.2.3 Cumulative Dose Distribution
Cumulative dose distribution Dcum is defined as the sum of dose distributions calculated for
all treatment fractions separately. Here it is the sum of dose distributions in case no setup
corrections were applied.
Gathered setup error data consisted of mp,f . Setup errors were measured in relation to
bony anatomy. In order to implement this setup errors into the TPS the isocenter position
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(a) 3D-CRT (b) IMRT
Figure 5.2: Distribution of isocenter positions for 3D-CRT (Fig. 5.2a) and IMRT (Fig. 5.2b)
plans.
had been shifted by −mp,f . Dose distributions were recalculated for the shifted isocenter with
preserved Monitor Units (MU) for each field. MU values were rounded to machine precision.
The dose distribution calculated with isocenter shifted for particular setup error was considered
to be the best representative of dose distribution in specified fraction (see Fig. 5.2). It is not
ideal dose distribution due to the intra- and inter- fraction changes in patient anatomy. The
only CT used in this analysis was that done before RT planning.
It has to be emphasized that it is known that in case of prostate irradiation prostate changes
its position depending on bladder and rectum filling [13]. Therefore in many hospitals, also
in COI, CBCT is used in order to minimize setup error. Still there are other treatment sites
for which tumor does not move relative to body anatomy. It is also important to mention
that for prostate cancer patients, in COI, setup errors are gathered in each fraction during
normal treatment (protocol described in Section 2.3.1). That is why I decided to test methods
of estimating cumulative dose distribution for data that were already gathered [33].
Denoting Dp,f (mp,f ) as the dose distribution in fraction f for patient p calculated with
isocenter shifted by −mp,f , cumulative dose for patient p — Dp,cum can be derived as:
Dp,cum =
nf∑
f=1
Dp,f (mp,f ) (5.1)
5.2.4 Methods of estimating Cumulative Dose Distribution
Cumulative dose distribution can be calculated only after the whole treatment and only in case
all setup errors were recorded and are known. That is why methods of estimating cumulative
dose distribution are searched.
5.2.4.1 Estimation with mean setup error
The first idea of estimating Dp,cum was to calculate the mean setup error (i.e. mean shift)
— mp,f (n) other n first treatment fractions, where n would be {2, 3, 4, ..., 14, 15, 20, 25}. Af-
terwards the isocenter was shifted according to mp,f (n) and Dose Distribution (for n known
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fractions) Dp,ms(n) was calculated:
Dp,ms(n) = Dp(mp,f (n)) = Dp
(
n∑
f=1
mp,f
n
)
(5.2)
5.2.4.2 Estimation with mean dose distribution
The second idea of estimating Dp,cum was to assume that the set of setup errors from first n
fractions is the best representative of the whole population of setup errors for that particular
patient. The dose distribution from this first n fractions was averaged and multiplied by total
number of fractions in order to calculate Dp,md(n).
Dp,md(n) = F · 1
n
n∑
f=1
Dp,f (mp,f ) (5.3)
5.2.5 Gamma Evaluation
In Quality Assurance (QA) of the radiotherapy process there is often a need to compare mea-
sured and calculated dose distribution. It happens for example during TPS commissioning [60]
or during pre-treatment verification of IMRT or VMAT plans [59]. Such a comparison consist
of comparing two dose distributions. Dimension in space of compared dose distributions can
be 1D (profile), 2D (plane) or 3D (volume). Another dimension is the dose value. In 1998 Low
et al. [53] proposed a gamma index concept as a simultaneous measure of dose and distance
difference between two dose distributions.
Gamma evaluation gives a single value which combines difference in dose and physical
distance, both scaled with the acceptance criteria. A schematic illustration of quantities used
in Eq. (5.4) is shown in Fig. 5.3. During calculation of gamma index we have to search over all
points in the reference dose distribution for such a point from the evaluated dose distribution
that its scaled distance in dose and physical space would be the smallest one. In order to do
that we have to compare the physical distance between points in the reference dose distribution
rr and the compared dose distribution rc and scale it by the accepted distance criteria ∆dM .
In the same manner we have to compare a dose in reference dose distribution — Dr(rr) with
a dose in compared dose distribution and scale it by the accepted dose difference ∆DM .
γ(rr) = min
{√
(Dc(rc)−Dr(rr))2
∆D2M
+
|rr − rc|2
∆d2M
}
∀{rc} (5.4)
Usually the ∆dM is chosen to be 2 mm or 3 mm, while ∆DM is 2% or 3%. As ∆DM is
given as a percent value it has to be explained that it can be a fraction of maximum dose in
distribution or local dose (i.e. Dr(rr)). Terms of global and local gamma evaluation are used
in order to differentiate between the two.
Gamma evaluation was used in order to compare cumulated and estimated dose distribu-
tions. Comparison was done with a Python script. Gamma evaluation parameters were set to
2 mm, 2%. Global as well as local gamma analysis was performed. The dose threshold was set
to 10%. That means that gamma evaluation was done only for points with dose equal or larger
than 10% of prescribed dose.
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Figure 5.3: Schematic illustration of the concept of gamma evaluation method. For readability
distance space is set to 2D. Point (rr, Dr) stands for point in reference dose distribution.
Point (rc, Dc) stands for exemplary point from compared dose distribution. ∆DM denotes
dose difference tolerance, while ∆dM denotes maximum allowed distance to agreement (graph
adapted from Depuydt et al. [19]).
5.2.6 DVHs Evaluation
I found it important to compare not only prediction of dose distribution but also dosimetric
parameters achieved for particular structures. Gamma evaluation do not take into account
how the dose is distributed in the structures and how well estimation is done in that sense. In
order to compare cumulative Dp,cum and estimated Dp,est dose distribution in terms of doses
delivered to structures I used DVHs (2.4). Dosimetric parameters in CTV, PTV and rectum
were investigated. For the plan performance the most important would be dose in CTV as
CTV-PTV margin was created in order to counteract setup errors. For CTV and PTV three
parameters were evaluated: Dmin, Dmean and D98%. For rectum V60 Gy and V65 Gy were eval-
uated. At first a difference between Dp,cum and Dp,ms or Dp,md was calculated. Afterwards a
statistical comparison was done in order to check if there is a significant difference between two
estimation methods in terms of doses in target volumes.
5.2.7 Statistical comparison
In order to statistically compare both methods of estimation i.e. Dms(n) and Dmd(n) Mann-
Whitney rank test was used. For each n, for each patient and each technique, a set of Dms(n)
and Dmd(n) was prepared. That gave 25 pairs of independent results (gamma index passing
rates, dosimetric parameters from DVH evaluation). According to that assumptions for Mann-
Whitney rank test were met. The null hypothesis stated that there is no difference between
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two methods of cumulative dose estimation. The p-value lower than 0.05 was considered as
significant, i.e. showing that there is reason to reject null hypothesis in favor of alternative
one.
5.3 Results
5.3.1 Gamma Evaluation
In clinical practice results of gamma evaluation are shown on 2D maps with color temperature
as a scale. It has to be kept in mind that voxels with gamma bigger than 1 did not pass
the criteria — i.e. the difference between dose distributions is bigger than the acceptance
criteria. Similar gamma maps were prepared for performed gamma analysis of Dp,est(n) and
some examples are shown in Fig. 5.4, 5.6, 5.8. Comparisons between n = 4 and n = 8 for 3D
(see Fig. 5.4), IMRT (see Fig. 5.6) show that for bigger n estimation of dose in the penumbra
region (i.e. in the region close to the field border) is better. It can be explained by dose blurring
increasing with n. Effect of dose blurring can be also seen for VMAT technique (see Fig. 5.8)
even if it is rather impossible to define field border there. The presented comparison shows also
that gamma results for Dp,md(n) estimation have lower gamma values than Dp,ms(n), especially
in high dose gradient regions. That can be explained by a dose blurring which is incorporated
in dose estimation only in Dp,md(n) method. Evaluated volume is biggest for VMAT technique,
and smallest for 3D-CRT. That is because IMRT uses more fields than 3D-CRT and VMAT
uses full arcs (so there is a beam from each gantry angle). As a consequence in both techniques
there is a rather big volume of normal tissue receiving low (but bigger than 10%) dose [35, 71].
5.3.1.1 Estimating with mean setup error
Results of gamma comparison for Dp,ms(n) are shown in Fig. 5.5, standard deviation of achieved
results is presented as errorbars. For 3D technique for Dp,ms(n > 9) (Dp,ms(n > 13)) the gamma
index 2 mm 2% of global (local) dose, with error, was smaller than 1 in at least 95% (90%) of
analyzed voxels. For IMRT technique for Dp,ms(n > 5) (Dp,ms(n > 7)) the gamma index 2 mm
2% of global (local) dose, with error, was smaller than 1 in at least 95% (90%) of analyzed
voxels. For VMAT technique for Dp,ms(n > 3) (Dp,ms(n > 4)) the gamma index 2 mm 2% of
global (local) dose with error was smaller than 1 in at least 95% (90%) of analyzed voxels.
5.3.1.2 Estimating with mean dose distribution
Results of gamma comparison for Dp,md(n) are shown in Fig. 5.7, standard deviation of achieved
results is presented as errorbars. For 3D technique for Dp,md(n > 8) (Dp,md(n > 8)) the gamma
index 2 mm 2% of global (local) dose, with error, was smaller than 1 in at least 95% (90%) of
analyzed voxels. For IMRT technique for Dp,md(n > 4) (Dp,md(n > 6)) the gamma index 2 mm
2% of global (local) dose, with error, was smaller than 1 in at least 95% (90%) of analyzed
voxels. For VMAT technique for Dp,ms(n > 3) (Dp,md(n > 4)) the gamma index 2 mm 2% of
global (local) dose with error was smaller than 1 in at least 95% (90%) of analyzed voxels.
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(a) Mean shift estimation: n = 4 (b) Mean dose estimation: n = 4
(c) Mean shift estimation: n = 8 (d) Mean dose estimation: n = 8
Figure 5.4: Examples of gamma evaluation result for 3D-CRT technique. Gamma below or
equal 1 (shown in blue and green) corresponds to voxels which fulfilled the dose and distance
difference tolerance: ∆DM = 2% max dose and ∆dM = 2 mm. Difference between estimation
from n = 4 (upper figures) and n = 8 (lower figures) known fractions is shown. Estimation
with mean shift is shown on the left, estimation with mean dose is shown on the right side of
figure. All presented gamma distributions were calculated for the same patient.
(a) global gamma (b) local gamma
Figure 5.5: Mean percent of voxels with gamma index not greater than 1 (γ 6 1) for comparison
between Dp,cum and Dp,ms(n). Standard deviation is presented as error. Gamma parameters
were set to 2 mm 2% of global dose (left) or local dose (right).
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(a) Mean shift estimation: n = 4 (b) Mean dose estimation: n = 4
(c) Mean shift estimation: n = 8 (d) Mean dose estimation: n = 8
Figure 5.6: Examples of gamma evaluation result for IMRT technique. Gamma below or equal 1
(shown in blue and green) corresponds to voxels which fulfilled the dose and distance difference
tolerance: ∆DM = 2% max dose and ∆dM = 2 mm. Difference between estimation from n = 4
(upper figures) and n = 8 (lower figures) known fractions is shown. Estimation with mean
shift is shown on the left, estimation with mean dose is shown on the right side of figure. All
presented gamma distributions were calculated for the same patient.
(a) global gamma (b) local gamma
Figure 5.7: Mean percent of voxels with gamma index not greater than 1 (γ 6 1) for comparison
between Dp,cum and Dp,md(n). Standard deviation is presented as error. Gamma parameters
were set to 2 mm 2% of global dose (left) or local dose (right).
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(a) Mean shift estimation: n = 4 (b) Mean dose estimation: n = 4
(c) Mean shift estimation: n = 8 (d) Mean dose estimation: n = 8
Figure 5.8: Examples of gamma evaluation result for VMAT technique. Gamma below or
equal 1 (shown in blue and green) corresponds to voxels which fulfilled the dose and distance
difference tolerance: ∆DM = 2% max dose and ∆dM = 2 mm. Difference between estimation
from n = 4 (upper figures) and n = 8 (lower figures) known fractions is shown. Estimation
with mean shift is shown on the left, estimation with mean dose is shown on the right side of
figure. All presented gamma distributions were calculated for the same patient.
(a) global gamma (b) local gamma
Figure 5.9: Number of patients with gamma index not greater than 1 (γ 6 1) in less than 95%
(90%) of voxels for global (local) gamma evaluation. Gamma parameters were set to 2 mm 2%
of global dose (left) or local dose (right).
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(a) global gamma (b) local gamma
Figure 5.10: Results of Mann-Whitney test performed for different n fractions used in dose
estimation. Gamma index passing rate for Dp,ms(n) and Dp,md(n) were compared. Gamma
parameters were set to 2 mm 2% of global dose (left) or local dose (right).
5.3.1.3 Comparison of estimation methods
In order to compare both methods of estimating Dp,cum number of patients who did not pass
the gamma evaluation — i.e. for whom gamma index 2 mm 2% of global (local) dose was in less
than 95% (90%) of voxels (see Fig. 5.9) — was also examined. It can be seen that in general,
with increasing number of fractions n taken into cumulative dose estimation, the number of
patients not passing gamma evaluation decreases. The effect is independent on the technique.
Results are similar for IMRT and VMAT technique, although for 3D technique difference might
be observed especially in local gamma evaluation.
Mann-Whitney rank test was performed in order to test the null hypothesis of no difference
between two methods of dose estimation (see Fig. 5.10). For global gamma evaluation we have
basis to neglect the null hypothesis for n > 5 for 3D-CRT technique (p 6 0.05). Also for
IMRT technique (apart from n = 11) we can neglect the null hypothesis for n > 6. For VMAT
technique for n < 10 we have no basis to reject the null hypothesis. It seems to be connected
with the bigger irradiated volume in case of VMAT technique. That technique seems to be most
robust for setup errors in terms of geometrical dose distribution. Dose blurring which may be
estimated with bootstrap methodology is more important in 3D-CRT where field borders are
seen and steeper dose gradients are achieved in the penumbra region (see Fig. 5.11).
5.3.2 DVHs Evaluation
5.3.2.1 Comparison of doses in CTV
Fig. 5.12 presents results of a comparison between dose in CTV for cumulative dose distribution
Dp,cum and estimated dose distribution: Dp,ms and Dp,md. It can be clearly seen that error
(which was the SD) does not change or change only slightly for Dp,ms. Also mean difference
is rather constant despite number of fractions n used for estimation. On the other hand SD
of difference between Dp,md and Dp,cum is decreasing with increasing n. For Dmin and D98%
also mean dose difference is decreasing with increasing n. It has to be stressed that negative
value of dose difference means that Dp,cum was bigger than Dest. In case of using this type of
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Figure 5.11: Comparison of profiles for Dp,cum, Dp,ms(n) and Dp,md(n). It can be seen that
Dp,ms(n) has the steepest dose gradient in penumbra region.
estimation and evaluation during routine planning it would be very important. For estimated
D98% lower than one for Dp,cum but still acceptable the actually delivered dose would be higher
than estimated one. Smallest dose differences for Dmin and D98% are seen for 3D technique
followed by IMRT and VMAT. For Dmean the smallest dose difference (and positive) is seen for
IMRT, 3D and VMAT are similar.
5.3.2.2 Comparison of doses in PTV
Fig. 5.13 presents results of comparison between cumulative dose distribution Dp,cum and es-
timated dose distribution: Dp,ms and Dp,md in terms of doses in PTV. Contrary to Fig. 5.12
it can be seen that mean dose difference for PTV is positive thus suggesting that Dp,cum was
lower than Dest. That should be kept in mind in case of clinical practice. The observations
about almost constant mean and SD of dose difference for Dp,ms despite n remains the same.
For Dp,md the mean dose difference as well as SD converges to zero with increasing n.
5.3.2.3 Comparison of doses in rectum
Comparison between cumulative dose distribution Dp,cum and estimated dose distribution:
Dp,ms and Dp,md in terms of doses in rectum is presented in Fig. 5.14. Mean and SD of
volume differences for both V60 Gy and V65 Gy decrease with increasing number of fractions used
in estimation for Dp,md.
5.3.2.4 Comparison of estimation methods
Results of statistical comparison between two methods of estimation can be seen in Fig. 5.15-
5.16. Null hyphotesis of no differences between the estimation methods cannot be rejected
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(a) Mean shift estimation: Dmin (b) Mean dose estimation: Dmin
(c) Mean shift estimation: Dmean (d) Mean dose estimation: Dmean
(e) Mean shift estimation: D98% (f) Mean dose estimation: D98%
Figure 5.12: Comparison of dosimetric parameters for CTV between Dp,cum and Dp,ms (left) or
Dp,md (right). Differences in Dmin, Dmean and D98% are shown. Number of fractions used for
dose estimation are shown in x axis. Negative values mean that Dp,cum was bigger than Dest.
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(a) Mean shift estimation: Dmin (b) Mean dose estimation: Dmin
(c) Mean shift estimation: Dmean (d) Mean dose estimation: Dmean
(e) Mean shift estimation: D98% (f) Mean dose estimation: D98%
Figure 5.13: Comparison of dosimetric parameters for PTV between Dp,cum and Dp,ms (left) or
Dp,md (right). Differences in Dmin, Dmean and D98% are shown. Number of fractions used for
dose estimation are shown in x axis. Negative values mean that Dp,cum was bigger than Dest.
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(a) Mean shift estimation: V60 Gy (b) Mean dose estimation: V60 Gy
(c) Mean shift estimation: V65 Gy (d) Mean dose estimation: V65 Gy
Figure 5.14: Comparison of dosimetric parameters for rectum between Dp,cum and Dp,ms (left)
or Dp,md (right). Differences in V60 Gy and V65 Gy are shown. Number of fractions used for dose
estimation are shown in x axis. Negative values mean that Dp,cum was bigger than Dest.
for CTV Dmean for all techniques. The null hypothesis has to be rejected for CTV Dmin and
D98% for VMAT technique for n bigger than 4 and 2 respectively. Combining that result with
Fig. 5.12 shows that the cumulative dose distribution is better estimated withDp,md. Estimation
is significantly different for IMRT and VMAT technique for PTV Dmean and n > 3 as well as
for rectum V65 Gy and n > 11.
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(a) CTV: Dmin (b) PTV: Dmin
(c) CTV: Dmean (d) PTV: Dmean
(e) Mean shift estimation: D98% (f) Mean dose estimation: D98%
Figure 5.15: Mann-Whitney sign rank test results for dose parameters in CTV and PTV.
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(a) rectum: V60 Gy (b) rectum: V60 Gy
Figure 5.16: Mann-Whitney sign rank test results for dose parameters in rectum.
5.4 Discussion
The effect of setup errors and target/organ motion on dose distribution was investigated by
many groups and summarized in [6].
Convolution method of incorporating setup uncertainties into the plan evaluation has been
widely used and discussed [11, 12, 89, 90]. That method stands also behind the van Herk’s
recipe for margin calculation (see Section 2.2.1). Craig et al. presented limitations of these
methodology [11, 12]. One limitation is that the convolution is usually done on the basis of
static dose cloud and so it does not incorporate anatomical changes which would influence the
dose distribution. Secondly, the convolution method assumes infinite number of infinitesimally
small fractions which is not the case in practice. The solution presented in this part of my
work deals with both these problems. The dose distribution was always calculated with the
isocenter shift and therefore the dose per fraction was not a fixed dose cloud. The limitation of
this study was the fixed CT image used. It is well known that for prostate irradiation changes
in target and OARs positions and shapes are observed. Still I found it important to investigate
with solid anatomy whether proposed methodology might be used. For further investigations
daily CBCT could be used in order to incorporate not only differences in dose distributions due
to beam shift but also due to anatomical changes.
Nowadays much effort is put into designing margin-less planning and patient specific treat-
ment. First approach is mainly based on probability distributions of possible setup errors or
organ motions [5, 27]. In second approach known target positions and shapes are incorporated
to create a patient specific margin [95] or to create plans for different patient geometries in plan
of the day approach [31, 41].
The proposed method of estimating the cumulative dose distribution may be used in order
to create a patient specific margin-less plan. Moreover, that methodology may be used for the
plan evaluation in daily practice without the need of new treatment planning software.
Chapter 6
Proposal of a new off-line verification
protocol
6.1 Background
No Action Level (NAL) Protocol [14], which was described in Section 2.3 is an example of an
off-line verification protocol (OVP). It provides a reduction in systematic error while keeping
the workload on a reasonably low level. In NAL one has to measure setup errors in n first
fractions (usually n = 3 or n = 4 [7, 14]) and then calculate mean value of setup error for each
axis which would be used as a correction value for all upcoming fractions. NAL doesn’t take
into account the possible time and trend therefore an eNAL was introduced [16]. As Bortfeld
[7] noticed the NAL does not always end up with a good estimation of systematic setup error.
That is why it can happen that pure (i.e. not corrected) setup errors would have smaller setup
error than those corrected with NAL (see Fig. 6.1).
The quality of NAL performance depends on the systematic setup error estimation. As
de Boer mentioned in [14]: "final distribution of systematic errors is basically independent of
the initial distribution of systematic errors, and determined only by SD of the random errors
and the number of measurements n per patient from which the systematic error of patient
is estimated." It is known from statistics that for larger SD the estimate of mean value is
usually worse with the same number of samples used. As a consequence it can be expected that
estimate of systematic setup errors for patients with large random error variation (so called
large movers) can have bigger uncertainty. From clinical experience it is also known that some
patients require an on-line verification for whole treatment. That is why I decided to check the
reliability (the accuracy) of mean setup error estimation calculated after first few fractions of
treatment.
The aim of this part of my work was to propose a new OVP taking into account the
uncertainty of systematic setup error estimation. In other words the idea was to identify
problematic patients from the whole cohort. I define a problematic patient here as the one
with high probability of bad estimation of mean setup error in the first fractions of treatment.
These patients would most probably have larger setup errors variations and that is why they
are called large movers.
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Figure 6.1: Example of of wrong estimation of mean setup error in NAL protocol. Arrow shows
an example shift between corrected an uncorrected setup error.
6.2 Material and methods
6.2.1 Individualized No Action Level Protocol (iNAL)
The proposed individualized No Action Level (iNAL) protocol starts as NAL. Images are taken
in the first 3 fractions, without any correction being applied. A setup correction factor is
calculated after the first 3 fractions. The difference in iNAL protocol is that starting from the
4th fraction the estimation of standard error of the mean from all previous fractions is also
examined. That value is a measure of uncertainty of the mean value. Due to the fact that
standard deviation is calculated from the sample of population the unbiased estimator of the
standard deviation is used:
SEMmp(n) =
SDp√
n
=
√√√√ n∑
f=1
(mpf −mp)2
n(n− 1) (6.1)
where:
SEM → standard error of mean
n→ number of fractions taken into calculation (i.e. the number of fractions with images)
The SEMmp(n) is compared with some arbitrarily chosen value called flag. If it is lower than
the flag then NAL protocol is applied until the end of the treatment. If it is not, the correction
is applied only in upcoming fraction with image being taken. Afterwards the procedure is done
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again and again — until SEMmp(n) is lower than the flag. After each new image taken a
correction as well as SEMmp(n) are recalculated.
6.2.2 Cumulative Average Protocol (CA)
In NAL protocol n fractions would be irradiated without setup error correction and all other
fractions will have it applied. In iNAL protocol all patients have correction applied after the
3rd fraction, although for some patients the correction value would be recalculated. Therefore
the question arises if the difference in protocols performance might be attributed to the number
of uncorrected fractions. That is why in order to provide a more fair comparison between
protocols I also tested the Cumulative Average (CA) OVP protocol.
The CA protocol started in the same manner as NAL. Three first fractions were done without
any corrections and the mean value of setup error was calculated. Afterwards the correction
was applied but also the image was taken until fraction m. After each fraction the correction
value was recalculated as an average from all previous fractions. After fraction m correction
was than applied to all upcoming fractions.
6.2.3 Synthetic Data (Monte Carlo patients)
In order to test different possible groups of patients I used different combinations of Σ ∈
{1, 2, 3} mm, σ ∈ {1, 2, 3, 4} mm and SDSD ∈ {0.5, 1.0, 1.5, 2.0} mm. For some simulations
SDSD was set to 0.26σ [91]. For each combination of Σ, σ and SDSD 104 patients were
simulated. I have tested the 25 and 39 fractions treatments.
Due to the fact that the aim of proposed protocol was to detect patients with large random
error deviation I was very interested in testing the iNAL protocol for such patients. In order to
look closely on large movers I also simulated them. In that case I set the condition that SDp
has be in upper 5% percentile of G(σ, SDSD) distribution. Having the same number of patients
for whole population and large movers I could provide a fair comparison between them.
6.2.4 Chi-square distribution theoretical background
In statistics the χ2 test is used to check the accuracy of standard deviation calculation from some
samples instead of whole population. The statistic χSTAT 2 is used in that case (see Eq. 6.2).
χSTAT
2 =
(k − 1) · S2
σo2
(6.2)
where:
k → sample size
S2 → sample variance
σo
2 → population variance as stated in the null hypothesis
In iNAL protocol the aim is to detect patients with large random error variation. It might
happen that having relatively small population variance σo2 the sample variance calculated
from first few fractions (i.e. from small sample size) would be big. For that patients, in iNAL
protocol, an additional imaging would be done. Of course the decision of the additional imaging
would depend on the value of arbitrary chosen flag used in the protocol. On the basis of χ2
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distribution it is possible to predict the number of images which will be done in the iNAL
protocol depending on the flag.
In case of the iNAL the Eq. (6.2) has to be rewritten due to the fact that we use standard
error of mean (SEMmp(n)) instead of variance to compare with the flag. In other words we are
interested in probability of finding the SEMmp(n) for n samples equal to the flag in case that
the population standard error of mean is SEMo.
χSTAT
2(SEMo(nf )) =
(nf − 1) · S
2
nf
σo
2
nf
=
(nf − 1) · flag2
SEMo
2 (6.3)
In Eq. (6.3) nf is the number of fractions with images for a particular patient (number of samples
in statistical terminology) and σo2 is the true variance of setup errors for examined population
of patients. In case of Monte Carlo patients it means that setup errors were randomly chosen
from the normal distribution with σo2 used as variance.
In iNAL protocol the number of images for a particular patient depends on the compari-
son between SEMmp(n) and the flag. That is why in order to calculate the probability that
patient would have nf fractions with images we have to calculate the area under the χ2 dis-
tribution. The example of shapes of Chi-square distributions for different number of degrees
of freedom (different nf ) are shown in Fig. 6.2. Due to the fact that our interest is in cal-
culating the probability of having exactly nf fractions with images we have to subtract the
probability calculated for (nf − 1) fractions from the one calculated for nf . This cannot be
done strictly because of the change in shape of Probability Density Function (PDF) as it is
shown in Fig. 6.2. The desired estimation can be done by calculating the Cumulative Distribu-
tion Function (CDF)1 of χ2STAT for
σo
2
nf − 1 and
σo
2
nf
(see Fig. 6.3). The white area in Fig. 6.3 is
equal to 1− CDF(χSTAT 2(SEMo(nf )), nf − 1). That area corresponds to the probability that
patient had less than nf fractions with images. Finally it can be written:
∆nf =
CDF
(nf − 1) · flag2σo2
nf
, nf − 1
− CDF
(nf − 1) · flag2σo2
nf − 1
, nf − 1


× 1−
∑nf−1
i=3 ∆nf
1− CDF
(nf − 1) · flag2σo2
nf − 1
, nf − 1

(6.4)
The χ2 methodology described above may be used in order to determine the average number
of images for the specified flag used. In that way it would be possible to predict the workload
needed to apply the iNAL protocol.
1notation CDF(χSTAT 2, dof) is used to determine the Cumulative Distribution Function for χSTAT 2 and
dof degrees of freedom
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(a) (b)
Figure 6.2: Probability density functions of χ2 distribution with different degrees of freedom:
3 (nf = 4) — left and 4 (nf = 5) — right. The shaded area shows the probability of observing
SEMm¯p equal or bigger than the flag.
In order to investigate relations between standard deviation of setup error and required
number of fractions with images a MC simulation of 104 patients setup errors was done. In
that case SDp was taken exactly from the set of {0.5, 1.0, ..., 9.5, 10.0} mm. In other words for
each patient SDp was kept the same. Systematic error was taken from the normal distribution
G(0,Σ) with Σ ∈ {1, 2, 3} mm.
6.2.5 Receiver Operating Characteristic curve
Receiver Operating Characteristic (ROC) curve is a well known characteristic used mostly in
diagnostic [88]. The aim of this curve is to check the sensitivity and specificity of the method.
Assume that we would like to detect large movers. In population of patients some of them
would be large movers and some not. We would like to find some classifier which would be
able to detect patients that really are large movers — that would be True Positive (TP) group.
It might happen that we would detect patients who were not large movers — that would be
False Positive (FP) group. On the other hand all patients that are not large movers and were
not detected would be True Negative (TN) group. Last, the False Negative (FN) group would
consist of those patients who were large movers but were not detected. The sensitivity is a
fraction of positive occurrences (here: large movers) correctly classified called the True Positive
Rate (TPR). The specificity is defined as a fraction of negative occurrences correctly classified
so it is True Negative Rate (TNR):
sensitivity = TPR =
TP
TP + FN
(6.5)
specificity = TNR =
TN
TN + FP
(6.6)
The ROC curve is a plot of TPR, i.e. sensitivity, against False Positive Rate (FPR) [36]. It
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Figure 6.3: Probability density function of χ2 distribution with 4 degrees of freedom (nf = 5).
The whole shaded area shows the probability of observing SEMmp equal or bigger than the flag
if the SEMo(nf ) = σo
2
(nf−1) . The blue area shows the probability of observing SEMmp equal or
bigger than the flag if the SEMo(nf ) = σo
2
nf
. Cyan area shows the probability of having exactly
nf fractions with images.
should be emphasized that:
FPR = 1− specificity = 1− TNR = 1− TN
TN + FP
=
FP
TN + FP
(6.7)
Due to the fact that we want to detect correctly large movers we would like to maximize TPR
(sensitivity) value. In the same time we would like to maximize TNR (specificity) in order to
correctly not detect patients who are not large movers. It is the same with minimizing the
FPR. That is why closer the ROC curve is to the top left corner better the detection method
is.
Area under ROC curve (AUC) is used to check the test method accuracy. It gives informa-
tion on probability of correctly classified positive occurrences [36]. The intuitive guide for the
tested method classifying accuracy can be as follows:
• AUC between 0.90 and 1 means excellent test accuracy
• AUC between 0.80 and 0.90 means good test accuracy
• AUC between 0.70 and 0.80 means fair test accuracy
• AUC between 0.70 and 0.60 means poor test accuracy
• AUC below 0.60 means that test fails
The classifier used in this work was the standard error of the mean setup error SEMmp
(see Eq. 6.1). The large movers were defined as those patients for whom the unbiased standard
deviation SDp (see Eq. 2.4) was at least equal to the value of 90th percentile of G(σ, SDSD).
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Analysis of ROC curves was done for whole Monte Carlo patients groups (including all possible
SDp).
6.2.6 Evaluation and comparison of protocols
Comparison of proposed iNAL protocol with NAL and eNAL protocols was done on the basis
of residual Σ (Σres). Σres is calculated in the same manner as normal Σ (see Eq. 2.6). The only
difference is that setup errors after an OVP was applied are used instead of pure ones. Value
of Σres influences the calculated margin size. That is why also the margin size and percentage
of patients were compared.
6.3 Results
6.3.1 Estimation of average number of images in iNAL protocol
Distribution of the fraction number with imaging for patients population with same SDp was
tested for a 25 and a 39 fractions treatment. A MC simulation of the protocol was compared
with theoretical values achieved with the χ2 statistics. Different SDp and the flag values were
evaluated. Results are presented in Fig. 6.4-6.5. It can be seen that for a bigger flag value
more patients have smaller number of images. With an increase in SDp the number of patients
with bigger number of fractions with images also increases. Theoretical curve fits well to the
simulated data. The peak observed in the last fraction for some SDp and flags may be explained
by the need of making images in all fractions. In a treatment with more fractions such peak
would disappear.
Knowing the number of patients with different number of images (Fig. 6.4-6.5) makes possi-
ble to predict the average number of images for the specified flag value. A comparison between
MC simulation and theoretical prediction was done. Results are presented in Fig. 6.6-6.7. It
can be seen that χ2 statistics methodology predicts very well the average number of images for
different SDp.
Fig. 6.8-6.9 show dependence between average number of images per patients, σ and flag.
With flag decreasing the average number of images increases. With increasing σ the average
number of images also increases. Results do not depend on Σ.
6.3.2 Accuracy test (ROC curves analysis)
A typical shape of ROC curve is shown in Fig. 6.10a. The classification based on SEMmp works
better with nf increase (see Fig. 6.10b). That result seems to be reasonable: with increasing
nf the estimate of standard deviation and therefore also estimate of standard mean error are
closer to the real value. The AUC depends mostly on σ and SDSD (see Fig. 6.11). Results
for different Σ and different total number of fractions F are very similar (see Tables 6.1-6.6).
The classification based on SEMmp(nf = 3) did not fail for any of tested parameters. Effect of
classification was worse with decrease of SDSD and increase of σ.
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(a) (b)
(c) (d)
(e) (f)
Figure 6.4: Histograms of number of patients with specified number of images. Theoretical
prediction of χ2 model is shown with cyan circles. Calculations done for 25 fractions treatment.
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(a) (b)
(c) (d)
(e) (f)
Figure 6.5: Histograms of number of patients with specified number of images. Theoretical
prediction of χ2 model is shown with cyan circles. Calculations done for 39 fractions treatment.
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Figure 6.6: Distributions of number of images for population of patients with constant SDp.
Theoretical prediction of average number of images is shown with yellow diamond. Achieved
mean value is shown with red square. Calculations done for 25 fractions treatment.
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Figure 6.7: Distributions of number of images for population of patients with constant SDp.
Theoretical prediction of average number of images is shown with yellow diamond. Achieved
mean value is shown with red square. Calculations done for 39 fractions treatment.
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Figure 6.8: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Width of Gaussian distribution of SDp was taken as SDSD = 0.26 · σ. Calculations done
for 25 fractions treatment.
Figure 6.9: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Width of Gaussian distribution of SDp was taken as SDSD = 0.26 · σ. Calculations done
for 39 fractions treatment.
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(a) (b)
Figure 6.10: The ROC curves achieved for Σ = 2 mm, σ = 2 mm and SDSD = 1.0 mm. Left
image shows ROC where the classifier was SEMmp(nf = 3). Right image shows ROC curves
for different classifiers: SEMmp(nf ), arrow indicates the direction of increasing nf .
(a) (b)
Figure 6.11: AUC dependence on number of fractions with imaging — nf , for Σ = 2 mm.
Dependencies on σ (left figure) and SDSD (right figure) are presented.
SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.76 0.73 0.68 0.70 0.68 0.68
1.0 0.82 0.80 0.76 0.72 0.70 0.69
1.5 0.85 0.83 0.81 0.78 0.74 0.73
2.0 0.87 0.84 0.82 0.79 0.78 0.75
2.5 0.89 0.87 0.85 0.83 0.79 0.77
3.0 0.90 0.87 0.86 0.83 0.81 0.79
Table 6.1: Values of AUC for nf = 3, Σ = 1 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 25. Values of σ and SDSD are given in mm.
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SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.77 0.73 0.71 0.68 0.64 0.67
1.0 0.82 0.79 0.76 0.74 0.72 0.69
1.5 0.85 0.82 0.80 0.77 0.76 0.72
2.0 0.87 0.85 0.81 0.80 0.78 0.75
2.5 0.89 0.86 0.84 0.82 0.80 0.79
3.0 0.90 0.87 0.85 0.83 0.82 0.79
Table 6.2: Values of AUC for nf = 3, Σ = 2 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 25. Values of σ and SDSD are given in mm.
SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.77 0.74 0.68 0.69 0.68 0.67
1.0 0.82 0.79 0.77 0.72 0.72 0.70
1.5 0.85 0.82 0.80 0.76 0.73 0.71
2.0 0.87 0.85 0.82 0.80 0.78 0.76
2.5 0.89 0.87 0.85 0.82 0.79 0.76
3.0 0.91 0.88 0.86 0.83 0.82 0.80
Table 6.3: Values of AUC for nf = 3. Σ = 3 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 25. Values of σ and SDSD are given in mm.
SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.76 0.71 0.71 0.69 0.67 0.66
1.0 0.81 0.78 0.75 0.72 0.70 0.69
1.5 0.84 0.82 0.79 0.77 0.72 0.73
2.0 0.87 0.85 0.81 0.80 0.76 0.73
2.5 0.88 0.86 0.83 0.82 0.79 0.77
3.0 0.90 0.87 0.85 0.84 0.81 0.78
Table 6.4: Values of AUC for nf = 3, Σ = 1 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 39. Values of σ and SDSD are given in mm.
6.3 Results 125
SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.76 0.71 0.68 0.70 0.67 0.65
1.0 0.82 0.79 0.74 0.74 0.72 0.69
1.5 0.84 0.82 0.79 0.77 0.72 0.72
2.0 0.87 0.85 0.82 0.79 0.76 0.74
2.5 0.89 0.86 0.84 0.81 0.80 0.77
3.0 0.91 0.87 0.85 0.83 0.80 0.78
Table 6.5: Values of AUC for nf = 3, Σ = 2 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 39. Values of σ and SDSD are given in mm.
SDSD
σ
1.0 2.0 3.0 4.0 5.0 6.0
0.5 0.75 0.71 0.69 0.66 0.67 0.62
1.0 0.81 0.78 0.75 0.71 0.71 0.66
1.5 0.85 0.81 0.79 0.75 0.73 0.69
2.0 0.87 0.84 0.81 0.79 0.77 0.74
2.5 0.89 0.86 0.84 0.81 0.79 0.76
3.0 0.90 0.87 0.85 0.83 0.82 0.79
Table 6.6: Values of AUC for nf = 3. Σ = 3 mm and different σ and SDSD. Total number of
fractions for this calculations was F = 39. Values of σ and SDSD are given in mm.
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6.3.3 Evaluation and comparison of protocols
Comparison of Σres was done for the simulated MC patient population as well as for the
population of large movers. In Fig. 6.12-6.13 it can be seen that for a small average number of
fractions with images N ≤ 5 the iNAL protocol has similar Σres, compared to NAL and CA, for
the whole population of patients. At the same time a decrease in Σres is observed with iNAL for
large movers. Comparison of distributions of residual systematic errors for the whole population
and large movers for CA and iNAL protocols is shown in Fig. 6.14-6.15. It can be seen that for
both protocols distributions of mp,i for the whole population of patients are similar. Contrary
to that for large movers distributions of mp,i achieved for both protocols are different in shape.
For iNAL protocol it can be seen that more patients has smaller residual systematic error
with simultaneous decrease in number of patients having big residual systematic error. Even
bigger effect can be observed while comparing iNAL with eNAL where bigger average number
of fractions with imaging is used (see Fig. 6.16-6.17). Additionally, all presented histograms
show a change in shape in the distribution of setup errors after implementation of verification
protocols. The distribution which initially was Gaussian was changed, and in consequence an
application of van Herk margin leads to bigger percentage of patients with CTV inside margin
(i.e. with residual systematic setup errors inside margin) than assumed (90%). That effect is
related to the fact that 2.5 factor in van Herk margin recipe (2.14) comes from analysis of 3D
Gaussians.
Fig. 6.18-6.21 show a comparison of OVP for different σ and SDSD. The percentage of
patients with residual systematic setup error inside the margin is shown. It can be seen that
with σ increasing the percentage of large movers with CTV inside the margin also increases.
With SDSD increasing the percentage decreases. The difference between the protocols is biggest
for the biggest SDSD. The bigger is the σ value the difference is slightly smaller.
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Figure 6.12: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 25 fractions treatment.
Figure 6.13: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 39 fractions treatment.
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Figure 6.14: Comparison of residual systematic setup errors mp distributions achieved with
two different OVP: CA and iNAL. Distributions for the whole population (upper figure) and
large movers (lower figure) are shown. Percentage of patients inside the margin calculated with
van Herk recipe is shown. Margin size is presented with dotted lines as calculated for whole
population. Calculations done for 25 fractions treatment.
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Figure 6.15: Comparison of residual systematic setup errors mp distributions achieved with
two different OVP: CA and iNAL. Distributions for the whole population (upper figure) and
large movers (lower figure) are shown. Percentage of patients inside the margin calculated with
van Herk recipe is shown. Margin size is presented with dotted lines as calculated for whole
population. Calculations done for 39 fractions treatment.
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Figure 6.16: Comparison of residual systematic setup errors mp distributions achieved with
two different OVP: eNAL and iNAL. Distributions for the whole population (upper figure) and
large movers (lower figure) are shown. Percentage of patients inside the margin calculated with
van Herk recipe is shown. Margin size is presented with dotted lines as calculated for whole
population. Calculations done for 25 fractions treatment.
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Figure 6.17: Comparison of residual systematic setup errors mp distributions achieved with
two different OVP: eNAL and iNAL. Distributions for the whole population (upper figure) and
large movers (lower figure) are shown. Percentage of patients inside the margin calculated with
van Herk recipe is shown. Margin size is presented with dotted lines as calculated for whole
population. Calculations done for 39 fractions treatment.
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Figure 6.18: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 25 fractions treatment.
Figure 6.19: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 25 fractions treatment.
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Figure 6.20: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 39 fractions treatment.
Figure 6.21: Dependence between average number of images per patient and the flag value.
Theoretical results are showed with dashed lines. Simulation results are showed with dotted
lines. Calculations done for 39 fractions treatment.
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6.4 Application recipe
In order to provide an easy way for implementing the proposed iNAL protocol into the clinical
practice a step-by-step approach is provided below. Prior to implementation of a new verifi-
cation protocol it is necessary to evaluate previously treated patients coming from the same
population group (i.e. receiving the same kind of treatment, the same cancer localization, the
same position during radiotherapy, the same setup verification method).
1. For previously treated patients perform a statistical analysis. Check whether a significant
inter-fraction time trend is found (see Section 3.6 for test description):
(yes) Consider application of eNAL verification protocol (see Section 2.3.2)
(no) Follow the remaining steps for application of iNAL verification protocol
2. Decide on average number of images in population which you want to use for patient
verification. Check the desired flag value. In order to do that you have to know Σ, σ and
SDSD values for your population. You may consider using Fig. 6.8-6.9 to find the relation
between average number of images in patient population and flag value. Alternatively,
the theory provided in Section 6.2.4 may be used. Please keep in mind that results do
not depend much on Σ.
3. Implement the iNAL protocol: create a workload in which it would be possible to calculate
SEMmp and compare it with flag. On the basis of this comparison a decision shall be
made to perform additional image or not.
6.5 Discussion
There are several off-line verification protocols still used in many clinics where on-line verifica-
tion have not been introduced. The most popular is NAL [14] and its extension to incorporate
time trends: eNAL [16]. The other popular protocol is Shrinking Action Level (SAL) [3] in
which number of fractions with images depends on the action level applied to mean setup error
value. The action level is decreasing with increasing number of images.
To the best of my knowledge the proposed iNAL protocol is the only one which tries to detect
problematic patients i.e. those with relatively large SD of setup errors. For these patients a
proper estimation of mean setup error require bigger number of images.
The proposed iNAL verification protocol allows to distribute performed images in a more
clever way. With the usage of iNAL more images would be done for patients with bigger
probability of being a large mover. Performance of iNAL protocol changes the distribution of
mp especially for large movers group.
Theoretical basis of the iNAL protocol has been given. It is possible to select an appropriate
flag for given population of patients on the basis of χ2 statistics. In clinical practice the balance
between adequate average number of fractions with imaging and sufficient detection of large
movers has to be found.
Chapter 7
CTV-PTV margins in case of time trends
7.1 Background
Generally, CTV-PTV margin recipes for coping with tumor set-up variations consider system-
atic and random patient set-up errors [82, 90]. As it was shown in Chapter 3 and further
investigated in Chapter 4 significant inter-fraction time trends may be observed during course
of treatment. To the best of my knowledge, there are no margin recipes that explicitly handle
inter-fraction time trends. To cover this gap a novel margin recipe is proposed [34]. The pro-
posed margin recipe was compared with the well-known recipe by van Herk et al. [90]. The
validation of the recipe was in part based on a large database with daily measured tumor set-up
errors for prostate cancer patients from Erasmus MC database.
7.2 Materials and Methods
7.2.1 Margin recipe in case of time trends
As it was shown in Chapter 4 in case of presence of time trends in order to describe setup errors
we have to use mean setup error or offset value, trend slope and standard deviation of residual
errors (see Fig. 7.1). In order to made the problem symmetrical a decision was made to use
mean setup error which is equal to middle position of setup error (see Section 7.2.1.1).
The derivation of the proposed margin recipe is the same as the one of Marcel van Herk et
al. [90] (see Section 2.2.1). At first the setup errors are divided into two groups: treatment
execution (random errors) and treatment preparation errors (systematic errors). In the pre-
sented approach the time trend is considered as a specific case of systematic error around which
random errors (residual ones) are distributed (see Fig. 7.1).
Requirement around which van Herk constructs his margin recipe (in case of systematic
errors) is that certain percentage of patient population would receive specified dose to CTV.
Marcel van Herk imposed a 90% probability that the full CTV, which would be shifted according
to systematic error, would be inside a CTV-to-PTV margin and therefore would receive required
dose (i.e. 95% of prescribed dose). With this requirement van Herk showed that margin size
have to be 1.64Σ in case of 1D and 2.5Σ in case of 3D errors. The formulae given by van Herk
(2.5Σ + 0.7σ) is used worldwide in clinical practice. In order to construct a 3D anisotropic
margin with this formulae, one has to apply it independently for each particular direction
(assuming a 3D symmetrical case — for details see Section 7.2.1.2).
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Figure 7.1: Example of setup errors for one patient. Trendline is shown. Red arrow indicates
one of residual errors (i.e. errors due to trend line). Black arrow indicates one of the trendline
errors (i.e. difference between zero position and trendline). Illustration of the concept of
maximum deviation is also provided: green arrow shows middle position value, while grey one
shows trend change for half of treatment.
The proposed novel recipe is based of a similar procedure. The distribution of CTV positions
(including time trends) for population of patients is considered and requirement that 90%
(or other percentage) of patients would receive 95% of dose is imposed. That gives margin
component relative to the systematic error. The margin component relative to random errors
is assumed to be exactly the same as in van Herk formulae. Because of that, in case of no time
trend the proposed recipe simplifies to the van Herk’s one.
In order to calculate the margin component for systematic errors a quantity called maximum
deviation is introduced (see Fig. 7.1). Maximum Deviation (MD) describes the maximum
absolute deviation from CT (according to trend) within each all systematic setup errors for a
particular patient would lie. The time trend can be expressed with middle position as:
xp,i(f) =
f − (F + 1)
2
· ap,i +mp,i (7.1)
where:
p→ patient
i→ direction
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Therefore MD can be calculated as:
MD = |mp,i|+(F − 1)
2
· |ap,i| (7.2)
Knowing the distribution of mp,i and ap,i the maximum deviation can be calculated by a simu-
lation. In order to do that the middle position as well as the slope have to be randomized many
times and for each randomization MDi has to be calculated. That provides the distribution
of MDi. In case of 1D calculation the margin size would be such a value of MDi that would
correspond to 90th percentile of its distribution.
In case of 3D similar approach as in van Herk recipe is used (see 7.2.1.2). The idea is
to calculate MDi for each direction as it would be a 3D case with the same distributions of
mp,i and ap,i in all axes: x, y and z. Simulations for each of x, y and z are done separately.
Afterwards the radius of MDi is calculated:
MDradius =
√
(MDx)2 + (MDy)2 + (MDz)2 (7.3)
The 3D margin for axis i is calculated as 90th percentile of MDradius distribution for that axis.
The Python code which was used in order to calculate 3D margin is presented below.
import numpy as np # import numpy package
def TimeTrend3Dmargin(F, mean_m , std_m , mean_a , std_a , percentile , N = 10 **7
):
# F - number of fractions
# mean_m - mean middle position for population of patients (in one
direction)
# std_m - std of middle position for population of patients (in one
direction)
# mean_a - mean slope position for population of patients (in one
direction)
# std_a - std of middle position for population of patients (in one
direction)
# N âĂŞ number of samples used for simulation
# percentile - imposed percentage of patients who should receive 95\% of
dose in CTV
# Calculate distribution of maximum deviation (MD) 3 times with same
parameters
# Calculation is done by simulation each time in 1D
mX = np.random.normal(loc=mean_m ,scale=std_m ,size=N)
aX = np.random.normal(loc=mean_a ,scale=std_a ,size=N)
MD_X = np.abs(mX) + (F-1)*np.abs(aX)/2
mY = np.random.normal(loc=mean_m ,scale=std_m ,size=N)
aY = np.random.normal(loc=mean_a ,scale=std_a ,size=N)
MD_Y = np.abs(mY) + (F-1)*np.abs(aY)/2
mZ = np.random.normal(loc=mean_m ,scale=std_m ,size=N)
aZ = np.random.normal(loc=mean_a ,scale=std_a ,size=N)
MD_Z = np.abs(mZ) + (F-1)*np.abs(aZ)/2
# Calculate the radius of 3D distribution
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MD_3D = np.vstack ((MD_X ,MD_Y ,MD_Z)).T
MD_radius = np.sqrt(MD_3D[:,0] **2+MD_3D[:,1]** 2+MD_3D[:,2] **2)
# return the margin size in one direction
return np.percentile(MD_radius , percentile)
It is important to notice that the mean slope value does not influence the calculated margin.
It can be explained by the fact that the middle position is used in MD concept. Even in case
of all positive slope values MD would remain the same — the middle position depends on
absolute slope value no matter the sign is. In case the mean middle position would not be equal
zero there is a systematic error for the whole population. That error should be eliminated or
the margin should be calculated for mean middle position equal to zero and shifted afterwards
by the vector: −M (see Eq. 2.5). That solution is the same as for van Herk recipe.
7.2.1.1 Proof that mean setup error is equal to the middle position
Let denote that:
rf → random error in fraction f (residual error)
x(f) = f · a+ b→ time trend
mf = f · a+ b+ rf → real setup errors (real positions)
F → total number of fractions
Middle position would be given as:
mid =
(a+ b) + (F · a+ b)
2
=
(F + 1)
2
· a+ b (7.4)
Mean position i.e. mean setup error can be calculated as:
mf =
1
F
F∑
f=1
(f · a+ b+ rf ) = 1
F
·
[
F∑
f=1
(f · a+ b) +
F∑
f=1
rf
]
(7.5)
According to the fact that the time trend is defined with OLS, for residuals errors it is true
that
∑F
f=1 rf = 0. Therefore:
mf =
1
F
F∑
f=1
(f · a+ b) = (F + 1)
2
· a+ b = mid (7.6)
Table 7.1 presents comparison between mean and SD calculated directly from the distribu-
tions of mp with those calculated as middle position and its SD. The only difference can be
seen for head-feet direction and is considered to be insignificant (0.01 mm).
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Standard Parametrization Time Trend Parametrization
M mm Σ mm M mm Σ mm
left-right -0.32 2.5 -0.32 2.5
anterior-posterior -0.54 3.47 -0.54 3.47
head-feet -0.97 3.37 -0.97 3.36
Table 7.1: Comparison of calculated parameters for standard and time trend parametriza-
tion. Mean position of standard parametrization is the same as middle position of time trend
parametrization.
7.2.1.2 3D margin calculation
Assume that systematic error is described in three principal directions with normal distribu-
tions: G(0,Σx), G(0,Σy), G(0,Σz). In order to calculate margin MPTVx in x direction one has
to find such MPTVx that probability of the setup error within the margin:
P
(
(xi)
2/(MPTVx )
2 + (xj)
2/(MPTVx )
2 + (xk)
2/(MPTVx )
2 ≤ 1)
would be equal to 90%, with xi, xj, xk randomized independently from G(0,Σx). As (xi)2/(Σx)2
has chi-squared distribution with one degree of freedom, the sum (xi)2/(Σx)2 + (xj)2/(Σx)2 +
(xk)
2/(Σx)
2 has chi-squared distribution with three degrees of freedom. Therefore discussed
probability can be rewritten as:
P
(
(xi)
2 + (xj)
2 + (xk)
2
(MPTVx )2
≤ 1
)
P
(
(xi)
2 + (xj)
2 + (xk)
2
(Σx)2
≤ (M
PTV
x )
2
(Σx)2
)
P
(
(xi)
2/(Σx)
2 + (xj)
2/(Σx)
2 + (xk)
2/(Σx)
2 ≤ (M
PTV
x )
2
(Σx)2
)
= CDF(χ2dof = 3) = 0.9
where (MPTVx )2/(Σx)2 = q0.9 stands for 0.9 quantil of chi-squared distribution with three degrees
of freedom (χ2dof = 3). The same applies for other two directions. For an anisotropic 3D margin
the probability would be written as: P
(
x2/(MPTVx )2 + y2/(M
PTV
y )
2 + z2/(MPTVz )2 ≤ 1
)
which
can be now rewritten as:
P
(
x2/(q0.9 · Σ2x) + y2/(q0.9 · Σ2y) + z2/(q0.9 · Σ2z) ≤ 1
)
P
(
x2/(Σx)
2 + y2/(Σy)
2 + z2/(Σz)
2 ≤ q0.9
)
As all (x2/(Σx)2), (y2/(Σy)2) and (z2/(Σz)2) have χ2 distributions with one degree of freedom,
their sum has a χ2 distribution with three degrees of freedom. Therefore probability can be
written as P (x2/(Σx)2 + y2/(Σy)2 + z2/(Σz)2 ≤ q0.9) = P (χ2dof=3 ≤ 0.9) which is equal to 0.9.
7.2.2 Fitting equation for time trend margin calculation
The proposed CTV-PTV margin can be calculated with usage of the Python code as presented
in Section 7.2.1. Alternatively, an analytical equation was searched. Equation (7.2) depends
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on total number of fractions F . For practical reasons that dependence should be removed. In
order to do that a variable A is introduced, representing the slope in one-half of the treatment
fractions. Distribution of A was described by MA and ΣA per direction i.
Ap =
(F − 1)
2
· ap (7.7)
MA,i =
(F − 1)
2
·Ma,i (7.8)
ΣA,i =
(F − 1)
2
· Σa,i (7.9)
After such a substitution (7.2) comes to:
MD = |mp,i|+|Ap,i| (7.10)
Equation (7.10) is symmetrical in behaviour for mp,i and Ap,i. That makes it easier to
interpret and use in further margin evaluation.
A fit was done with least squares method as implemented in scipy package in caseM = 0 mm
and Ma = 0 mm/fraction. A wide range of Σ = [0, 5] mm and ΣA = [0, 5] mm values were used
giving in total 441 points for each fit. It was assumed that fitted equation should simplify to
van Herk recipe in case of ΣA = 0 mm. The fit was evaluated in terms of difference between
values calculated with the Python code (Section 7.2.1) and those achieved with the proposed
equation.
7.2.3 Synthetic populations
Synthetic populations were used to compare the proposed margin recipe (Section 7.2.1) with
the one of van Herk (Section 2.2.1). A general description of synthetic populations was given
in Section 4.2.1. All synthetic populations used at this step consist of 104 patients with 39
fractions treatment.
In order to perform 3D margin tests two types of synthetic populations were prepared. At
first, populations with isotropic setup errors distributions were created. That means that
a population distribution in each principal axis was the same. Parameters taken to cre-
ation of these populations were: Σ ∈ {1, 2, 3, 4} mm, σ ∈ {1, 2, 3} mm, σσ = 0.75 mm,
Σa ∈ {0.0, 0.05, 0.1, 0.15} mm/fraction and Ma ∈ {0.0,−0.05,−0.1} mm/fraction. In total
144 isotropic populations were generated.
Secondly anisotropic populations were created. At first populations with setup error only
in 1D were created with the same parameters used as for isotropic populations generation.
Afterwards 3D populations were created by randomly choosing (with replacements) populations
with randomized parameters. It was forced that each set of parameters would be present in at
least one anisotropic population. In total 144 anisotropic populations were generated.
7.2.4 Clinical Data
In order to test the proposed margin recipe for clinical data, setup errors gathered for 835
prostate cancer patients from Erasmus MC hospital were used. For detailed description of the
data see Section 3.2.2. Margins were calculated with assumption that no verification protocol
is used (so no setup correction was applied).
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7.2.5 Validation of margin recipe – Ellipsoid test
Validation of margin recipe would be based on determination of percentage of patients with sys-
tematic setup error not inside the margin. According to the assumption made during derivation
of margin recipe it should be 10% if 90% of population is required to have CTV within pre-
scribed dose. For each patient and each fraction setup error can be described as [xp,f , yp,f , zp,f ].
If that setup error lies within the margin specified as [Mx,My,Mz] true would be:
(xp,f )
2
(Mx)2
+
(yp,f )
2
(My)2
+
(zp,f )
2
(Mz)2
≤ 1 (7.11)
In order to check performance of the described above ellipsoid test the simulation was done.
For each combination of Σ ∈ {0.5, 1.0, . . . , 5.0} mm and Σa,i ∈ {0.0, 0.01, . . . , 0.10}mm/fraction
setup errors in 39 fractions for 105 patients were simulated, with i denoting the principal axis.
Mean population middle position M as well as mean slope Ma were assumed to be zero. Slope
was assumed to be independent for all three directions. For each set of parameters a margin
was calculated assuming 80th, 85th, 90th, 95th or 99th percentile. Afterwards the ellipsoid test
was performed. Results can be seen in Fig. 7.2-7.6. The ellipsoid test applied for simulated
population of patients with time trends showed that for 90th percentile derivation of margin
recipe on average 9.99± 0.09% of patients have at least one fraction outside the margin (range:
9.61-10.44%). Summary of results for all tested values of percentiles used for margin definition
are given in Table 7.2. For all tested combinations the difference between expected and achieved
values did not exceed 0.7%.
80% 85% 90% 95% 99%
19.97± 0.13
[19.33, 20.45]
14.98± 0.11
[14.49, 15.43]
9.99± 0.09
[9.61, 10.44]
5.00± 0.07
[4.73, 5.27]
1.00± 0.03
[0.88, 1.12]
Table 7.2: Validation of time trend margin recipe for different percentile values used to margin
size definition. For each percentile more than 13310 combinations of time trend parameters
(Σ, Σa) were used. For every combination of parameters 105 patients with their setup errors
were simulated. First row gives mean achieved value and its standard deviation. Second row
provides range of achieved values.
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Figure 7.2: Distribution of percentage of patients outside the margin achieved for different
standard deviations of mean setup position. In each case 11 different standard deviations of
time trend slope were used. Each set of parameters was used to simulate treatment setup errors
for 105 patients.
Figure 7.3: Distribution of percent of patients outside the margin achieved for different standard
deviations of mean setup position. In each case 11 different standard deviations of time trend
slope were used. Each set of parameters was used to simulate treatment setup errors for 105
patients.
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Figure 7.4: Distribution of percent of patients outside the margin achieved for different standard
deviations of mean setup position. In each case 11 different standard deviations of time trend
slope were used. Each set of parameters was used to simulate treatment setup errors for 105
patients.
Figure 7.5: Distribution of percent of patients outside the margin achieved for different standard
deviations of mean setup position. In each case 11 different standard deviations of time trend
slope were used. Each set of parameters was used to simulate treatment setup errors for 105
patients.
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Figure 7.6: Distribution of percent of patients outside the margin achieved for different standard
deviations of mean setup position. In each case 11 different standard deviations of time trend
slope were used. Each set of parameters was used to simulate treatment setup errors for 105
patients.
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7.3 Results
In case of van Herk’s recipe the time trend is not considered and therefore it influences the
magnitude of random errors. That is why there is a small difference between σi and σtti . In order
to make fair a comparison, 0.7σtti was subtracted from both margins to calculate their systematic
part. In other words van Herk’s systematic margin was calculated as: 2.5Σ + 0.7(σi − σtti ).
7.3.1 Synthetic populations
Fig. 7.7 presents detailed results achieved for 144 isotropic populations. Both margin recipes
(van Herk’s and the proposed one) are compared in terms of percentage of patients with at
least one trend error lying outside the margin. Trend error is defined here as error according
to trendline as shown in Fig. 7.1. For the proposed margin recipe the percentage of patients
with at least one trendline error outside the margin was 10.0% ± 0.2%. Contrary, even 100%
of patients had at least one trendline error outside the margin for van Herk’s recipe. With
Σ increasing the margin size increases and therefore the percentage achieved for van Herk’s
recipe decreases. For populations without time trends (yellow squares in Fig. 7.7) the van
Herk’s recipe ended with 10.0% of patients with non-random error lying outside the margin.
Percentage of patients outside van Herk’s margin increases with increasing values of trendline
parameters (Ma and Σa).
Results for 289 populations (among which was one clinical population) are presented in
Fig. 7.8. It can be clearly seen that the percentage of patients with at least one trend setup
error lying outside the CTV-PTV for van Herk’s margin recipe is always bigger than for the
proposed margin. Only for populations without time trend van Herk’s margin recipe leads to
assumed 10%. Depending on parameters the van Herk margin can be too small for the whole
population (all patients outside). It has to be stressed that the percentage of patients outside
the proposed margin was on average 10.0% (range [9.39,10.72]).
7.3.2 Clinical Data
The margin was calculated for Erasmus MC database using both recipes (van Herk and the
proposed one).
Achieved margin sizes are presented in Table 7.3. The proposed recipe yields to bigger
margin size. The difference is in order of 1.3-2 mm. The ellipsoid test described in 7.2.5 was
used to calculate the percentage of patients with non-random errors lying outside the margin.
Calculations were done for Erasmus MC database. The proposed recipe fulfills the assumption
of 10% of patients outside the margin. On the other hand, usage of van Herk recipe will end
up with 23.7% of patients with CTV outside the margin.
7.3.3 Fitting equation for time trend margin calculation
The fitted margin equation, for a principal direction i, in case when the mean slopeMA = 0 mm,
is given below. Fitted parameters α, δ and γ depend on assumed percentile of patients who
can experience non-random errors exceeding margin during the entire treatment time. Fitted
values are presented in Table 7.3.3. In the same table a summary of comparison between margin
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Figure 7.7: Comparison of percentage of patients with at least one trendline error lying out-
side the margin for van Herk and the proposed margin recipe. Results achieved for isotropic
populations with different time trend simulation parameters (M = 0 mm, Σ, Ma, Σa and σ′).
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Figure 7.8: Percentage of patients with at least one trend setup error lying outside CTV-PTV
3D margin for two compared margin recipes: van Herk (x axis) and the time trend margin (y
axis). In total 290 populations were analyzed.
van Herk’s Recipe The proposed Recipe
non-random / total non-random / total
left-right 6.3 mm / 7.6 mm 7.6 mm / 8.9 mm
head-feet 8.6 mm / 10.2 mm 10.8 mm / 12.5 mm
anterior-posterior 8.8 mm / 10.6 mm 11.0 mm / 12.8 mm
% of patients outside 3D margin 23.7% 9.6%
Table 7.3: Comparison between van Herk’s and the proposed margin recipes in terms of margin
size and percentage of patients with at least one trendline error lying outside the 3D margin.
Values were calculated for real patient data from Erasmus MC database. Percentage of patients
outside the margin was calculated with Ellipsoid Test.
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percentile α δ γ ∆margin mm α by van Herk et al.
80 2.15 -0.94 0.86 2.65 · 10−5; [-0.005, 0.004] 2.16
85 2.31 -1.08 0.67 4.33 · 10−5; [-0.006, 0.005] 2.31
90 2.50 -1.27 0.52 8.19 · 10−5; [-0.008, 0.007] 2.50
95 2.79 -1.54 0.38 1.11 · 10−4; [-0.015, 0.012] 2.79
99 3.37 -2.09 0.26 1.75 · 10−4; [-0.016, 0.019] 3.36
Table 7.4: Fit parameters for margin equation (Eq. (7.12)) as a function of percentile of patients
with all non-random errors inside the CTV-PTV margin. The ∆margin expresses mean dif-
ference of comparison between margin calculation with the Python code and direct calculation
using Eq. (7.12), additionally the range is given in brackets. For comparison purposes the last
column contains α values as derived by van Herk et al.[90].
calculation methods (Python calculation vs direct calculation using Eq. (7.12)) is presented.
More detailed comparison is shown in Fig. 7.13-7.9.
MPTVtrend,i(Mi = 0,Σi,MA,i = 0,ΣA,i) = α · (Σi + ΣA,i) +
δ · Σi · ΣA,i√
Σ2i + γ · Σi · ΣA,i + Σ2A,i
(7.12)
It is also possible to fit the 4D equation in case MA 6= 0 mm. In this case the equation
become complicated with nine parameters which have to be fitted.
MPTVtrend,i(Mi = 0,Σi,MA,i,ΣA,i) = α · (Σi + ΣA,i) + β1 · |MA,i|+
β2 · Σi · ΣA,i√
Σ2i + β3 · Σi · ΣA,i + Σ2A,i
+
β4 ·M2A,i√
β5 · Σ2i + β6 · Σi · |MA,i|+M2A,i
+
β7 ·M2A,i√
β8 · Σ2A,i + β9 · ΣA,i · |MA,i|+M2A,i
(7.13)
Results of Eq. (7.13) performance, in case of 90% assumption, are presented in Fig. 7.14-7.16.
These figures present 3D plots for different values of MA (Fig. 7.14), ΣA (Fig. 7.15) and Σ
(Fig. 7.16) as it is not possible to present 4D equation fit in one graph. The equation fitting
was done for 5733 points. The fitted α parameter, which corresponds to van Herk equation,
was equal 2.49. Achieved values of β parameters were: −0.12, −1.31, 0.91, 1.57, 1.61, 1.32,
0.25, 1.69 and −0.25. Mean difference between margin calculated with Python script and using
Eq. (7.13) was 0.0007 (range: [−0.1, 0.1]). Similar results were achieved for other percentiles of
patients assumed to have all trend errors lying within the CTV-PTV margin.
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Figure 7.9: Comparison between margin calculation methods (Python code vs direct equation)
for 80% of patients assumed to have all non-random error within the margin.
Figure 7.10: Comparison between margin calculation methods (Python code vs direct equation)
for 85% of patients assumed to have all non-random error within the margin.
Figure 7.11: Comparison between margin calculation methods (Python code vs direct equation)
for 90% of patients assumed to have all non-random error within the margin.
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Figure 7.12: Comparison between margin calculation methods (Python code vs direct equation)
for 95% of patients assumed to have all non-random error within the margin.
Figure 7.13: Comparison between margin calculation methods (Python code vs direct equation)
for 99% of patients assumed to have all non-random error within the margin.
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Figure 7.14: Comparison between margin calculation methods (Python code vs 4D direct equa-
tion) for 90% of patients assumed to have all non-random error within the margin.
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Figure 7.15: Comparison between margin calculation methods (Python code vs 4D direct equa-
tion) for 90% of patients assumed to have all non-random error within the margin.
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Figure 7.16: Comparison between margin calculation methods (Python code vs 4D direct equa-
tion) for 90% of patients assumed to have all non-random error within the margin. Σm = Σ
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7.4 Discussion
To the best of my knowledge this is the first attempt to provide margin recipe that explicitly
copes with inter-fraction time trends. In presented work I showed that van Herk’s recipe in case
of trends gives smaller margin which does not fulfill the assumption of 90% of patients inside
the margin. Both recipes were tested for synthetic populations (isotropic and anisotropic) and
for clinical population.
Trend-margin problem was considered in case of intra-fraction motion [75]. Authors pro-
posed that Σ values achieved for localization accuracy, intra-fraction motion and respiratory
motion shall be added in quadratic way. That was done with the assumption of on-line veri-
fication at the beginning of treatment (giving initial setup error of zero value). In worst case
scenario intra-fraction motion would happen immediately after on-line verification.
In proposed approach we do not assume ideal patient position in first fraction of treatment.
Therefore it can happen that error during time of treatment would become smaller or greater.
Let mp,i(f) denote setup error in fraction f , of patient p in direction i. In case of time trends
mp,i(1) can be used as a ’classic’ systematic component. Distribution of mp,i(1) over the popu-
lation of patients P would be described with the mean value (surrogate of GM for van Herk):
mp,i(1) and standard deviation: Σmp,i(1). The difference between first and last fraction can be
expressed as: ∆mp,i(F ) = mp,i(F )−mp,i(1) = (F − 1) · ap,i.
Distribution of ∆mp,i(F ) can be also evaluated. Mean value of ∆mp,i(F ) would be: ∆mp,i(F )
and its standard deviation: Σ∆mp,i(F ). The setup error in last fraction mp,i(F ) can be expressed
asmp,i(1)+∆mp,i(F ). Standard deviation ofmp,i(F ) can be calculated as
√
Σ2mp,i(1) + Σ
2
∆mp,i(F )
.
Although mathematically it is corrected we cannot use it to calculate the margin. It is because
searched margin has to be large enough to have both mp,i(1) and mp,i(F ) inside in 90% of pa-
tients. In Section 3.5 I showed that in some cases the |mp,i(F )| would be greater but in others
|mp,i(1)| would be greater. That is why the greater value of the two: mp,i(1), mp,i(F )) has to be
searched. Fig. 7.17-7.19 show comparison between discussed methods. A drop in distributions
of max{|mp(0)|, |mp(F )|} can be observed for all principal directions. Distribution of mp(F )
would be equal to max{|mp(0)|, |mp(F )|} only if |mp,i(F )|≥ |mp,i(1)|, which is not always the
case.
Second idea of calculating margins in terms of time trends would be to calculate middle
position (see Eq. 7.4), as in proposed approach, and afterwards the extend from middle position
to first/last fraction. That could be expressed as:
∆1 = mp,i −mp(1) = (F − 1) · a/2
∆F = mp(F )−mp,i = (F − 1) · a/2
As the ∆1 and ∆F are expressed in the same way, they are highly dependent and therefore
cannot be added in quadratic way.
In 2015 Namysł-Kaletka et al. [67] investigated gastric cancer patients. They reported
inter-fraction time trends up to 1.6mm during entire treatment. Still they used classical van
Herk’s recipe to derive margins.
Nowadays the on-line verification has a major role during radiotherapy. That become pos-
sible due to the technological progress. With on-line verification approach time trends can be
resolved unless there are two target volumes which move independently. In such a case even if
on-line verification assures correct position of one target the other one(s) can experience time
trends. Such independent movement was reported for breast [29] and laryngeal irradiation [72].
Similar behavior can be expected for lung cancer [93].
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Figure 7.17: Comparison of discussed methods of calculating margin in case of time trends.
Distribution of time trend setup error (without random component) in last fraction mp(F ) is
shown in blue. Second distribution presents max{|mp(0)|, |mp(F )|} with the sign of mp(0) or
mp(F ). Gaussian plot was calculated with the SD given as
√
Σ2mp,i(1) + Σ
2
∆mp,i(F )
. Presented
data come from Erasmus MC database — in left-right direction.
Figure 7.18: Comparison of discussed methods of calculating margin in case of time trends.
Distribution of time trend setup error (without random component) in last fraction mp(F ) is
shown in blue. Second distribution presents max{|mp(0)|, |mp(F )|} with the sign of mp(0) or
mp(F ). Gaussian plot was calculated with the SD given as
√
Σ2mp,i(1) + Σ
2
∆mp,i(F )
. Presented
data come from Erasmus MC database — in head-feet direction.
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Figure 7.19: Comparison of discussed methods of calculating margin in case of time trends.
Distribution of time trend setup error (without random component) in last fraction mp(F ) is
shown in blue. Second distribution presents max{|mp(0)|, |mp(F )|} with the sign of mp(0) or
mp(F ). Gaussian plot was calculated with the SD given as
√
Σ2mp,i(1) + Σ
2
∆mp,i(F )
. Presented
data come from Erasmus MC database — in anterior-posterior direction.
Proposed recipe is based on folded normal distributions of middle setup error and trend
slope. Although it is possible to give equation for time trend margin calculation (see Sec-
tion 7.3.3) the form of these equation is sophisticated especially in case MA 6= 0. That is why
I propose to use look-up tables instead (Section 7.5).
7.5 Look-up tables
Tables 7.5-7.9 present margin values for different Σm and Σa. Simulations were done for 107
cases. Both mean middle position and mean slope were set to zero. Presented tables can be
used in order to interpolate the margin for real patient population. First row of each presented
table corresponds to van Herk recipe and is in agreement with it. It should be noticed that
even in case of small Σa, which might be related to limited number of fractions and not to
physiological time trends (see Section 3.6), the difference in margin size may be relatively big.
For example in case of 90% requirement Σa = 0.02 mm/fraction leads to 0.5 mm change in
margin size.
Tables 7.10-7.16 present values of the time trend margin for different MA (see Eq. 7.8), ΣA
(see Eq. 7.9) and ΣM with assumption that 90% of patients would have all non-random errors
within the margin.
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Σa
Σm 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0 0.0 1.1 2.2 3.2 4.3 5.4 6.5 7.5 8.6 9.7 10.8
0.01 0.4 1.3 2.4 3.5 4.5 5.6 6.7 7.8 8.9 9.9 11.0
0.02 0.8 1.7 2.7 3.7 4.8 5.9 6.9 8.0 9.1 10.2 11.2
0.03 1.2 2.0 3.0 4.0 5.1 6.1 7.2 8.3 9.3 10.4 11.5
0.04 1.6 2.4 3.3 4.3 5.4 6.4 7.5 8.5 9.6 10.7 11.7
0.05 2.0 2.8 3.7 4.6 5.7 6.7 7.7 8.8 9.9 10.9 12.0
0.06 2.5 3.2 4.0 5.0 6.0 7.0 8.0 9.1 10.1 11.2 12.3
0.07 2.9 3.6 4.4 5.3 6.3 7.3 8.3 9.4 10.4 11.5 12.5
0.08 3.3 4.0 4.8 5.7 6.6 7.6 8.6 9.7 10.7 11.8 12.8
0.09 3.7 4.4 5.1 6.0 7.0 7.9 8.9 10.0 11.0 12.0 13.1
0.1 4.1 4.8 5.5 6.4 7.3 8.3 9.3 10.3 11.3 12.3 13.4
Table 7.5: Margin values for requirement of 80% of patient population to have CTV within the
prescribed dose. Margins were calculated for different SD of middle position and slope with M
and Ma set to zero. First row of the presented table corresponds to van Herk margin recipe,
which in case of 80% gives 2.16Σm. The Σm values are given in mm and Σa values are given in
mm/fraction.
Σa
Σm 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0 0.0 1.2 2.3 3.5 4.6 5.8 6.9 8.1 9.2 10.4 11.5
0.01 0.4 1.4 2.6 3.7 4.8 6.0 7.2 8.3 9.5 10.6 11.8
0.02 0.9 1.7 2.8 4.0 5.1 6.2 7.4 8.5 9.7 10.8 12.0
0.03 1.3 2.1 3.1 4.2 5.4 6.5 7.7 8.8 9.9 11.1 12.2
0.04 1.8 2.5 3.5 4.6 5.7 6.8 7.9 9.1 10.2 11.4 12.5
0.05 2.2 2.9 3.8 4.9 6.0 7.1 8.2 9.3 10.5 11.6 12.8
0.06 2.6 3.3 4.2 5.2 6.3 7.4 8.5 9.6 10.8 11.9 13.0
0.07 3.1 3.8 4.6 5.6 6.6 7.7 8.8 9.9 11.0 12.2 13.3
0.08 3.5 4.2 5.0 6.0 7.0 8.0 9.1 10.2 11.3 12.5 13.6
0.09 3.9 4.6 5.4 6.3 7.3 8.4 9.4 10.5 11.6 12.8 13.9
0.1 4.4 5.0 5.8 6.7 7.7 8.7 9.8 10.9 11.9 13.1 14.2
Table 7.6: Margin values for requirement of 85% of patient population to have CTV within the
prescribed dose. Margins were calculated for different SD of middle position and slope with M
and Ma set to zero. First row of the presented table corresponds to van Herk margin recipe,
which in case of 85% gives 2.31Σm. The Σm values are given in mm and Σa values are given in
mm/fraction.
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Σa
Σm 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0 0.0 1.3 2.5 3.8 5.0 6.3 7.5 8.8 10.0 11.3 12.5
0.01 0.5 1.5 2.7 4.0 5.2 6.5 7.7 9.0 10.2 11.5 12.7
0.02 1.0 1.9 3.0 4.3 5.5 6.7 8.0 9.2 10.5 11.7 13.0
0.03 1.4 2.2 3.4 4.6 5.8 7.0 8.2 9.5 10.7 12.0 13.2
0.04 1.9 2.7 3.7 4.9 6.1 7.3 8.5 9.8 11.0 12.2 13.5
0.05 2.4 3.1 4.1 5.2 6.4 7.6 8.8 10.0 11.3 12.5 13.7
0.06 2.9 3.6 4.5 5.6 6.7 7.9 9.1 10.3 11.5 12.8 14.0
0.07 3.3 4.0 4.9 5.9 7.1 8.2 9.4 10.6 11.8 13.1 14.3
0.08 3.8 4.5 5.3 6.3 7.4 8.6 9.7 10.9 12.1 13.4 14.6
0.09 4.3 5.0 5.8 6.7 7.8 8.9 10.1 11.3 12.4 13.7 14.9
0.1 4.8 5.4 6.2 7.2 8.2 9.3 10.4 11.6 12.8 14.0 15.2
Table 7.7: Margin values for requirement of 90% of patient population to have CTV within the
prescribed dose. Margins were calculated for different SD of middle position and slope with M
and Ma set to zero. First row of the presented table corresponds to van Herk margin recipe,
which in case of 90% gives 2.50Σm. The Σm values are given in mm and Σa values are given in
mm/fraction.
Σa
Σm 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0 0.0 1.4 2.8 4.2 5.6 7.0 8.4 9.8 11.2 12.6 14.0
0.01 0.5 1.7 3.0 4.4 5.8 7.2 8.6 10.0 11.4 12.8 14.2
0.02 1.1 2.0 3.3 4.7 6.1 7.5 8.9 10.3 11.7 13.1 14.4
0.03 1.6 2.5 3.7 5.0 6.4 7.7 9.1 10.5 11.9 13.3 14.7
0.04 2.1 2.9 4.1 5.3 6.7 8.0 9.4 10.8 12.2 13.6 15.0
0.05 2.7 3.4 4.5 5.7 7.0 8.3 9.7 11.1 12.5 13.8 15.2
0.06 3.2 3.9 4.9 6.1 7.4 8.7 10.0 11.4 12.7 14.1 15.5
0.07 3.7 4.4 5.4 6.5 7.7 9.0 10.3 11.7 13.0 14.4 15.8
0.08 4.3 4.9 5.9 6.9 8.1 9.4 10.7 12.0 13.4 14.7 16.1
0.09 4.8 5.5 6.3 7.4 8.5 9.8 11.0 12.3 13.7 15.0 16.4
0.1 5.3 6.0 6.8 7.8 8.9 10.1 11.4 12.7 14.0 15.4 16.7
Table 7.8: Margin values for requirement of 95% of patient population to have CTV within the
prescribed dose. Margins were calculated for different SD of middle position and slope with M
and Ma set to zero. First row of the presented table corresponds to van Herk margin recipe,
which in case of 95% gives 2.79Σm. The Σm values are given in mm and Σa values are given in
mm/fraction.
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Σa
Σm 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0 0.0 1.7 3.4 5.1 6.7 8.4 10.1 11.8 13.5 15.2 16.8
0.01 0.6 2.0 3.6 5.3 7.0 8.7 10.3 12.0 13.7 15.4 17.1
0.02 1.3 2.4 3.9 5.6 7.2 8.9 10.6 12.3 13.9 15.6 17.3
0.03 1.9 2.9 4.3 5.9 7.5 9.2 10.9 12.5 14.2 15.9 17.6
0.04 2.6 3.4 4.7 6.3 7.9 9.5 11.2 12.8 14.5 16.2 17.8
0.05 3.2 4.0 5.2 6.7 8.2 9.8 11.5 13.1 14.8 16.4 18.1
0.06 3.8 4.6 5.7 7.1 8.6 10.2 11.8 13.4 15.1 16.7 18.4
0.07 4.5 5.2 6.3 7.6 9.0 10.6 12.1 13.8 15.4 17.0 18.7
0.08 5.1 5.8 6.8 8.1 9.5 11.0 12.5 14.1 15.7 17.4 19.0
0.09 5.8 6.5 7.4 8.6 9.9 11.4 12.9 14.5 16.1 17.7 19.3
0.1 6.4 7.1 8.0 9.1 10.4 11.8 13.3 14.9 16.4 18.0 19.7
Table 7.9: Margin values for requirement of 99% of patient population to have CTV within the
prescribed dose. Margins were calculated for different SD of middle position and slope with M
and Ma set to zero. First row of the presented table corresponds to van Herk margin recipe,
which in case of 99% gives 3.36Σm. The Σm values are given in mm and Σa values are given in
mm/fraction.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 0.0 0.6 1.3 1.9 2.5 3.1 3.8 4.4 5.0 5.6 6.2 6.9 7.5 8.1 8.8 9.4 10.0 10.6 11.3 11.9 12.5
0.25 0.6 1.1 1.6 2.2 2.8 3.5 4.1 4.7 5.3 5.9 6.6 7.2 7.8 8.4 9.1 9.7 10.3 10.9 11.6 12.2 12.8
0.5 1.3 1.6 2.1 2.7 3.2 3.8 4.4 5.1 5.7 6.3 6.9 7.5 8.1 8.8 9.4 10.0 10.6 11.3 11.9 12.5 13.1
0.75 1.9 2.2 2.7 3.2 3.7 4.3 4.9 5.4 6.1 6.7 7.3 7.9 8.5 9.1 9.7 10.4 11.0 11.6 12.2 12.8 13.5
1 2.5 2.8 3.2 3.7 4.2 4.7 5.3 5.9 6.5 7.1 7.7 8.3 8.9 9.5 10.1 10.7 11.3 12.0 12.6 13.2 13.8
1.25 3.1 3.5 3.8 4.3 4.7 5.3 5.8 6.3 6.9 7.5 8.1 8.7 9.3 9.9 10.5 11.1 11.7 12.3 12.9 13.6 14.2
1.5 3.8 4.1 4.4 4.9 5.3 5.8 6.3 6.8 7.4 8.0 8.5 9.1 9.7 10.3 10.9 11.5 12.1 12.7 13.3 13.9 14.5
1.75 4.4 4.7 5.1 5.4 5.9 6.3 6.8 7.4 7.9 8.4 9.0 9.6 10.1 10.7 11.3 11.9 12.5 13.1 13.7 14.3 14.9
2 5.0 5.3 5.7 6.1 6.5 6.9 7.4 7.9 8.4 8.9 9.5 10.0 10.6 11.2 11.8 12.3 12.9 13.5 14.1 14.7 15.3
2.25 5.6 5.9 6.3 6.7 7.1 7.5 8.0 8.4 8.9 9.5 10.0 10.5 11.1 11.6 12.2 12.8 13.4 14.0 14.6 15.1 15.7
2.5 6.3 6.6 6.9 7.3 7.7 8.1 8.5 9.0 9.5 10.0 10.5 11.0 11.6 12.1 12.7 13.3 13.8 14.4 15.0 15.6 16.2
2.75 6.9 7.2 7.5 7.9 8.3 8.7 9.1 9.6 10.0 10.5 11.0 11.6 12.1 12.6 13.2 13.7 14.3 14.9 15.4 16.0 16.6
3 7.5 7.8 8.1 8.5 8.9 9.3 9.7 10.1 10.6 11.1 11.6 12.1 12.6 13.1 13.7 14.2 14.8 15.3 15.9 16.5 17.1
3.25 8.1 8.4 8.8 9.1 9.5 9.9 10.3 10.7 11.2 11.6 12.1 12.6 13.1 13.7 14.2 14.7 15.3 15.8 16.4 16.9 17.5
3.5 8.7 9.1 9.4 9.7 10.1 10.5 10.9 11.3 11.8 12.2 12.7 13.2 13.7 14.2 14.7 15.2 15.8 16.3 16.9 17.4 18.0
3.75 9.4 9.7 10.0 10.4 10.7 11.1 11.5 11.9 12.3 12.8 13.3 13.7 14.2 14.7 15.2 15.8 16.3 16.8 17.4 17.9 18.5
4 10.0 10.3 10.6 11.0 11.3 11.7 12.1 12.5 12.9 13.4 13.8 14.3 14.8 15.3 15.8 16.3 16.8 17.3 17.9 18.4 19.0
4.25 10.6 10.9 11.3 11.6 11.9 12.3 12.7 13.1 13.5 14.0 14.4 14.9 15.3 15.8 16.3 16.8 17.3 17.9 18.4 18.9 19.5
4.5 11.3 11.6 11.9 12.2 12.6 12.9 13.3 13.7 14.1 14.6 15.0 15.4 15.9 16.4 16.9 17.4 17.9 18.4 18.9 19.4 20.0
4.75 11.9 12.2 12.5 12.8 13.2 13.6 13.9 14.3 14.7 15.1 15.6 16.0 16.5 16.9 17.4 17.9 18.4 18.9 19.4 20.0 20.5
5 12.5 12.8 13.1 13.5 13.8 14.2 14.5 14.9 15.3 15.7 16.2 16.6 17.1 17.5 18.0 18.5 19.0 19.5 20.0 20.5 21.0
Table 7.10: 3D margin calculated for Mm,i = 0 mm and MA,i = 0 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 0.9 1.4 2.0 2.7 3.3 3.9 4.5 5.1 5.8 6.4 7.0 7.6 8.3 8.9 9.5 10.1 10.8 11.4 12.0 12.6 13.3
0.25 1.2 1.7 2.2 2.8 3.4 4.0 4.6 5.2 5.8 6.4 7.0 7.7 8.3 8.9 9.5 10.2 10.8 11.4 12.0 12.7 13.3
0.5 1.7 2.1 2.5 3.0 3.6 4.2 4.8 5.4 6.0 6.6 7.2 7.8 8.5 9.1 9.7 10.3 10.9 11.6 12.2 12.8 13.4
0.75 2.2 2.6 3.0 3.5 4.0 4.5 5.1 5.7 6.3 6.9 7.5 8.1 8.7 9.4 10.0 10.6 11.2 11.8 12.4 13.1 13.7
1 2.8 3.1 3.5 4.0 4.4 5.0 5.5 6.1 6.7 7.3 7.9 8.5 9.1 9.7 10.3 10.9 11.5 12.1 12.7 13.4 14.0
1.25 3.4 3.7 4.1 4.5 5.0 5.5 6.0 6.5 7.1 7.7 8.3 8.8 9.4 10.0 10.6 11.3 11.9 12.5 13.1 13.7 14.3
1.5 3.9 4.3 4.6 5.0 5.5 6.0 6.5 7.0 7.5 8.1 8.7 9.3 9.8 10.4 11.0 11.6 12.2 12.8 13.4 14.1 14.7
1.75 4.5 4.9 5.2 5.6 6.0 6.5 7.0 7.5 8.0 8.6 9.1 9.7 10.3 10.9 11.4 12.0 12.6 13.2 13.8 14.4 15.0
2 5.2 5.5 5.8 6.2 6.6 7.1 7.5 8.0 8.5 9.1 9.6 10.2 10.7 11.3 11.9 12.5 13.0 13.6 14.2 14.8 15.4
2.25 5.8 6.1 6.4 6.8 7.2 7.6 8.1 8.6 9.1 9.6 10.1 10.6 11.2 11.8 12.3 12.9 13.5 14.1 14.6 15.2 15.8
2.5 6.4 6.7 7.0 7.4 7.8 8.2 8.6 9.1 9.6 10.1 10.6 11.1 11.7 12.2 12.8 13.4 13.9 14.5 15.1 15.7 16.3
2.75 7.0 7.3 7.6 8.0 8.4 8.8 9.2 9.7 10.1 10.6 11.1 11.6 12.2 12.7 13.3 13.8 14.4 15.0 15.5 16.1 16.7
3 7.6 7.9 8.2 8.6 9.0 9.4 9.8 10.2 10.7 11.2 11.7 12.2 12.7 13.2 13.8 14.3 14.9 15.4 16.0 16.6 17.1
3.25 8.2 8.5 8.9 9.2 9.6 10.0 10.4 10.8 11.3 11.7 12.2 12.7 13.2 13.7 14.3 14.8 15.3 15.9 16.5 17.0 17.6
3.5 8.8 9.1 9.5 9.8 10.2 10.6 11.0 11.4 11.8 12.3 12.8 13.2 13.7 14.3 14.8 15.3 15.8 16.4 16.9 17.5 18.1
3.75 9.5 9.8 10.1 10.4 10.8 11.2 11.6 12.0 12.4 12.9 13.3 13.8 14.3 14.8 15.3 15.8 16.4 16.9 17.4 18.0 18.5
4 10.1 10.4 10.7 11.1 11.4 11.8 12.2 12.6 13.0 13.4 13.9 14.4 14.8 15.3 15.8 16.4 16.9 17.4 17.9 18.5 19.0
4.25 10.7 11.0 11.3 11.7 12.0 12.4 12.8 13.2 13.6 14.0 14.5 14.9 15.4 15.9 16.4 16.9 17.4 17.9 18.4 19.0 19.5
4.5 11.3 11.6 11.9 12.3 12.6 13.0 13.4 13.8 14.2 14.6 15.1 15.5 16.0 16.4 16.9 17.4 17.9 18.4 19.0 19.5 20.0
4.75 11.9 12.2 12.6 12.9 13.3 13.6 14.0 14.4 14.8 15.2 15.6 16.1 16.5 17.0 17.5 18.0 18.5 19.0 19.5 20.0 20.5
5 12.6 12.9 13.2 13.5 13.9 14.2 14.6 15.0 15.4 15.8 16.2 16.7 17.1 17.6 18.0 18.5 19.0 19.5 20.0 20.5 21.1
Table 7.11: 3D margin calculated for Mm,i = 0 mm and MA,i = ±0.5 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 1.7 2.3 2.9 3.5 4.1 4.7 5.3 5.9 6.6 7.2 7.8 8.4 9.0 9.7 10.3 10.9 11.5 12.2 12.8 13.4 14.0
0.25 2.1 2.5 3.0 3.6 4.2 4.8 5.4 6.0 6.6 7.2 7.8 8.5 9.1 9.7 10.3 10.9 11.6 12.2 12.8 13.4 14.0
0.5 2.5 2.9 3.3 3.8 4.4 4.9 5.5 6.1 6.7 7.3 7.9 8.5 9.2 9.8 10.4 11.0 11.6 12.2 12.9 13.5 14.1
0.75 2.9 3.3 3.7 4.2 4.7 5.2 5.8 6.3 6.9 7.5 8.1 8.7 9.3 9.9 10.5 11.2 11.8 12.4 13.0 13.6 14.2
1 3.4 3.8 4.1 4.6 5.1 5.6 6.1 6.6 7.2 7.8 8.4 9.0 9.6 10.2 10.8 11.4 12.0 12.6 13.2 13.8 14.4
1.25 3.9 4.3 4.6 5.0 5.5 6.0 6.5 7.0 7.6 8.1 8.7 9.3 9.9 10.5 11.1 11.7 12.3 12.9 13.5 14.1 14.7
1.5 4.5 4.8 5.1 5.5 6.0 6.4 6.9 7.4 8.0 8.5 9.1 9.7 10.2 10.8 11.4 12.0 12.6 13.2 13.8 14.4 15.0
1.75 5.0 5.3 5.7 6.1 6.5 6.9 7.4 7.9 8.4 9.0 9.5 10.1 10.6 11.2 11.8 12.4 13.0 13.6 14.2 14.8 15.4
2 5.6 5.9 6.2 6.6 7.0 7.5 7.9 8.4 8.9 9.4 10.0 10.5 11.1 11.6 12.2 12.8 13.4 13.9 14.5 15.1 15.7
2.25 6.1 6.5 6.8 7.2 7.6 8.0 8.4 8.9 9.4 9.9 10.4 11.0 11.5 12.1 12.6 13.2 13.8 14.3 14.9 15.5 16.1
2.5 6.7 7.0 7.4 7.7 8.1 8.5 9.0 9.4 9.9 10.4 10.9 11.4 12.0 12.5 13.1 13.6 14.2 14.8 15.3 15.9 16.5
2.75 7.3 7.6 8.0 8.3 8.7 9.1 9.5 10.0 10.4 10.9 11.4 11.9 12.4 13.0 13.5 14.1 14.6 15.2 15.8 16.3 16.9
3 7.9 8.2 8.5 8.9 9.3 9.7 10.1 10.5 11.0 11.4 11.9 12.4 12.9 13.5 14.0 14.5 15.1 15.7 16.2 16.8 17.4
3.25 8.5 8.8 9.1 9.5 9.9 10.2 10.7 11.1 11.5 12.0 12.5 12.9 13.5 14.0 14.5 15.0 15.6 16.1 16.7 17.2 17.8
3.5 9.1 9.4 9.7 10.1 10.4 10.8 11.2 11.7 12.1 12.5 13.0 13.5 14.0 14.5 15.0 15.5 16.1 16.6 17.1 17.7 18.3
3.75 9.7 10.0 10.3 10.7 11.0 11.4 11.8 12.2 12.7 13.1 13.6 14.0 14.5 15.0 15.5 16.0 16.6 17.1 17.6 18.2 18.7
4 10.3 10.6 10.9 11.3 11.6 12.0 12.4 12.8 13.2 13.7 14.1 14.6 15.1 15.5 16.0 16.5 17.1 17.6 18.1 18.7 19.2
4.25 10.9 11.2 11.5 11.9 12.2 12.6 13.0 13.4 13.8 14.2 14.7 15.1 15.6 16.1 16.6 17.1 17.6 18.1 18.6 19.2 19.7
4.5 11.5 11.8 12.2 12.5 12.8 13.2 13.6 14.0 14.4 14.8 15.3 15.7 16.2 16.6 17.1 17.6 18.1 18.6 19.1 19.7 20.2
4.75 12.1 12.4 12.8 13.1 13.4 13.8 14.2 14.6 15.0 15.4 15.8 16.3 16.7 17.2 17.7 18.1 18.6 19.1 19.7 20.2 20.7
5 12.7 13.1 13.4 13.7 14.1 14.4 14.8 15.2 15.6 16.0 16.4 16.8 17.3 17.7 18.2 18.7 19.2 19.7 20.2 20.7 21.2
Table 7.12: 3D margin calculated for Mm,i = 0 mm and MA,i = ±1.0 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 2.6 3.2 3.7 4.3 4.9 5.5 6.1 6.8 7.4 8.0 8.6 9.2 9.8 10.5 11.1 11.7 12.3 12.9 13.6 14.2 14.8
0.25 2.9 3.3 3.9 4.4 5.0 5.6 6.2 6.8 7.4 8.0 8.6 9.3 9.9 10.5 11.1 11.7 12.3 13.0 13.6 14.2 14.8
0.5 3.3 3.7 4.1 4.6 5.2 5.7 6.3 6.9 7.5 8.1 8.7 9.3 9.9 10.6 11.2 11.8 12.4 13.0 13.6 14.3 14.9
0.75 3.7 4.1 4.5 5.0 5.5 6.0 6.5 7.1 7.7 8.3 8.9 9.5 10.1 10.7 11.3 11.9 12.5 13.1 13.7 14.3 15.0
1 4.2 4.5 4.9 5.3 5.8 6.3 6.8 7.4 7.9 8.5 9.1 9.7 10.3 10.9 11.5 12.1 12.7 13.3 13.9 14.5 15.1
1.25 4.7 5.0 5.4 5.8 6.2 6.7 7.2 7.7 8.2 8.8 9.4 9.9 10.5 11.1 11.7 12.3 12.9 13.5 14.1 14.7 15.3
1.5 5.1 5.5 5.8 6.2 6.6 7.1 7.6 8.1 8.6 9.1 9.7 10.3 10.8 11.4 12.0 12.6 13.2 13.8 14.4 15.0 15.6
1.75 5.6 6.0 6.3 6.7 7.1 7.5 8.0 8.5 9.0 9.5 10.1 10.6 11.2 11.7 12.3 12.9 13.5 14.1 14.7 15.3 15.9
2 6.2 6.5 6.8 7.2 7.6 8.0 8.5 8.9 9.4 10.0 10.5 11.0 11.6 12.1 12.7 13.3 13.8 14.4 15.0 15.6 16.2
2.25 6.7 7.0 7.4 7.7 8.1 8.5 9.0 9.4 9.9 10.4 10.9 11.4 12.0 12.5 13.1 13.6 14.2 14.8 15.4 15.9 16.5
2.5 7.2 7.6 7.9 8.3 8.6 9.0 9.5 9.9 10.4 10.9 11.4 11.9 12.4 12.9 13.5 14.0 14.6 15.2 15.7 16.3 16.9
2.75 7.8 8.1 8.4 8.8 9.2 9.6 10.0 10.4 10.9 11.4 11.8 12.4 12.9 13.4 13.9 14.5 15.0 15.6 16.2 16.7 17.3
3 8.4 8.7 9.0 9.3 9.7 10.1 10.5 11.0 11.4 11.9 12.3 12.8 13.3 13.9 14.4 14.9 15.5 16.0 16.6 17.1 17.7
3.25 8.9 9.2 9.6 9.9 10.3 10.7 11.1 11.5 11.9 12.4 12.9 13.3 13.8 14.3 14.9 15.4 15.9 16.5 17.0 17.6 18.1
3.5 9.5 9.8 10.1 10.5 10.8 11.2 11.6 12.0 12.5 12.9 13.4 13.9 14.3 14.8 15.3 15.9 16.4 16.9 17.5 18.0 18.6
3.75 10.1 10.4 10.7 11.1 11.4 11.8 12.2 12.6 13.0 13.5 13.9 14.4 14.9 15.3 15.8 16.4 16.9 17.4 17.9 18.5 19.0
4 10.7 11.0 11.3 11.6 12.0 12.4 12.8 13.2 13.6 14.0 14.5 14.9 15.4 15.9 16.4 16.9 17.4 17.9 18.4 19.0 19.5
4.25 11.3 11.6 11.9 12.2 12.6 12.9 13.3 13.7 14.1 14.6 15.0 15.5 15.9 16.4 16.9 17.4 17.9 18.4 18.9 19.4 20.0
4.5 11.8 12.2 12.5 12.8 13.2 13.5 13.9 14.3 14.7 15.1 15.6 16.0 16.5 16.9 17.4 17.9 18.4 18.9 19.4 19.9 20.5
4.75 12.4 12.8 13.1 13.4 13.8 14.1 14.5 14.9 15.3 15.7 16.1 16.6 17.0 17.5 17.9 18.4 18.9 19.4 19.9 20.4 21.0
5 13.0 13.4 13.7 14.0 14.4 14.7 15.1 15.5 15.9 16.3 16.7 17.1 17.6 18.0 18.5 19.0 19.4 19.9 20.4 21.0 21.5
Table 7.13: 3D margin calculated for Mm,i = 0 mm and MA,i = ±1.5 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 3.5 4.0 4.6 5.2 5.8 6.4 7.0 7.6 8.2 8.8 9.4 10.0 10.7 11.3 11.9 12.5 13.1 13.7 14.4 15.0 15.6
0.25 3.8 4.2 4.7 5.3 5.8 6.4 7.0 7.6 8.2 8.8 9.4 10.1 10.7 11.3 11.9 12.5 13.1 13.8 14.4 15.0 15.6
0.5 4.2 4.5 5.0 5.5 6.0 6.6 7.2 7.7 8.3 8.9 9.5 10.1 10.7 11.4 12.0 12.6 13.2 13.8 14.4 15.0 15.7
0.75 4.6 4.9 5.3 5.8 6.3 6.8 7.4 7.9 8.5 9.1 9.7 10.3 10.9 11.5 12.1 12.7 13.3 13.9 14.5 15.1 15.7
1 5.0 5.3 5.7 6.2 6.6 7.1 7.6 8.2 8.7 9.3 9.9 10.4 11.0 11.6 12.2 12.8 13.4 14.0 14.6 15.2 15.9
1.25 5.4 5.8 6.1 6.6 7.0 7.5 8.0 8.5 9.0 9.6 10.1 10.7 11.3 11.8 12.4 13.0 13.6 14.2 14.8 15.4 16.0
1.5 5.9 6.2 6.6 7.0 7.4 7.8 8.3 8.8 9.3 9.9 10.4 11.0 11.5 12.1 12.7 13.3 13.8 14.4 15.0 15.6 16.2
1.75 6.4 6.7 7.0 7.4 7.8 8.3 8.7 9.2 9.7 10.2 10.7 11.3 11.8 12.4 13.0 13.5 14.1 14.7 15.3 15.9 16.5
2 6.9 7.2 7.5 7.9 8.3 8.7 9.2 9.6 10.1 10.6 11.1 11.6 12.2 12.7 13.3 13.9 14.4 15.0 15.6 16.2 16.8
2.25 7.4 7.7 8.0 8.4 8.8 9.2 9.6 10.1 10.5 11.0 11.5 12.0 12.6 13.1 13.7 14.2 14.8 15.3 15.9 16.5 17.1
2.5 7.9 8.2 8.5 8.9 9.3 9.7 10.1 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.6 15.2 15.7 16.3 16.8 17.4
2.75 8.4 8.7 9.0 9.4 9.8 10.2 10.6 11.0 11.5 11.9 12.4 12.9 13.4 13.9 14.5 15.0 15.5 16.1 16.7 17.2 17.8
3 8.9 9.2 9.6 9.9 10.3 10.7 11.1 11.5 12.0 12.4 12.9 13.4 13.9 14.4 14.9 15.4 16.0 16.5 17.1 17.6 18.2
3.25 9.5 9.8 10.1 10.5 10.8 11.2 11.6 12.0 12.5 12.9 13.4 13.8 14.3 14.8 15.3 15.9 16.4 16.9 17.5 18.0 18.6
3.5 10.0 10.3 10.7 11.0 11.4 11.7 12.1 12.5 13.0 13.4 13.9 14.3 14.8 15.3 15.8 16.3 16.8 17.4 17.9 18.5 19.0
3.75 10.6 10.9 11.2 11.6 11.9 12.3 12.7 13.1 13.5 13.9 14.4 14.8 15.3 15.8 16.3 16.8 17.3 17.8 18.4 18.9 19.4
4 11.1 11.5 11.8 12.1 12.5 12.8 13.2 13.6 14.0 14.5 14.9 15.4 15.8 16.3 16.8 17.3 17.8 18.3 18.8 19.4 19.9
4.25 11.7 12.0 12.3 12.7 13.0 13.4 13.8 14.2 14.6 15.0 15.4 15.9 16.3 16.8 17.3 17.8 18.3 18.8 19.3 19.8 20.4
4.5 12.3 12.6 12.9 13.2 13.6 14.0 14.3 14.7 15.1 15.5 16.0 16.4 16.9 17.3 17.8 18.3 18.8 19.3 19.8 20.3 20.8
4.75 12.9 13.2 13.5 13.8 14.2 14.5 14.9 15.3 15.7 16.1 16.5 17.0 17.4 17.9 18.3 18.8 19.3 19.8 20.3 20.8 21.3
5 13.4 13.7 14.1 14.4 14.7 15.1 15.5 15.9 16.2 16.7 17.1 17.5 17.9 18.4 18.9 19.3 19.8 20.3 20.8 21.3 21.8
Table 7.14: 3D margin calculated for Mm,i = 0 mm and MA,i = ±2.0 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 4.3 4.9 5.5 6.0 6.6 7.2 7.8 8.4 9.0 9.6 10.2 10.9 11.5 12.1 12.7 13.3 13.9 14.6 15.2 15.8 16.4
0.25 4.7 5.1 5.6 6.1 6.7 7.3 7.9 8.5 9.1 9.7 10.3 10.9 11.5 12.1 12.7 13.3 14.0 14.6 15.2 15.8 16.4
0.5 5.0 5.4 5.8 6.3 6.9 7.4 8.0 8.6 9.2 9.8 10.4 11.0 11.6 12.2 12.8 13.4 14.0 14.6 15.2 15.8 16.5
0.75 5.4 5.8 6.2 6.6 7.1 7.7 8.2 8.8 9.3 9.9 10.5 11.1 11.7 12.3 12.9 13.5 14.1 14.7 15.3 15.9 16.5
1 5.8 6.2 6.6 7.0 7.4 7.9 8.5 9.0 9.5 10.1 10.7 11.2 11.8 12.4 13.0 13.6 14.2 14.8 15.4 16.0 16.6
1.25 6.2 6.6 7.0 7.4 7.8 8.3 8.8 9.3 9.8 10.3 10.9 11.5 12.0 12.6 13.2 13.8 14.4 15.0 15.6 16.2 16.8
1.5 6.7 7.0 7.4 7.8 8.2 8.6 9.1 9.6 10.1 10.6 11.2 11.7 12.3 12.9 13.4 14.0 14.6 15.2 15.8 16.4 17.0
1.75 7.1 7.5 7.8 8.2 8.6 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.6 13.1 13.7 14.3 14.8 15.4 16.0 16.6 17.2
2 7.6 7.9 8.3 8.6 9.0 9.5 9.9 10.4 10.8 11.3 11.8 12.4 12.9 13.4 14.0 14.6 15.1 15.7 16.3 16.8 17.4
2.25 8.1 8.4 8.7 9.1 9.5 9.9 10.3 10.8 11.2 11.7 12.2 12.7 13.3 13.8 14.3 14.9 15.4 16.0 16.6 17.1 17.7
2.5 8.6 8.9 9.2 9.6 10.0 10.4 10.8 11.2 11.7 12.1 12.6 13.1 13.6 14.2 14.7 15.2 15.8 16.3 16.9 17.5 18.0
2.75 9.1 9.4 9.7 10.1 10.4 10.8 11.2 11.7 12.1 12.6 13.1 13.5 14.0 14.6 15.1 15.6 16.2 16.7 17.3 17.8 18.4
3 9.6 9.9 10.2 10.6 10.9 11.3 11.7 12.1 12.6 13.0 13.5 14.0 14.5 15.0 15.5 16.0 16.5 17.1 17.6 18.2 18.7
3.25 10.1 10.4 10.7 11.1 11.5 11.8 12.2 12.6 13.1 13.5 14.0 14.4 14.9 15.4 15.9 16.4 17.0 17.5 18.0 18.6 19.1
3.5 10.6 10.9 11.3 11.6 12.0 12.3 12.7 13.1 13.6 14.0 14.5 14.9 15.4 15.9 16.4 16.9 17.4 17.9 18.5 19.0 19.5
3.75 11.2 11.5 11.8 12.1 12.5 12.9 13.3 13.7 14.1 14.5 14.9 15.4 15.9 16.3 16.8 17.3 17.8 18.4 18.9 19.4 20.0
4 11.7 12.0 12.3 12.7 13.0 13.4 13.8 14.2 14.6 15.0 15.4 15.9 16.4 16.8 17.3 17.8 18.3 18.8 19.3 19.9 20.4
4.25 12.2 12.6 12.9 13.2 13.6 13.9 14.3 14.7 15.1 15.5 16.0 16.4 16.9 17.3 17.8 18.3 18.8 19.3 19.8 20.3 20.8
4.5 12.8 13.1 13.4 13.8 14.1 14.5 14.8 15.2 15.6 16.1 16.5 16.9 17.4 17.8 18.3 18.8 19.3 19.8 20.3 20.8 21.3
4.75 13.4 13.7 14.0 14.3 14.7 15.0 15.4 15.8 16.2 16.6 17.0 17.4 17.9 18.3 18.8 19.3 19.8 20.2 20.7 21.2 21.8
5 13.9 14.2 14.6 14.9 15.2 15.6 16.0 16.3 16.7 17.1 17.5 18.0 18.4 18.9 19.3 19.8 20.3 20.7 21.2 21.7 22.2
Table 7.15: 3D margin calculated for Mm,i = 0 mm and MA,i = ±2.5 mm. Values of Σm and ΣA are given in mm.
ΣA
Σm 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3 3.25 3.5 3.75 4 4.25 4.5 4.75 5
0 5.2 5.8 6.3 6.9 7.5 8.1 8.7 9.3 9.9 10.5 11.1 11.7 12.3 12.9 13.5 14.1 14.7 15.4 16.0 16.6 17.2
0.25 5.5 5.9 6.4 7.0 7.5 8.1 8.7 9.3 9.9 10.5 11.1 11.7 12.3 12.9 13.5 14.2 14.8 15.4 16.0 16.6 17.2
0.5 5.9 6.3 6.7 7.2 7.7 8.3 8.8 9.4 10.0 10.6 11.2 11.8 12.4 13.0 13.6 14.2 14.8 15.4 16.0 16.7 17.3
0.75 6.3 6.6 7.0 7.5 8.0 8.5 9.0 9.6 10.2 10.7 11.3 11.9 12.5 13.1 13.7 14.3 14.9 15.5 16.1 16.7 17.3
1 6.6 7.0 7.4 7.8 8.3 8.8 9.3 9.8 10.4 10.9 11.5 12.1 12.7 13.2 13.8 14.4 15.0 15.6 16.2 16.8 17.4
1.25 7.1 7.4 7.8 8.2 8.6 9.1 9.6 10.1 10.6 11.2 11.7 12.3 12.8 13.4 14.0 14.6 15.2 15.8 16.4 17.0 17.6
1.5 7.5 7.8 8.2 8.6 9.0 9.5 9.9 10.4 10.9 11.4 12.0 12.5 13.1 13.6 14.2 14.8 15.4 16.0 16.5 17.1 17.7
1.75 7.9 8.3 8.6 9.0 9.4 9.8 10.3 10.8 11.3 11.8 12.3 12.8 13.4 13.9 14.5 15.0 15.6 16.2 16.8 17.3 17.9
2 8.4 8.7 9.0 9.4 9.8 10.2 10.7 11.1 11.6 12.1 12.6 13.1 13.7 14.2 14.7 15.3 15.9 16.4 17.0 17.6 18.2
2.25 8.8 9.2 9.5 9.9 10.3 10.7 11.1 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.1 15.6 16.2 16.7 17.3 17.9 18.4
2.5 9.3 9.6 10.0 10.3 10.7 11.1 11.5 12.0 12.4 12.9 13.4 13.9 14.4 14.9 15.4 15.9 16.5 17.0 17.6 18.2 18.7
2.75 9.8 10.1 10.4 10.8 11.2 11.6 12.0 12.4 12.8 13.3 13.8 14.3 14.7 15.3 15.8 16.3 16.8 17.4 17.9 18.5 19.0
3 10.3 10.6 10.9 11.3 11.6 12.0 12.4 12.9 13.3 13.7 14.2 14.7 15.2 15.7 16.2 16.7 17.2 17.7 18.3 18.8 19.4
3.25 10.8 11.1 11.4 11.8 12.1 12.5 12.9 13.3 13.7 14.2 14.6 15.1 15.6 16.1 16.6 17.1 17.6 18.1 18.7 19.2 19.7
3.5 11.3 11.6 11.9 12.3 12.6 13.0 13.4 13.8 14.2 14.7 15.1 15.6 16.0 16.5 17.0 17.5 18.0 18.5 19.1 19.6 20.1
3.75 11.8 12.1 12.4 12.8 13.1 13.5 13.9 14.3 14.7 15.1 15.6 16.0 16.5 17.0 17.4 17.9 18.4 19.0 19.5 20.0 20.5
4 12.3 12.6 13.0 13.3 13.7 14.0 14.4 14.8 15.2 15.6 16.1 16.5 17.0 17.4 17.9 18.4 18.9 19.4 19.9 20.4 20.9
4.25 12.9 13.2 13.5 13.8 14.2 14.5 14.9 15.3 15.7 16.1 16.5 17.0 17.4 17.9 18.4 18.9 19.3 19.8 20.3 20.9 21.4
4.5 13.4 13.7 14.0 14.4 14.7 15.1 15.4 15.8 16.2 16.6 17.1 17.5 17.9 18.4 18.8 19.3 19.8 20.3 20.8 21.3 21.8
4.75 13.9 14.2 14.6 14.9 15.2 15.6 16.0 16.3 16.7 17.1 17.6 18.0 18.4 18.9 19.3 19.8 20.3 20.8 21.3 21.8 22.3
5 14.5 14.8 15.1 15.4 15.8 16.1 16.5 16.9 17.3 17.7 18.1 18.5 18.9 19.4 19.8 20.3 20.8 21.3 21.7 22.2 22.7
Table 7.16: 3D margin calculated for Mm,i = 0 mm and MA,i = ±3.0 mm. Values of Σm and ΣA are given in mm.
Chapter 8
Summary
The presented work aimed to study an influence of patient setup errors on the radiotherapy
process and distribution of received dose. Performed studies evaluated parametrization of pop-
ulation of patients’ setup error, estimation of cumulative dose distribution, off-line verification
protocols and CTV-PTV margins.
I started with analyzing two different clinical datasets of setup errors for prostate cancer
treatments in Chapter 3. A group of 100 patients was treated in COI and their setup errors
were defined on the basis of bony anatomy in 25 fractions treatment. The second group of
patients was treated in Erasmus MC and consisted of 835 patients with 39 fractions treatment.
The setup errors of these patients were acquired on the basis of gold fiducials implanted into
the prostate. To the best of my knowledge this is the largest analyzed database for prostate
cancer treatment. For both groups of patients the distribution of setup errors did not have a
Gaussian distribution. That finding was in agreement with [51]. Evaluation was done to check
whether this non-Gaussian distribution of setup errors may be attributed to inter-fraction time
trends. As in radiotherapy there is always a finite number of fractions some trend can always
be fitted to measured setup errors, even if there would be no trend in case of infinite fraction
number. The test was provided to check probability that observed trends have a physiological
and not statistical nature — see Section 3.6.
Many groups showed existence of inter-fraction time trends for different cancer sites [23, 29,
37, 67, 72, 83, 87, 93]. Therefore I decided to check ability of currently mostly applied con-
ventional parametrization of population of patients’ setup error to reproduce the original data
(ground truth) and to reproduce behaviour of original data in case the offline verification proto-
col (NAL or eNAL) would be applied. The results showed that the conventional parametrization
method overestimates performance of NAL off-line verification protocol for populations of pa-
tients experiencing inter-fraction time trends. The alternative trendline parametrization was
also examined — see Chapter 4. It was shown that trendline parametrization can correctly
describe population of patients experiencing time trends as well as their behaviour after ap-
plication of verification protocols. Usage of a wrong parametrization for data evaluation may
lead to overestimation of Σres and, in consequence, too small CTV-PTV margins. That is why
it is of crucial importance to evaluate datasets in terms of inter-fraction setup errors existence
and apply an appropriate parametrization. Currently investigated concepts of probability and
margin-less planning are based on conventional parametrization [5, 27, 28]. Implementing a
trendline parametrization for that purpose should be considered.
Currently used methods of CTV-PTV margin calculation [90] as well as methods used in
probability and margin-less planning [5, 27, 28] are based on the cumulative dose distribution.
168 8 Summary
This cumulative dose distribution is estimated based on population parametrization. In Chap-
ter 5 a novel method of estimating the cumulative patient dose distribution per patient was
investigated. It has been shown that depending on RT technique, after first few fractions a
patient specific estimation of cumulative dose distribution can be performed. That result can
be used in several ways. First of all, it is quite easy to implement it to a clinical usage without
the need of TPS change. Such implementation can improve methods of adaptive radiotherapy
as a new plan can be generated on the basis of the estimated cumulative dose. Secondly, this
approach can be also used in patient-specific probabilistic or margin-less planning.
In clinical practice it can be seen that for some patients undergoing radiotherapy an on-line
verification is required even if it is not a part of procedure. Currently applied NAL protocol
does not consider such patients. In NAL protocol all patients have exactly the same number of
fractions with imaging. The quality of NAL performance depends on estimation of mean setup
error done after first few fractions (usually 3 or 4). The new iNAL protocol was proposed in order
to distinguish patients with potentially erroneous estimation of mean setup error (Chapter 6).
In the iNAL protocol the number of fractions with imaging is individualized. Still, the average
number of fractions with imaging can be as low as four. The proposed iNAL protocol was
compared with NAL and iNAL protocols. The change in distribution of residual systematic
errors showed that indeed problematic patients (large movers) can be distinguished. It was
shown that with the same or even smaller margins, calculated on the basis of van Herk recipe,
bigger group of large movers would have CTV within the margin.
Currently in clinical practice van Herk recipe is mostly used for CTV-PTV margin cal-
culation. This recipe is based on the conventional parametrization of population of patients’
setup error and therefore leads to too small margins for patients experiencing inter-fraction
time trends. For big time trends even all the patients have at least one trendline error outside
the margin. In chapter Chapter 7, the previously presented trendline parametrization was used
to propose a new margin recipe. The proposed formalism of margin calculation guarantees that
assumed number of patients outside the margin (usually 90%) is met. In case of no time trends
the proposed recipe simplifies to van Herk’s one. Three alternative methods of calculating
margin with new recipe were presented: direct equation, Python code and look-up tables.
It can be concluded that aim of presented studies was reached. Analysis of large group of
patients showed problems with currently applied methods. Solutions to overcome this problems
were proposed and evaluated. Simple methods of radiotherapy individualization were also
investigated. The proposed iNAL offline verification protocol can be applied without increase
in workload. Presented method of patient-specific estimation of cumulative dose distribution
does not require new TPS systems or algorithms.
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